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 Summary 
 
Iturin A, an antifungal lipopeptide, is produced by Bacillus subtilis. This cyclic peptide 
consists of seven D- and L-α-amino acid residues (L-Asn2-D-Tyr3-D-Asn4-L-Gln5-L-Pro6-D-
Asn7-L-Ser8) and a β-amino fatty acid residue. Eight analogues of iturin A2 were synthesised 
and purified by high performance chromatography (HPLC). Electrospray ionisation mass 
spectrometry (ESI-MS), amino acid analysis and HPLC confirmed high chemical purity of the 
synthetic products. The influence of primary structure on conformation, hydrophobicity, 
interaction with alkali metal ions and bioactivity was investigated using the purified peptides. 
Two low energy in vacuo structures of a linear iturin A2 analogue (8-Beta), one with a 
distorted W-backbone structure and one with a twisted S-backbone structure, were predicted 
with HyperChem®4.5. Nuclear magnetic resonance spectrometry confirmed the existence of 
two slow interconverting conformations, possibly a W↔S equilibrium. The predicted S-
structure of 8-Beta includes two turns that approximate β-turns. In natural iturin A, the same 
two peptide moieties, β-aminotetradecanoyl-L-Asn2-D-Tyr3-D-Asn4 and L-Gln5-L-Pro6-D-
Asn7-L-Ser8, each adopt a type II β-turn conformation. ESI-MS fragmentation patterns of 
sodiated 8-Beta indicated that the sodium interacts with the majority of the amide bond 
oxygens in the predicted turns. The linear peptides associated with either one or two alkali 
metal ions, while the cyclic analogues associated only with one ion. The alkali metal ion 
selectivity sequence of all the lipopeptides was Na+>K+>Rb+, indicating a size limitation in 
interaction cavities. Iturin A possibly has a direct interaction with alkali metal ions and it is 
proposed that these ions are chelated by the carbonyl oxygens in either one of the two β-turns 
of natural iturin A. 
It was found that the more hydrophobic the iturin A2 analogue, the better it interacted with 
lipid membranes and octadecanoylsilane matrices (HPLC retention), except if it had a high 
tendency to aggregate in solution. Aggregation in the membrane is part of iturin A’s 
mechanism of action. It is proposed that solution-phase aggregates are not the active form of 
iturin A as the lipopeptide preparations, which self-aggregated in solution, lost their 
antibacterial activity. Circular dichroism (CD) spectra of the peptides in liposomes revealed 
the possibility of type II β-turns in all the octalipopeptides. There is, however, a marked 
difference between the overall cyclic and linear structures in membranes, although 
diastereomers, differing in configuration of β-aminotetradecanoic acid (β-NC14) residue, had 
Stellenbosch University http://scholar.sun.ac.za
 iv
similar structures. The possibility of self-assembly of synthetic iturin A2 in antiparallel β-
sheets was also indicated by CD. 
Haemolytic activity of the iturin A2 analogues depended on cyclisation, inclusion of L-Asn2 
and β-NC14 configuration. This activity is possibly stereoselective as synthetic iturin A2 and 
its linear analogue were the most haemolytic. Growth inhibition of Micrococcus luteus mainly 
depended on hydrophobic interaction and not on cyclisation or configuration of the β-NC14 
residue, therefore this activity differs in mechanism of action from that of haemolysis. Lysis of 
M. luteus protoplasts, however, decreased with decrease in peptide length: 8-Beta>7-Beta>6-
Beta. The activity against Botrytis cinerea depended mainly on cyclisation. The hydrophobic 
hub, formed by the invariant Tyr residue and the β-NC14 residue, is a possible key to 
antifungal activity. This hub is absent in the predicted S-structure of 8-Beta and may be 
influenced in cyclic 8-Beta and shorter analogues by the configuration of the β-NC14 residue, 
resulting in good overall bioactivity of only the synthetic iturin A2.  
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Opsomming 
 
 
Iturin A, ’n antifungiese lipopeptied, word deur Bacillus subtilis geproduseer. Hierdie sikliese 
peptied bestaan uit sewe D- en L-α-aminosuurresidue (L-Asn2-D-Tyr3-D-Asn4-L-Gln5-L-Pro6-
D-Asn7-L-Ser8) en ’n β-aminovetsuurresidu. Agt analoë van iturin A2 is gesintetiseer en 
m.b.v. hoë doeltreffendheid chromatografie (HPLC) gesuiwer. Die hoë chemiese suiwerheid 
van die sintetiese produkte is deur elektrosproei-ionisasie massaspektrometrie (ESI-MS), 
aminosuuranalise en HPLC bevestig. Die gesuiwerde peptiede is gebruik om die invloed van 
primêre struktuur op konformasie, hidrofobisiteit, interaksie met alkalimetaal-ione en 
bioaktiwiteit te ondersoek. 
Twee lae-energie in vacuo strukture van die lineêre iturin A2 analoog (8-Beta), een met ‘n  
verwronge W-ruggraatstruktuur en een met ’n gedraaide S-ruggraatstruktuur, is deur 
HyperChem®4.5 voorspel. Kernmagnetiese resonansspektrometrie het die bestaan van twee 
interomskakelende konformasies bevestig, moontlik ’n W↔S ewewig. Die voorspelde S-
struktuur van 8-Beta bevat twee draaie wat neig na β-draaie. Dieselfde twee peptiedeenhede, 
β-aminotetradekanoiël-L-Asn2-D-Tyr3-D-Asn4 en L-Gln5-L-Pro6-D-Asn7-L-Ser8, neem elk ’n 
tipe II β-draai konformasie in die natuurlike iturin A aan. ESI-MS fragmentasiepatrone van 
die 8-Beta natruimaddukte het aangedui dat die natriumione met die meeste van die 
amiedbinding-suurstowwe in die voorspelde draaie interaksie het. Die lineêre peptiede het met 
een of twee alkalimetaal-ione geassosieer, terwyl die sikliese analoë slegs met een ioon 
geassosieer het. Al die lipopeptiede se alkalimetaal-ioon selektiwiteitsvolgorde was 
Na+>K+>Rb+, wat aandui dat daar ’n grootte limiet is in die interaksieholtes. Iturin A het 
moontlik ’n direkte interaksie met alkalimetaal-ione en dit word voorgestel dat hierdie ione 
deur die karbonielsuurstowwe in enige een van die twee β-draaie van natuurlike iturin A 
gechelateer word. 
Daar is gevind dat hoe meer hidrofobies die iturin A2 analoog is, hoe beter is die interaksie 
daarvan met lipiedmembrane en oktadekanoïelsilaanmatrikse (HPLC retensie), behalwe as dit 
’n groot tendens het om in oplossing te aggregeer. Aggregasie in die membraan is deel van 
iturin A se meganisme van aksie. Daar word voorgestel dat die aggregate in oplossing nie die 
aktiewe vorm van iturin A is nie, omdat die lipopeptiedpreparate wat in oplossing 
selfaggregeer antibakteriële aktiwiteit verloor. Sirkulêre dichroïsme (CD) spektra van die 
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peptiede in liposome het die moontlikheid van tipe II β-draaie in al die oktalipopeptiede 
uitgewys. Alhoewel daar merkbare verskille tussen die totale sikliese en lineêre strukture in 
die membrane voorgekom het, was die diastereomere, wat  verskil  t.o.v.  konfigurasie  van  
β-aminotetradekanoësuurresidu (β-NC14), se strukture baie dieselfde. Die moontlikheid van 
selfverpakking van sintetiese iturin A2 in antiparallele β-plate is ook deur CD aangedui. 
Hemolitiese aktiwiteit van die iturin A2 analoë het afgehang van siklisering, die insluiting van 
L-Asn2 en die β-NC14-konfigurasie. Hemolise is moontlik stereoselektief want sintetiese iturin 
A2 en sy lineêre analoog was die aktiefste. Groei-inhibisie van Micrococcus luteus het 
hoofsaaklik afgehang van hidrofobiese interaksie en nie van siklisering of die konfigurasie 
van die β-NC14-residu nie, dus verskil hierdie aktiwiteit in meganisme van aksie van diè van 
hemolise. Die lise van M. luteus protoplaste daarenteen neem af met verkorting van 
peptiedketting: 8-Beta>7-Beta>6-Beta. Die aktiwiteit teen Botrytis cinerea het hoofsaaklik 
afgehang van siklisering. Die hidrofobiese eenheid, gevorm deur die invariante Tyr-residu en 
die β-NC14-residu, is ’n moontlike sleutel tot die antifungiese aktiwiteit. Hierdie eenheid is 
afwesig in die voorspelde S-struktuur van 8-Beta en mag ook in die sikliese 8-Beta en korter 
analoë beïnvloed word deur die konfigurasie van die β-NC14-residu, wat lei tot goeie 
algemene bioaktiwiteit van slegs die sintetiese iturin A2.  
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Preface 
 
About 50 years ago in the Belgium Congo a scientist collected a soil sample. This sample 
harboured a treasure-trove of microscopic organisms. One such treasure was a new strain of 
Bacillus subtilis, which produced cyclic lipopeptides that inhibit fungal growth. These 
compounds were called iturins; many of them were isolated and characterised during the 
following years, and some were even tested in clinical trails, patented and used as 
biofungicides. This long history of research included structure-function studies which lead to 
a partial elucidation of their mechanism of action, particularly that of iturin A. All but one of 
these studies used natural iturins, leaving open a whole spectrum of possibilities for using 
synthetic analogues of iturin A for structure-function studies. 
This thesis describes how some of these possibilities were exploited by synthesising analogues 
of iturin A2 and characterising them in terms of their chemical and biological nature. First, a 
short overview of the history of iturins is given in Chapter 1. The following five chapters 
describe the experimental results obtained in this study. To ease future publication, each of 
these chapters were written with an article format in mind and form, to a degree, independent 
units. Although some repetition is unavoidable, it has been kept to a minimum. In the final 
chapter the results of this study are related to iturin A’s mechanism of action. 
In short, the aim of this Ph.D. project was to propose a more detailed mechanism of action of 
iturin A. To achieve this, the following objectives were set: 
• the synthesis, purification and chemical characterisation of eight iturin A2 analogues 
(Chapters 2 and 3); 
• structural investigation of octalipopeptide analogues of iturin A2, using nuclear magnetic 
resonance, circular dichroism and computer-assisted modelling (Chapter 4); 
• investigation, using electrospray ionisation mass spectrometry, of the influence of 
structure and chirality on the ability of the iturin A analogues to associate with alkali metal 
ions (Chapter 5); 
• investigation of the influence of structure and chirality of the iturin A2 analogues on 
hydrophobicity and biological activity (Chapter 6). 
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Before any of these objectives could be met, a peptide synthesis facility and techniques 
necessary for the purification and analysis of peptides had to be established. In this we were so 
successful that our facility currently has the ability to synthesise high purity peptides on a 
regular basis for research purposes and commercial use. A number of new techniques, 
especially those related to the investigation of biological activity, were also developed. This 
project helped to lay the foundation for three other current projects, all around the central 
theme of antimicrobial peptides. 
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Chapter 1  
The iturins: Cyclic antimicrobial peptides 
 produced by Bacillus subtilis 
1.1 Introduction 
In a world laden with bacteria, fungi and parasites, many strategies of defence have evolved 
among the living organisms in the fight for survival. One of the weapons in this repertoire of 
host defence mechanisms is a group of peptides with antimicrobial activity. Although most of 
these peptides share functional similarities, such as interacting in some way with a target cell 
membrane, wide structural diversity exists among these peptides. The antimicrobial peptides 
consist of between 5 and 50 residues and are either cyclic, linear or contain disulphide bonds. 
Many of these peptides, contain only the natural L-amino acids, while others contain highly 
modified and non-amino acid residues. Among this chemical diversity these peptides share 
one important feature namely, an amphipathic character enabling them to interact with both 
non-polar lipids and the aqueous environment. 
Many microorganisms produce antimicrobial peptides, as the excretion of an antibiotic 
obviously provides a competitive advantage to the producing microorganism. Some of these 
organisms have been very successful in the fight for survival, such as the archaic soil 
bacterium Bacillus subtilis that has been around for millennia. B. subtilis produces, depending 
on environmental pressures, many different cyclic peptides with antimicrobial activity, and 
especially, broad spectrum antifungal activity. These cyclic peptides include mycobacillin [1], 
subsporins [2], fungistatin [3], bacilysin [4], fengimycin [4], surfactin [5] and a group of 
peptides collectively known as the iturins [6-24]. The iturins will be discussed in the rest of 
this chapter with specific emphasis on iturin A, the focus of this thesis. 
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1.2 The iturins−an overview 
One of the iturins, iturin A, was the active compound in some of the first antibiotic 
preparations from B. subtilis. In 1946 Johnson and Burdon [9] isolated eumycin from B. 
subtilis, which was active against pathogenic fungi. In 1950, Raubitschek and Dostrovsky [10] 
described an antibiotic, also isolated from B. subtilis cultures, that was active against 
dermatophytes. In 1952 Babad et al. [11] reported the isolation of bacillomycin R and in 1954 
Shibasaki and Terui [12] isolated bacillomycin B. In 1957 Delcambe and Devignat [13] 
described the properties of an antibiotic preparation from the cultures from a strain of B. 
subtilis isolated by Devignat in the Belgian Congo (presently the Democratic Republic of 
Congo). They called their preparation “iturine”, after the iturinic acid (β-amino fatty acid) 
found in the preparation. This preparation consisted of three compounds, A, B and C of which 
iturin A was the sole active agent [14]. In 1976 it was shown that eumycin, Raubitschek’s 
antibiotic, bacillomycin B and bacillomycin R were identical to iturin A [15]. To date eight 
peptide families in the iturin group have been isolated and characterised (Table 1.1) [6-24]. 
1.2.1 Structures 
The iturins have many structural features in common, such as a constant LDDLLDL chiral 
sequence of seven α-amino acids, a β-D-amino fatty acid residue and a cyclic structure closed 
by a lactam ring at the β-D-amino acid. All the iturins, except iturin C and bacillomycin F, 
contain an invariable tetrapeptide moiety, namely β-amino fatty acyl-L-Asn2-D-Tyr3-D-Asn4 
(Table 1.1). 
The three-dimensional structures of only two iturins, mycobacillin and iturin A, have been 
elucidated using nuclear magnetic resonance (NMR) spectroscopy and computer assisted 
molecular modelling [25, 26]. Although the only difference in primary structure between 
iturin A and mycosubtilin is the inversion of the D-Asn-L-Ser sequence to D-Ser-L-Asn in 
mycosubtilin, a striking difference in three-dimensional structure was found. 
Iturin A’s three-dimensional structure was originally proposed by Garbay-Jaureguiberry et al. 
[27] and refined by Marion et al. [25] (Fig. 1.1). The cyclic peptide structure of iturin A is 
stabilised by two type II β-turns in the two tetrapeptide units: β-amino fatty acyl-Asn2-D-Tyr3-
D-Asn4 (turn A) and L-Gln5-L-Pro6-D-Asn7-L-Ser8 (turn B). Turns A and B are linked by a 
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third turn, consisting of L-Asn2-D-Tyr3-D-Asn4-L-Gln5 (turn C), that could be classified as a 
type I’ or III’ β-turn or the beginning of a 310-helix. The hydrogen bonds are somewhat 
distorted in the turns, with the carboxyl oxygen of L-Gln5 acting as the hydrogen acceptor for 
the amino group of L-Ser8 and the amino group of the β-amino fatty acid, and the peptide 
bond amino group of L-Gln5 interacting with the carboxyl oxygen of L-Asn2. The peptide 
backbone of iturin A appears somewhat rigid with the polar side chains having a larger degree 
of freedom allowing interaction with the aqueous environment [25]. Also refer to Chapter 4 
for more information on iturin A’s structure. 
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Figure 1.1     The structure of iturin A. The dashed lines represent hydrogen bonds that 
stabilise the structure [25]. 
The structure of mycosubtilin contains a rigid C7-bend (γ-turn) involving L-Gln5-L-Pro6-D-
Ser7-L-Asn8 [26]. This bend allows the carboxyl group of D-Ser7 to form a hydrogen bond 
with its own hydroxyl group. In contrast, the region around the D-Tyr3 residue was found to 
be more flexible. The L-Gln5 side chain is exposed to the solvent [26] in contrast to its hidden 
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position in iturin A [25]. This difference in structure demonstrates the crucial role of sequence 
in conformation, and as we shall see, also in activity (discussed in section 1.2.4). 
 
Table 1.1      The primary structures of the eight different iturin A families. The shaded areas 
show the α-amino acid residues that are identical to that of iturin A 
(major β-amino acids = >30% of total content, n = normal; i = iso;  
a = ante-iso) 
 Major β-
amino 
fatty acids 
α-amino acid 
N                        position                        C 
 
 
Iturin family position  
1 
2  3 4 5 6 7 8 Refs. 
Iturin A n-C14, i-C15, a-C15 
L-Asn D-Tyr D-Asn L-Gln L-Pro D-Asn L-Ser 6, 14, 
16-18 
Iturin AL n-C16,i-C16, L-Asn D-Tyr D-Asn L-Gln L-Pro D-Asn L-Ser 6, 19 
Iturin C n-C14, i-C15, a-C15 
L-Asp D-Tyr D-Asn L-Gln L-Pro D-Asn L-Ser 6, 20 
Mycosubtilin i-C16, a-C17 L-Asn D-Tyr D-Asn L-Gln L-Pro D-Ser L-Asn 6, 21 
Bacillomycin F i-C16, i-C17, a-C17 
L-Asn D-Tyr D-Asn L-Gln L-Pro D-Asn L-Thr 6, 22 
Bacillomycin D n-C14, i-C15, a-C15 
L-Asn D-Tyr D-Asn L-Pro L-Gln D-Ser L-Thr 6, 23 
Bacillomycin L n-C14, i-C15, a-C15 
L-Asp D-Tyr D-Asn L-Ser L-Gln D-Ser L-Thr 6, 24 
Bacillopeptin/ 
Bacillomycin Lc 
n-C14,a-C15 
i-C15, i-C16 
L-Asn D-Tyr D-Asn L-Ser L-Glu D-Ser L-Thr 7, 8 
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1.2.2 Biosynthesis 
Many antibiotic peptides, including the iturins, contain non-protein constituents such as  
D-amino acids, β-amino acids, modified amino acids and unusual residues. The biosynthesis 
of most of these peptides is non-ribosomal and they are the metabolic end products of an 
enzymatic system that uses a thiotemplate multienzymic mechanism [28]. In this biosynthetic 
pathway the constituent residues are activated by ATP to form amino acyl-AMP 
(ATP/pyrophosphate exchange) on the enzymatic template. The amino acyl group is then 
coupled to specific template thiols; modifications, such as epimerisation occur at this stage. A 
phoshopanthetheine swinging arm in the multienzyme structure directs the elongation steps 
(including possible cyclisation or terminal modification reactions). None of the iturin 
synthetases have been fully characterised, except for two subunits of the iturin A synthetase. 
For the iturin A synthetase it was shown that subunit Its only activated L-Ser and the subunit 
ITagp activated L-Asn, D-Asn, L-Gln and L-Pro [29]. The precise mechanism and structure of 
the iturin A multienzyme system is still unknown. The excretion mechanism and storage of 
the iturins also have not been elucidated. 
The synthesis of antibiotics in the Bacillus species is regulated by mechanisms shared with 
starvation induced activities such as sporulation [30]. The production of bacillomycin L by  
B. subtilis NCIB 8872 takes place during the stationary phase and a direct correlation between 
sporulation and antibiotic production has been found [31]. Another factor is temperaturefor 
B. subtilis RB14, a duel producer of iturin A and surfactin, the optimal temperature for the 
production of iturin A was found to be 25oC, while 37oC gave the best yield of surfactin [32]. 
The carbon and nitrogen sources in the culture medium also have a strong influence on 
antibiotic production. For a bacillomycin F producer, B. subtilis I164, isoleucine was found to 
be a good carbon source for the biosynthesis of the branched (anteiso C17) β-amino fatty acid, 
and also enhanced bacillomycin F production [33]. In an iturin A producer, however, leucine 
was the better option for normal (n-C16) and branched (iso, anteiso C15) β-amino fatty acid 
biosynthesis and iturin A production [34]. The B. subtilis strains can consequently be divided 
into two groups, the first containing the producers of mycosubtilin and bacillomycin F, which 
synthesise high levels of the longer branched β-amino acids, and the second containing the 
producers of bacillomycin D, bacillomycin L and iturin A which synthesise predominantly 
unbranched β-amino acids [35]. For the biosynthesis of the peptidic part in iturin A, 
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asparagine was found to be the best precursor [36, 37] and for the overall production of iturin 
A, mannitol is also a good general carbon source [37]. Culture conditions consequently have a 
large influence on the production of the iturins. 
1.2.3 Bioactivity and antimicrobial specificity 
Iturin A and the rest of the iturin family have a wide spectrum of antifungal activities and are 
regarded as strongly antifungal [6]. The original iturin A isolates were shown to be effective 
against a number of dermatophytes, plant pathogens and yeasts [9-16]. Phae et al. [38] 
showed that purified peptide fractions of the iturin A producer B. subtilis NB22 inhibited 
phytopathogenic fungi. These fungi included Fusarium oxysporum (wilt), Botrytis cinerea 
(grey mould) and Rhizoctonia solani (sheath blight of rice). Some antibacterial activity against 
Xanthomonas oryzae and Pseudomonas lachrymans was also observed in the purified 
fractions [39]. Antibacterial activity of all the iturins is generally restricted to activity against 
gram-positive bacteria such as Micrococcus luteus [6, 39-42]. The iturins are also active 
against Saccharomyces cerevisiae [43-46]. They possess lytic activity and are able to lyse 
protoplasts from M. luteus [39-41], spheroplasts from S. cerevisiae [43] and erythrocytes [47, 
48]. The plasma membrane seems to be the primary target of the iturins and their specificity 
must be linked to one or more components in the cell membrane. 
1.2.4 Structure-function relationship 
The inclusion of the lipid moiety, with a C14 to C17 aliphatic chain in the polar peptide ring, 
ensures the amphipathic nature of the iturins. Amphipathic properties promote the interaction 
of any antibiotic peptide with the plasma membrane. Amphipathic compounds, or 
amphiphiles, aggregate spontaneously to form micelles in an aqueous medium and they can 
act as surfactants, lowering the surface tension of aqueous solutions by forming monolayers at 
the air/water interface. The critical micellular concentration (CMC) of iturin A decreases with 
an increase in aliphatic chain length [49]. This decrease corresponds with an increase in 
antifungal activity [50]. The hydrophobic moiety was found to be absolutely critical for iturin 
activity. The removal of the aliphatic chain, by replacing the β-amino fatty acid with a β-
alanine in iturin A, leads to total loss of bioactivity [51].  
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The differences between the sequences of the peptide moiety contributed to the partial 
elucidation of its role in the mechanism of action. That a carboxyl group, in the vicinity of the 
β-amino fatty acid, eradicates the activity of iturin A, is exemplified by the natural inactive 
analogue, iturin C. This iturin analogue has an L-Asp residue in position 2, at the C-terminal 
side of the β-amino fatty acid [20, 47]. Two α-amino residues, D-Tyr3 and L-Asn4, on the C-
terminal side of the β-amino fatty acid, are conserved in all the iturins (Table 1.1) [6]. The O-
methylation or O-acetylation of the D-Tyr3 residue in iturin A, mycosubtilin and bacillomycin 
L [46], eradicates all activity against S. cerevisiae. The haemolytic activity of the iturin A 
derivative with the O-methylated Tyr (MeTyr-iturin A)[52] is also lost, probably due to 
modification of its interaction with membranes. MeTyr-iturin A aggregates at a ten times 
lower concentration than iturin A and tended to form stable monolayers [53, 54]. Modification 
in the region flanking the N-terminal side of the β-amino fatty acid seems to be a natural 
evolution in the peptide sequence (Table 1.1). The O-acetylation of the L-Ser residue in iturin 
A and mycosubtilin did not alter the activity to the same extent [46]. Mycosubtilin, with a D-
Ser7-L-Asn8 sequence (inverted from that of iturin A) flaking the N-terminal side of the β-
amino fatty acid, were more active against S. cerevisiae than iturin A [46]. The tetrapeptide 
moiety, β-amino fatty acyl-L-Asx2-D-Tyr3-D-Asn4, (Asx = Asp or Asn) may have a conserved 
role in the mechanism of action of the iturins. 
1.2.5 Mechanism of action 
The iturin cytotoxic action causes an initial K+ release from the target cell, followed by the 
leakage of cellular contents (including proteins and nucleic acids) and release of vesicles 
(containing membrane lipids and iturins) [55, 56]. The steps in this mechanism of action, and 
that of most antimicrobial peptides, can be described as follows: (a) recognition of target cell, 
(b) interaction with, or transport over plasma membrane, (c) formation of active complexes 
and (d) disruption/inhibition of cellular function causing the death of the cell. 
The recognition of membrane components such as lipids or a chiral receptor determines target 
cell specificity. In fungal membranes, the interaction of iturin A with different membrane 
lipids possibly forms part of its recognition mechanism. Iturin A’s action against S. cerevisiae 
is inhibited by cholesterol, ergosterol (a sterol in fungal membranes), oleic acid, cis-vaccenic 
acid, phosphatidylcholine (PC), phosphatidic acid and petroselinic acid [45]. The lytic action 
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of the iturins on erythrocytes is probably dependent on the PC and cholesterol in the outside 
layer of their membranes [57]. It is possible that the iturins recognise cholesterol or ergosterol 
and PC in its eukaryotic target cell membranes. The preference of iturin A for specific 
membrane lipids is probably part of the immunity of the B. subtilis producer against iturin A 
lysis. B. subtilis contains phosphatidylethanolamine and lysophosphatidylglycerol in the outer 
membrane leaflet, but no PC or membrane sterols [58]. 
It has been suggested that iturin A first penetrates the lipid layer and, after lateral diffusion 
self-associates to form aggregated structures of unknown size and conformation [6, 54, 58]. 
The invariant Tyr plays a significant role in membrane interaction and in aggregation [54, 58, 
59]. The aggregates in dimiristoylphosphatidylcholine (DMPC) membranes consist of only 
iturin A molecules, while that of mycosubtilin consists of a mycosubtilin-DMPC (1:2) 
complex [58]. MeTyr-iturin A also forms a 1:2 complex with DMPC, but in contrast to 
mycosubtilin this complex is miscible with the lipid film [58]. Mycosubtilin interacts better 
with cholesterol than iturin A and here a complex stoichiometry of 1:2 for mycosubtilin-
cholesterol and 1:1 for iturin-cholesterol is found [58]. Iturin A has weaker interaction with 
ergosterol, forming a 2:3 iturin A-ergosterol complex [58]. Mycosubtilin’s superior 
interaction with lipids may be an explanation for its higher activity [46]. The immiscibility of 
these complexes with the lipid bilayer lead to the formation of clusters, possibly the active 
complexes that function as ion-pores [59-62].  
It has also been suggested that iturin A interacts with membrane proteins. For example, iturin 
A activates phospholipases in membrane vesicles of S. cerevisiae [63]. This activation can be 
direct and stereoselective or indirect by exposure of the phospholipid substrates to the action 
of the enzyme. Other interactions may also take place such as the recently observed 
synergistic interaction between the co-produced cyclic lipopeptide, surfactin, and iturin A [32, 
64]. 
The influence of iturins on cellular function depends mainly on disruption of the osmotic 
balance in the cell and the membrane potential. Iturin A causes a slow increase in membrane 
conductance—an action independent of the membrane potential [6]. This is the result of the 
formation of ion-conducting pores by iturin A [59-62], but their precise composition and 
structure has not been elucidated [1]. Membranes doped with iturin A or mycosubtilin are 
slightly anion selective [59, 60, 62]. It has been suggested the binding of cations in the pores 
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will lead to anion selective pores [6]. This is indeed possible, as the CMC values (2-8x10-5 M) 
of the iturins is not affected by the presence of 0.1 M electrolytes, whereas the formation of 
monolayers (as deduced from surface tension data) is reduced by 50% by the presence of 
chloride salts [65]. Because of iturin A and mycosubtilin’s ability to bind cations [65] they 
may also act as ionophores [6]. This disruption of the osmotic balance and membrane 
potential by the ion-pores, and possible transport by iturin ionophores, plus the possible 
destructive action of the activated phospholipases on the plasma membrane, finally leads to 
cell death. 
1.2.6 Pharmaceutical and agricultural use of iturins 
It is well known that a group of “super” microorganisms have emerged because of the overuse 
of antibiotics and fungicides in medicine and agriculture [66, 67]. The search is therefore on 
for alternative agents. Because of a wide spectrum of activity, the iturins are promising 
candidates as the antifungal agents in seed, vegetable and food preservation and as antifungal 
antibiotics in medicine. 
The use of the iturins as antibiotics is hampered by various factors such as high production 
costs, proteolytic susceptibility, toxicity and delivery of the peptide to its target. The difficulty, 
and high cost, of synthesis and purification of the cyclic iturin analogues, makes this 
methodology unsuitable for large scale production. On a more positive side, iturins are less 
susceptible to proteolytic degradation, because of their cyclic nature and the inclusion of three 
D-amino acids and the β-amino acid in their structures. This means lower dosages which 
counteracts the high production costs. As many fungal infections in mammals are topical, 
iturins can be applied topically. As early as 1958 crude iturin A was submitted for clinical 
trials as treatment for dermatomycoses in animals and man and it was shown to have excellent 
potential because of its low toxicity, wide antifungal spectrum and low allergenic effect [68]. 
One of the iturins, bacillomycin F, has been patented for application in medicine and 
agriculture [69]. It may be worthwhile to investigate some of the iturins again as antifungal 
agents in the treatment of fungal infections in humans and animals in the light of the immense 
increase in resistant fungi in the last decade [66]. There is already a renewed interest in iturin 
A after the observation that this peptide works synergistically with a co-produced peptide 
surfactin [32, 62]. Surfactin is similar to iturin A, but acts as a powerful biosurfactant [70]. 
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The removal of many synthetic fungicides from the market has created a demand for new, 
environmentally safe, fungicides. Because of their low mammalian toxicity, iturins has 
enormous potential as fungicides in agriculture. Many iturin producer organisms have been 
identified [71] and used on several occasions as bio-fungicides. B. subtilis RB14, a producer 
the antibiotics iturin A and surfactin, inhibited the damping-off of tomato seedlings caused by 
Rhizoctonia solani [72]. Bacillus subtilis B-3, an iturin A producer, was shown to control 
brown fruit rot (Monilinia fructicola) of stone fruits [73] and also a spectrum of other 
phytopathogenic fungi [74]. In one field study it was found that 50 to 100 ppm of purified 
iturin A significantly reduced the total mycoflora on stored feed grains such as corn, peanuts 
and cottonseed [75]. 
The pharmacological and agricultural use of iturins is hampered by high production costs, 
which is presently preventing their application as environmental friendly fungicides and new 
antibiotics. The financial problem may be overcome by the improved biological production 
and isolation of the peptides. The antibiotic resistance crisis will undoubtedly increase the 
future use of antibiotic peptides in food, agricultural and pharmaceutical, especially because 
of their “green” character. 
This study of the iturins was initiated with the intention to find a short active iturin A 
analogue that could be readily synthesised at low cost. As discussed in this chapter, the 
mechanism of action of iturin A is not fully elucidated and the influence of primary structure 
on activity must first be understood before such an iturin A analogue can be designed. The 
next five chapters in this thesis are dedicated to the characterisation of selected synthetic iturin 
A2 analogues and the search for “just one more piece in the iturin A puzzle”. 
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Chapter 2  
Synthesis and purification of iturin A2 and analogues 
2.1 Introduction 
Synthetic peptides have been used in the study of structure-function relationships of a number 
of antibiotic peptides such as gramicidin S [1], melittin and melittin hybrids [2], magainin and 
magainin analogues [3]. This approach also contributed to the development of a new 
generation of antibiotic peptide analogues of, for example magainin [3], with potential 
pharmaceutical applications. Studies using synthetic model peptides with antimicrobial 
activity have been very successful in identifying highly active non-toxic peptides [4]. In 
contrast, studies on iturin A have mostly used the natural products isolated from Bacillus 
subtilis [5]; the mechanism of action of iturin A has only been partially elucidated (as 
discussed in Chapter 1). An opportunity therefore existed for investigation of the structure-
function relationship of this antimicrobial lipopeptide using synthetic analogues. 
Chemical peptide synthesis has been extensively reviewed in the literature [6-11]; only a brief 
overview will be given in this section. The chemical synthesis of any given peptide involves a 
number of steps, including the activation of groups participating in the peptide bond to 
facilitate formation, and protection of other chemically active groups to limit side reactions. 
Challenged by the formidable task of peptide synthesis, organic chemists developed various 
different synthesis techniques over the last century. These techniques can be divided into two 
principal categories: solution phase and solid phase peptide synthesis. The latter has proved to 
be the most successful, eliminating many of the laborious isolation and purification steps 
necessary in solution phase synthesis. Solid phase peptide synthesis was pioneered by R.B. 
Merrifield in 1959, who subsequently won the Nobel prize for Chemistry in 1984 in 
recognition of the impact of this approach. Two of Merrifield’s early achievements were the 
first solid phase synthesis of a biologically active peptide, bradykinin in 1964 [12], and the 
first active enzyme, ribonuclease A, in 1969 [13]. 
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Solid phase peptide synthesis entails the following: 
• covalent attachment or anchoring of the first amino acid to a functionalised insoluble 
polymeric support; 
• elongation of the peptide chain by stepwise addition of activated amino acid derivatives 
(suitably and reversibly protected); 
• removal of excess reagents and by-products by filtration; 
• and, the release of the assembled crude peptide from the support followed by purification 
and characterisation.  
In all current solid phase methods peptide chain elongation proceeds from the C-terminal 
towards the N-terminal. Synthesis in the C→N direction lends itself to better chemical control 
than the N→C direction, where the activation of the acyl-amino acids results in optically 
impure peptides because of racemisation [7]. Peptide bond formation in the C→N direction 
requires the activation of the α-carboxyl group (to facilitate bond formation) and reversible 
protection of the α-amino group of the incoming amino acid (to limit polymerisation). 
Usually, the protection schemes used in the synthesis methods are two-dimensional in that 
they provide “permanent” protection for the functional amino acid side-chains and 
“temporary” protection for the α-amino group during synthesis, as will become clear in the 
following discussion. 
The Merrifield peptide synthesis protocol uses functionalised cross-linked polystyrene as solid 
phase and a protection scheme based on graduated acidolysis. The “temporary” protection of 
the α-amino group is provided by the Nα-tertiary-butyloxycarbonyl (tBoc) group, which is 
removed with trifluoroacetic acid (TFA) [7, 12-14]. The “permanent” side-chain protection is 
conferred by ether, ester and urethane derivatives based on benzyl alcohol with electron-
withdrawing halogens for greater acid stability. Other side-chain protection schemes are based 
on ether and ester derivatives of cyclopentyl and cyclohexyl alcohol. These “permanent” 
groups are removed when the anchoring linkages are cleaved with hydrofluoric acid (HF) in 
the presence of carbonium ions such as anisole [7]. The Merrifield protection scheme is 
summarised in Fig. 2.1. 
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Although many peptides of high purity have been, and are still being produced, the Merrifield 
protocol is associated with several problems caused by the successive harsh acid treatments 
needed to remove the α-amino tBoc-group, and by the HF treatment for the final release of the 
assembled peptide. These problems include premature loss of the peptide from solid phase, 
trifluoroacetylation, and destructive side reactions during the HF exposure [7, 11]. Laborious 
neutralisation and capping steps and the need for special apparatus for the hazardous HF 
treatments also encouraged researchers to look for alternative protection schemes. 
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Figure 2.1    A two-dimensional protection scheme for solid phase synthesis of the standard 
Merrifield protocol based on graduated acidolysis [11]. 
An alternative synthesis protocol, developed by Atherton, Sheppard and Dryland (reviewed in 
6, 9, 10), employs a protection scheme in which the acid-labile tBoc-amino protective group 
was replaced with a base-labile N9-fluorenylmethyloxycarbonyl (Fmoc) group requiring only 
mild removal conditions [15, 16]. This base-labile Fmoc-group, developed by Capino and Han 
[17], can be rapidly removed by a β-elimination mechanism brought about by secondary 
amines such as piperidine, which also scavenges the dibenzofulvene intermediate and thereby 
prevents back-addition to the peptide chain [7, 15, 17]. This replaced the harsh acid treatments 
of the tBoc procedure with a mild basic treatment and reduces the extent of destructive side 
reactions. The “permanent” side-chain protection is provided by tertiary butanol-based ether, 
ester and urethane derivatives, which are cleaved under relatively moderate conditions by 
TFA with concomitant release of the peptide acid from the solid phase [7, 18]. An additional 
feature of the Atherton, Sheppard, Dryland synthesis protocol is the use of a rigid solid phase 
consisting of functionalised dimethylacrylamide polymerised within Kieselguhr (marketed as 
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Pepsyn K or NovaSyn®K) which allows continuous solvent flow synthesis [9, 19, 20]. The 
protection scheme based on the Fmoc-chemistry is summarised in Fig. 2.2. 
polydimethylacrylamide
 in Kieselguhr
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Figure 2.2    A two-dimensional protection scheme for solid phase synthesis by the Fmoc-
polyamide protocol based on mild base treatment to remove the N-terminal 
protection and mild acid treatment to release the free peptide [11]. 
Considering the whole scheme of reactions in peptide synthesis, the most important reaction is 
obviously the formation of the peptide bond. The coupling of the incoming amino derivative 
to the peptide chain does not occur spontaneously; it must be facilitated by some form of 
activation. A number of activation methods are suitable for peptide synthesis. Only three of 
the most widely used methods will subsequently be discussed.  
• The α-carboxyl group of an amino acid can be activated by formation of an active 
anhydride. Carbodiimides, such as dicyclohexylcarbodiimide (DCC) and 
diisopropylcarbodiimide (DIPCIDI), are frequently used in this type of in situ activation of 
amino acids. Side reactions, such as racemisation of amino acids and dehydration of the 
acid amide side-chains of asparagine and glutamine residues during the coupling, can be 
eliminated by the use of 1-hydroxybenzotriazole (HOBt), a so-called “trapping agent” [7, 
10, 21]. In Fig. 2.3 the coupling reactions with DCC as activation agent are summarised. 
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Figure 2.3    The activation of amino acids with DCC and HOBt to yield a 
dicyclohexylcarbodiimide-activated amino acid (A), a symmetrical anhydride of 
the amino acid (B) or a oxybenzotriazolyl ester of the amino acid (C). [7] 
• Active esters amino acid esters of p-nitrophenyl [9], 3,4-dihydro-4-oxo-1,2,3-benzotriazin-
3-yl (Dhbt) [9, 10, 22-24], and pentafluorophenyl (Pfp) [9, 10, 16, 19, 25, 26] are 
generally used with HOBt as acylation catalyst (Fig. 2.4). The latter two esters are 
generally suitable for peptide synthesis when used in polar aprotic solvents such as 
dimethylformamide (DMF). Most of the active esters are commercially available, 
consequently avoiding the laborious preparation of activated amino acids (e.g. 
symmetrical anhydrides). A reaction scheme, illustrating the use of active esters, is given 
in Fig. 2.4. 
• A third type of in situ activation of amino acids employs benzotriazol-1-yl-oxy-tris-
dimethylaminophosphonium hexafluorophosphate (BOP) [27, 28] and its lesser toxic 
analogue, benzotriazol-1-yl-oxy-tris-pyrrolidinophosphonium hexafluorophosphate 
(PyBOP®) [29, 30], both of which proved to be promising and relatively low cost reagents 
(Fig. 2.5). These reagents react with the Nα-protected amino acids in the presence of a 
base to form highly active oxybenzotriazolyl esters [7, 30]. These reagents also eliminate 
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the laborious symmetrical anhydride preparation and are cheap alternatives for the 
expensive active esters. 
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Figure 2.4     Reactions in peptide bond formation facilitated by using Fmoc-amino acyl-OPfp 
or Fmoc-amino acyl-ODhbt with HOBt as catalyst [adapted from 6]. 
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Figure 2.5    Reactions in peptide bond formation facilitated by using benzotriazol-1-yl-oxy-
tris-dimethylaminophosphonium hexafluorophosphate (BOP) [27, 28] or its 
lesser toxic analogue benzotriazol-1-yl-oxy-tris-pyrrolidinophosphonium 
hexafluorophosphate (PyBOP®) [29, 30]. 
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The establishment of an easily maintained peptide synthesis facility, preferably mechanised 
and automated, was a prerequisite for this investigation of iturin A. The peptide synthesis 
protocol of Atherton, Sheppard and Dryland, also called the Fmoc-polyamide peptide 
synthesis method, was chosen because of its milder chemical approach and previous 
experience with this method [6]. The simplicity and elegance of the Fmoc-polyamide 
chemistry allows the use of only one solvent throughout synthesis and has the added 
convenience that the Fmoc-group allows UV-monitoring of coupling reactions. Small scale 
syntheses in this study were conducted in a continuous flow system, while larger scale 
syntheses were done with a shake flask method (refer to section 2.3.3 for more detail). 
When commercially available, the Pfp and Dbht active esters of the Fmoc-amino acids were 
used; otherwise the Fmoc-amino acids were activated using either DCC or the PyBOP® 
reagent. The efficiency of the coupling reactions was monitored by destructive procedures 
such as amino acid analysis, a simple ninhydrin test (Kaiser test [31]) or a Fmoc test [10]. The 
Kaiser test was used for monitoring the disappearance of amino groups during coupling and 
the appearance of amino groups after deblocking. Amino acid side-chain protection was 
provided by t-butyl ester (tBu), and in some cases by ether and urethane derivatives. These 
groups are cleaved under relatively moderate acidic conditions (95% TFA) used for releasing 
the peptide acid from the acid-labile linkage on the resin.  
Eight different iturin A2 analogues were synthesised (the subscript 2 in the name refers to the 
β-aminotetradecanoic acid residue in these iturin A analogues). One, two or all three of the 
amino acid residues in the conserved iturin sequence (L-Asn2-D-Tyr3-D-Asn4), were omitted 
in the shorter peptides (Table 2.1). Two factors limited the range of synthetic analogues: (i) 
the financial expense of anchoring any one of the D-amino acids to the resin (first amino acid 
or C-terminal), and (ii) the β-aminotetradecanoic acid (β-NC14) in the sequence. Because the 
synthesis of the Fmoc-derivative of the β-NC14 was greatly impaired by solubility factors, the 
tBoc derivative was prepared, even though this derivative is not compatible with the Fmoc-
chemistry. This restricted the incorporation of the β-NC14 residue at the N-terminal in the final 
synthesis step (Table 2.1). The insolubility and pronounced amphipathic character of the 
peptide products restricted final purification to high performance liquid chromatography 
(HPLC). Chemical purity of products was evaluated with amino acid analysis, thin layer 
chromatography (TLC), fast atom bombardment mass spectrometry (FAB-MS) and 
electrospray ionisation mass spectrometry (ESI-MS). 
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Table 2.1      Primary structures of the iturin A2 analogues synthesised in this study. 
Iturin A2 
analogue 
Peptide primary structure Mr 
5-Beta β-NC14—L-Gln—L-Pro—D-Asn—L-Ser 670.82 
6-Beta β-NC14—D-Asn—L-Gln—L-Pro—D-Asn—L-Ser 783.92 
7-Beta β-NC14—D-Tyr—D-Asn—L-Gln—L-Pro—D-Asn—L-Ser 947.10 
8-Beta 
(linear Iturin A2) β-NC14—L-Asn—D-Tyr—D-Asn—L-Gln—L-Pro—D-Asn—L-Ser 1061.20 
cyclic 7-Beta β-NC14—D-Tyr—D-Asn—L-Gln—L-Pro—D-Asn—L-Ser 929.09 
cyclic 8-Beta 
(Iturin A2) β-NC14—L-Asn—D-Tyr—D-Asn—L-Gln—L-Pro—D-Asn—L-Ser 1043.20 
YNQPNS D-Tyr—D-Asn—L-Gln—L-Pro—D-Asn—L-Ser 721.72 
NYNQPNS L-Asn—D-Tyr—D-Asn—L-Gln—L-Pro—D-Asn—L-Ser 835.83 
 
2.2 Materials 
2.2.1 General reagents and solvents 
N, N'-dimethylformamide (DMF; 99.5%), potassium hydroxide (KOH), sodium carbonate 
(anhydrous) and self-indicating silica gel were from Saarchem (Krugersdorp, South Africa). 
Trifluoroacetic acid (TFA; >98% and 99.5%), glacial acetic acid, chloroform (>99%), 
dichloromethane (DCM; 99.5%), diethyl ether (99.5%), petroleum ether (boiling point 
40−60oC), ethanol (99.8%), butan-1-ol (99.5%), pyridine (99.5%), hexane (99.8 %), citric 
acid-1-hydrate (99.5%), potassium cyanide (KCN), di-phosphorous-pentoxide, 2',7'-
dichlorofluorescein, ninhydrin, molecular sieve (0.3 nm pore size), aluminium oxide 90 and 
Kieselgel 60-F254 thin layer plates were from Merck (Darmstadt, Germany). Piperidine (98%), 
ethyl acetate (99.8%) and 2-methylbutan-2-ol (t-amyl alcohol; 98%) were from BDH 
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Chemicals (Poole, UK). TFA (>98%) and piperidine (98%) were also purchased from Sigma 
Chemical Co. (St. Louis, USA). Fluka Chemicals (Buchs, Switzerland) supplied 1-fluoro-2,4-
dinitrobenzene (FDNB). High purity dry nitrogen gas was from Afrox, South Africa. 
2.2.2 Derivatives, catalysts and resins for peptide synthesis 
Fmoc-L-Ser(tBu)-Pepsyn KA-resin (0.09 meq/g), Fmoc-L-Asn-OPfp, Fmoc-L-Asn(mbh)-OH, 
Fmoc-D-Asn-OPfp, Fmoc-L-Gln-OPfp, Fmoc-L-Pro-OPfp, Fmoc-L-Pro-OH, Fmoc-L-
Ser(tBu)-OPfp, Fmoc-L-Ser(tBu)-OH and Fmoc-D-Tyr(tBu)-OPfp were from Milligen-
Millipore (Milford, USA). Fmoc-D-Asn-OH and Fmoc-L-Ser(tBu)-OH and pentafluorophenol 
were from Sigma Chemical Co. (St. Louis, USA). Fmoc-D-Tyr(tBu)-OH and benzotriazol-1-
yl-oxy-tris-pyrrolidinophosphonium hexafluorophosphate (PyBOP®) were from Calbiochem-
Novabiochem Co. (La Jolla, USA). N, N’-dicyclohexylcarbodiimide (DCC) was from Merck 
(Darmstadt, Germany). Fluka Chemicals (Buchs, Switzerland) supplied 1-hydroxy-
benzotriazole (HOBt), N, N’-diisopropylethyl amine (DIPEA) and 2-(BOC-oxyimino)-2-
phenylacetonitrile (BOC-ON). The HCl salt of β-aminotetradecanoic acid (β-NC14.HCl) was 
donated by Dr. R. Levitt, formerly from Fine Chemicals, South Africa. 
2.2.3 Reagents and solvents for amino acid analysis and chromatography 
TFA (99.5%), constant boiling hydrochloric acid (HCl, 30%), sodium acetate (99.5%) and 
phenol (99.5%) were from Merck (Darmstadt, Germany). Phenylisothiocyanate (PITC) and 
amino acid standards were from Pierce Chemicals (Rockford, USA). 
Ethylenediaminetetraacetic acid tetrasodium salt dihydrate (EDTA, >98%) was from Fluka 
Chemicals (Buchs, Switserland). Methanol (HPLC-grade, UV cut-off 205 nm) and acetonitrile 
(HPLC-grade, UV cut-off 190 nm) were from Romil LTD (Cambridge, UK). Pico-Tag® 
sample diluent, Nova-Pak analytical HPLC columns, 0.45 mikron HV membrane filters were 
from Waters-Millipore (Milford, USA). Polygosil (C18, 60 Å, irregular particles) packing 
material, used to prepare the semi-preparative HPLC column, was from Macherey-Nagel 
(Düren, Germany). High quality triethylamine (TEA) was from Aldrich Chemical Co. 
(Gillingham, UK). Sephadex LH20 was from Pharmacia (Uppsala, Sweden). Analytical grade 
water was prepared by filtering glass distilled water through a Millipore Milli Q® water 
purification system. 
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2.2.4 Drying and storage of reagents and products 
Fmoc-amino acids, peptide synthesis resins, β-NC14.HCl, tBoc-β-NC14, BOC-ON and HOBt 
were stored at 4oC in desiccators with silica gel as drying agent. The FDNB was stored at 
10oC and PyBOP® at −20oC, both with silica gel (with indicator) as drying agent. Before use, 
amino acid derivatives, resin, PyBOP® and HOBt were dried overnight under high vacuum, 
with 
 di-phosphorous-pentoxide as drying agent. The DMF was stored over molecular sieve (0.3 
nm)
 
at room temperature. PITC and amino acid standards were stored at −20oC and TEA (high 
quality for amino acid analysis) at 10oC, all under N2-atmosphere. Lyophilised peptides were 
stored under vacuum at room temperature in a desiccator with silica gel as drying agent. All 
other reagents were stored at room temperature.  
Great care was also taken to avoid detergent contamination of glassware, as such 
contamination of peptide preparation could influence the structure-function studies. Detergent 
contamination could easily be detected with ESI-MS as most laboratory detergents contain 
highly charged compounds. The glassware, returned from the regular wash, was rinsed three 
times with distilled water, three times with 60% ethanol and then washed three times with 
analytical grade water. It was placed in a oven to dry at temperatures ranging between 110°C 
and 140°C. Bottles for amino acid derivatives and purified peptide were also prepared in the 
same way and then pyrolised at 565 - 570°C for two hours. 
2.3 Methods 
2.3.1 Preparation of solvents 
2.3.1.1 Distillation and testing of N, N’-dimethylformamide [adapted from 6] 
DMF is the principal solvent used in the Fmoc-polyamide peptide synthesis method. Impure 
DMF contains contaminants such as secondary amines and H2O, causing to the loss of the 
Fmoc and active ester groups respectively. DMF also reacts with water to form dimethylamine 
and formic acid: (CH3)2NCOH  +  H2O  →  (CH3)2NH  +  HCOOH  
To avoid side reactions with the amines, water and other impurities it was imperative to use 
freshly distilled, high purity DMF in the Fmoc-polyamide peptide synthesis procedure. DMF 
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was shaken up with 10-20 g/L dry potassium hydroxide pellets or 0.3 nm molecular sieve to 
remove residual water. Other impurities such as volatile secondary amines were removed by 
fractional distillation under reduced pressure (high vacuum pump, 5-10 mm Hg) and a dry 
nitrogen bleed. As DMF has a boiling point of 153oC at atmospheric pressure, it was 
necessary to distil DMF under vacuum to avoid possible decomposition at high temperatures. 
The first 10% of the distillate was discarded and the constant boiling fraction (45oC at 10 mm 
Hg) was collected. The distilled DMF was stored in dark bottles at room temperature over 0.3 
nm molecular sieve. If it passed the Sanger test (see below), the freshly distilled DMF was 
used within seven days, otherwise it was re-distilled. 
2.3.1.2 Sanger's test for amines 
It was necessary to test for amines in DMF, because the Fmoc-group is very labile in the 
presence of secondary amines. Sanger's test for amines [32] was carried out by mixing equal 
volumes of 1-fluoro-2,4-dinitrobenzene (1.0 mg/mL FDNB in 95% ethanol) and DMF and 
leaving it at room temperature for 30 minutes. The absorbance of the reaction mixture was 
determined at 381 nm and 0.5 mg/mL FDNB in 95% ethanol was used as blank. The blank's 
absorbance was normally in the region of 0.2 absorbance units, while suitably pure DMF had 
an absorbance at 38l nm of not more than 0.07 units higher than the blank. 
To ensure the removal of all traces of piperidine (used in the deblocking steps, refer to section 
2.3.3.3) during the peptide synthesis protocol, the Sanger test was performed on DMF samples 
from final washing steps. The samples were in most cases incubated for 2-3 minutes and 
compared to a blank solution. 
2.3.1.3 Distillation of piperidine and pyridine 
Piperidine used in peptide synthesis must also be of a high purity, for the same reasons as the 
DMF. Piperidine was purified by distillation over dry potassium hydroxide (10 to 20 g/L) and 
a dry nitrogen bleed at atmospheric pressure. The first 10% of the distillate was discarded and 
the constant boiling fraction (105oC) was collected. The distilled piperidine was stored in dark 
bottles [33]. Pyridine used in the Kaiser test was prepared in the same manner. 
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2.3.2 Preparation of amino acid derivatives 
2.3.2.1 Synthesis of Nβ-t-butyloxycarbonyl-β-aminotetradecanoic acid [adapted from 34] 
The HCl salt of β-aminotetradecanoic acid (1.05 g, 3.75 mmole) was suspended in 5 mL 
freshly distilled DMF. TEA (2 mL) was added to the suspension while stirring at 50oC over an 
oil-bath. An 1.2 fold excess (1.16 g; 4.6 mmole) of 2-tertiary-butyloxycarbonyl-oxyimino-2-
phenylacetonitrile (BOC-ON) was dissolved in 1.5 mL DMF and added drop-wise to the 
stirring suspension. The resulting yellow suspension was stirred for 2 hours at 50oC until the 
solution became clear. (In some cases it was necessary to add additional amounts of 100 µL 
10% BOC-ON in DMF.) The reaction mixture was evaporated to an oil under high vacuum at 
45oC. The residual oil was dissolved in 25 mL diethyl ether (filtered though activated 
aluminium oxide to remove residual peroxides) and extracted twice with 5 mL saturated 
aqueous citric acid (59.2% m/m at 20oC) to remove residual BOC-ON. The aqueous fractions 
were combined and extracted twice with 5 mL diethyl ether. The combined diethyl ether 
fraction was washed twice with 25 mL water and dried with anhydrous sodium sulphate. The 
diethyl ether was evaporated under vacuum and residual oil dissolved in 5 volumes (10 mL) 
heated acetonitrile (40oC). It was allowed to cool in an ice-bath and left overnight at 4oC. The 
resulting white crystalline material was filtered, washed with chilled acetonitrile and dried 
overnight under vacuum at room temperature. The product showed a negative Kaiser test and 
the yield was 91%. The melting point was 56−58oC. 
TLC was performed on aluminium backed Kieselguhr 60-F254 TLC-plates developed in 
chloroform:methanol:acetic acid (85:10:5) [6, 8]. Plates were carefully air-dried and first 
visualised under UV-light (254 nm). The dried plates were sprayed with 0.025% of 2',7'-
dichlorofluorescein in 95% ethanol, developed for 5 minutes at 110oC and visualised under 
UV-light. The plates were then sprayed with 0.2% ninhydrin in 95% ethanol and developed at 
110oC for 10 minutes to detect residual amino groups. A single spot (Rf of 0.66) for the 
product was detected with the 2',7'-dichlorofluorescein reagent and there was no visible 
contamination from BOC-ON or β-NC14. 
Electron impact ionisation mass spectrometry analyses of the product yielded results 
corresponding to that obtained by Levitt [34] and confirmed the integrity of the product. 
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2.3.2.2 Preparation of the Fmoc-amino acid derivatives 
Most of the Fmoc-amino acid derivatives were readily available commercially, but at a 
considerable expense. The syntheses of most Fmoc-amino acids have been described in 
literature [9, 35, 36] and de novo synthesis was sometimes a way to reduce excessive costs 
associated with peptide synthesis. Kaiser tests (which must be negative), melting point 
determinations (which must be within 5oC literature value [10, 36]) and TLC on each of the 
amino acids derivatives used in synthesis were done to ensure product quality. Kaiser positive 
samples of Fmoc-amino acids without acid-labile side-chain protection were suspended in 1% 
acetic acid (or 0.1% acetic acid if it contained acid-labile side-chain protection) and the 
precipitate collected by filtration. The precipitate was then washed with water, ice-cold 
methanol, ethyl acetate and diethyl ether and subsequently dried under vacuum. This 
procedure normally gave Kaiser-negative samples. If the derivative remained outside quality 
control limits it was recrystallised from hexane/ethyl acetate. The Pfp esters were 
recrystallised from hexane and/or washed with ice-cold ethyl acetate and n-hexane. 
The pre-activation of Fmoc-Asn-OH and Fmoc-Gln-OH to form their pentafluorophenyl 
esters was necessary. Other activation procedures, such as with PyBOP® and DCC, lead to the 
dehydration of their side-chains to form aspartimides and glutamimides [10]. As an 
alternative, the addition of HOBt to Fmoc-Asn-OH or Fmoc-Gln-OH, before addition of 
PyBOP® and DIPEA, limits the dehydration of the acid amide side-chain a.  
A method described by Atherton et al. [25] for the synthesis of Fmoc-L-Leu-OPfp was 
adapted for the synthesis of Fmoc-D-Asn-OPfp. Fmoc-D-Asn-OH (3.54 g; 10 mmole) and 
pentafluorophenol (2.02 g; 11 mmole) was suspended in 17 mL dioxan and cooled in an ice-
bath. DCC (2.27 g; 11 mmole) in 8 mL dioxan was added drop-wise to the stirring slurry. The 
stirring solution was left to react for 75 minutes in the ice-bath. The white creamy slurry was 
further diluted with 27 mL dioxan and stirred for another 23 hours at room temperature. The 
reaction mixture was filtered to remove the white dicyclohexylurea (DCU) precipitate. The 
precipitate was washed with two times 10 mL dioxan and the combined filtrate was 
evaporated under vacuum. The pentafluorophenyl ester crystallised when n-hexane was added. 
The slightly yellow crystals were washed with ice-cold ethyl acetate and methanol and then 
dried under vacuum (68% yield). The melting point of the product was 156oC-160oC, which 
                                                 
a
 The protection of the side-chain with e.g. 4, 4’-dimethoxybenzhydryl-group (mbh) is recommended [10], when 
using PyBOP® or DCC. 
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agreed with that of commercial Fmoc-L-Asn-OPfp. The product was further evaluated by TLC 
(refer to section 2.3.2.1) which showed a UV detectable spot (Rf = 0.7) corresponding to that 
of the commercial Fmoc-L-Asn-OPfp. Both the commercial and the synthesised product 
contained a small amount of Fmoc-L-Asn-OH. The product was further tested by a small scale 
coupling to 10 mg of the solid phase resin (Pepsyn KA with L-Ser(OtBu) as the first amino 
acid; see 2.3.3.2). After 60 minutes coupling an Fmoc-test (see 2.3.3.5) confirmed completion 
of acylation of the resin, and by implication the integrity of the activated amino acid. 
2.3.2.3 Preparation of symmetrical anhydrides of amino acid derivatives  
The reactive anhydrides were prepared immediately before their use in the elongation step in 
peptide synthesis [6, 20]. Eight times molar excess of the protected amino acid was dissolved 
in a small volume (<4 mL/mmole) of dichloromethane (DCM) by stirring in a closed vessel. A 
few drops of DMF were added to improve solubility. Four times molar excess of crystalline 
DCC dissolved in minimum DCM (<2 mL/mmole) was added to the amino acid solution, and 
stirred for 15 minutes at room temperature in the closed vessel. The progression of the 
reaction was indicated by the formation of the insoluble by-product DCU. The white DCU 
precipitate was removed from the reaction mixture by filtration on a sintered glass filter, 
before drying by rotary evaporation. The symmetrical anhydrides were dissolved in minimum 
DMF (1−2 mL) shortly before use. 
2.3.3 Synthesis of the linear peptides 
The peptides were synthesised at room temperature using the Fmoc-polyamide protocol on 
either a self-assembled manual peptide synthesiser (Fig. 2.6) for small scale synthesis or using 
a shake flask bench procedure for larger scale synthesis (Fig. 2.7). The first synthesis of 8-
Beta was done separately using the continuous flow method in the Econopep MRII 
Synthesiser (Fig. 2.6). The synthesis of 7-Beta, 6-Beta and 5-Beta, up to the tetrapeptide unit  
L-Gln-L-Pro-D-Asn-L-Ser, was done with the shake flask method on the same batch of resin 
The resin batch was split in two and the β-amino acid residue was coupled to one batch to 
produce 5-Beta. D-Asn was coupled to the other tetrapeptide containing batch and the resin 
batch was split again. One batch was used for the synthesis of 6-Beta and the other for 7-Beta. 
In the third and fourth synthesis 8-Beta, 7-Beta and 6-Beta were synthesised using our shake 
flask method (Fig. 2.7), each time starting with one batch of Pepsyn KA resin. Small 
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quantities of the peptides YNQPNS and NYNQPNS were also synthesised and purified (refer 
to Chapter 3 for more detail). 
P
Reagents
Column 
Reactor
UV
Waste
DMF 20 % piperidine
V1 V2
Sample
Chamber
Pump
Detector
 
Figure 2.6    "Econopep MRII Synthesiser": A schematic representation of a manually 
controlled peptide synthesiser. V1 and V2 are selector valves. 
Transfer 
of resin
Amino acid
derivative + 
catalyst
1. DMF wash
2. Deblocking with 20% 
piperidine for 30 minutes
3. Wash with DMF until Sanger 
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Figure 2.7    Apparatus set-up and methodology used in the shake-flask procedure. 
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The protocol for a complete cycle of operations including washing, coupling, deblocking and 
sampling steps for the continuous flow and bench Fmoc-polyamide solid phase peptide 
synthesis is set out in Table 2.2. 
Table 2.2      Operations for one cycle of the peptide synthesis procedure 
Synthesis step Time  Volume Monitoring Comment 
1. Swelling of resin 20 
min. 
4 bed volumes  bed volume = 5 mL/gram 
resin 
1. Anchoring of first amino 
acid using activated 
Fmoc-amino acid to resin 
2 
hours 
< ½ bed volume Fmoc-test Refer to sections 2.3.3.1 
and 2.3.3.5 
1. DMF wash  6 X 3 bed volumes Absorbance at 
290 or 310 nm 
Absorbance must be 
baseline or zero 
1. Resin sample A   i.  Kaiser test 
(2.3.3.4) 
 
(ii. Amino acid 
analysis; 2.3.6.3 ) 
i.  If test not negative, 
extent or repeat 
coupling step in 
elongation. 
ii.  Amino acid analysis is 
used in monitoring 
anchoring step 
1. Removal of Fmoc group 
(deblocking) with 20% 
piperidine in DMF 
30 
min. 
3 bed volumes Absorbance at 
290 or 310 nm or  
Fmoc test 
Refer to sections 2.3.3.3 
and 2.3.3.5 
1. DMF wash  10 X 3 bed 
volumes 
  
1. DMF wash sample  0.5 mL Sanger test Wash until test is negative 
(refer to 2.3.1.2) 
1. Resin sample B   i.  Kaiser test 
 
ii. Amino acid 
analysis 
i.  If test is not positive, 
repeat deblocking  
ii.  Post synthesis 
evaluation  
1. Coupling of next amino 
acid using activated 
Fmoc-amino acid  
60 
min. 
< ½ bed volume  Refer to 2.3.3.2  
Repeat steps 3 and 9 if 
necessary 
1. Repeat steps 3 to 8     
1. Repeat steps 9 and 10 for 
α-amino acids in 
sequence 
    
1. Coupling of activated 
tBoc derivative of β-
NC14 residue 
   Refer to 2.3.3.2 and 2.3.2.3 
1. Repeat steps 3 and 4     
1. Washing and drying of 
resin 
   Refer to 2.3.3.6 
1. Liberation of peptide 
acid from resin 
   Refer to 2.3.3.6 
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2.3.3.1 Coupling of the first amino acid 
Commercially available Pepsyn KA-resin (capacity of 0.09 milli-equivalent per gram of dry 
resin), with Fmoc-L-Ser(tBu) acid already attached, was used in all the syntheses. For each 
synthesis the resin was swollen for 20 minutes in high purity DMF (20 mL/g). Resin samples, 
taken to evaluate the resins, were treated with 20% piperidine for the Fmoc test (see section 
2.3.3.5) or washed with ether and dried for amino acid analysis and the Kaiser test. 
2.3.3.2 Elongation of the peptide chain  
For the elongation steps the required reagent quantities were calculated from the resin capacity 
(0.09 milli-equivalent per gram of dry resin). A three times molar excess of the subsequent 
active Fmoc-amino acids and HOBt as catalyst were used in the elongation of the peptide 
chain. The pentafluorophenyl esters of Fmoc-L-Pro, Fmoc-L-Asn, Fmoc-L-Gln, Fmoc-D-Asn 
and Fmoc-D-Tyr(OtBu) were used in the relevant coupling reactions. The tBoc derivative of 
the β-aminotetradecanoic was coupled after activation by the symmetrical anhydride method 
(described under section 2.3.2.3) or activation by the PyBOP® reagent. Fmoc-D-Tyr(OtBu)-
OH, Fmoc-L-Asn(mbh)-OH and Fmoc-L-Pro-OH were coupled using the PyBOP® reagent. 
The PyBOP® reagent was used as follows: a three fold molar excess of both the protected 
amino acid and HOBt, each in minimum DMF (0.5-1.0 mL), were mixed thoroughly with the 
resin, followed by the addition of three fold molar excess PyBOP® mixed with a six fold 
molar excess N, N’-diisopropylethyl amine (DIPEA) in minimum DMF (0.5-1 mL) [30]. In 
the shake flask method the total volume of DMF was limited to <5 mL/gram of resin. The 
reaction time of the coupling steps varied from 60 to 90 minutes. The coupling time depended 
on the completeness of acylation as determined with the Kaiser test (section 2.3.3.4) or the 
Fmoc test (section 2.3.3.5). 
2.3.3.3 Removal of Fmoc-group from the attached amino acid 
After the coupling step was completed (as determined by two consecutive negative Kaiser 
tests; refer to section 2.3.3.4), the resin was washed thoroughly to remove any trace of active 
amino acid derivative and catalyst. Piperidine (20% in DMF) was added to the resin and the 
deblocking reaction was allowed to proceed for 30 minutes. The absorbance of the piperidine 
mixture was measured at 290 nm (refer to 2.3.3.5) or the deblocking step was continuously 
monitored at 310 nm in order to follow the liberation of the Fmoc group. The piperidine was 
removed and the resin washed with DMF until the DMF-wash tested negative with the Sanger 
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test (refer to 2.3.1.2). For a successful synthesis it was imperative that all the piperidine be 
removed from the resin and glassware in contact with the reaction mixture. 
2.3.3.4 Kaiser test for free primary amino groups  
The Kaiser test [31] is specific for primary amino groups and was conducted on resin samples 
to monitor the completeness of the acylation reaction or removal of the Fmoc-group. Three 
solutions are required: (a) 500 mg ninhydrin in 10 ml 95% ethanol, (b) 40 g phenol in 10 ml 
95% ethanol, and (c) 2 ml 0.001 M KCN solution diluted to 100 ml with distilled pyridine. 
(The test was adapted by using only half the recommended phenol.) 
Four drops of each of these solutions were mixed with an ether-washed and dried resin sample 
taken during peptide synthesis; the mixture was heated for 5 to 10 minutes on a 80oC water 
bath. The presence of remaining free amino groups caused the resin beads to turn a 
characteristic deep blue colour. Otherwise, the reaction solution and resin particles remained 
yellow. Two (or more) samples were taken during synthesis, one during the coupling step 
(sample A at 60 minutes), which should be negative, and one after the piperidine deblocking 
step (sample B), which should be positive before the synthesis can be continued. If the test did 
not confirm completion of the reaction, that particular step was repeated or the reaction time 
extended. Some of the N-terminal amino acids gave anomalous bead colours and not the 
intense blue of the free amino acid when reacting with the ninhydrin, e.g. proline gave a 
brown colour and serine, asparagine and glutamine a green-orange colour.  
Quality control of Fmoc-amino acid derivatives was also done by dissolving 5.0 mg derivative 
in 100 µL DMF and adding 100 µL of each of the Kaiser test solutions. Colours were 
evaluated after 5 minutes incubation in a 80oC water bath by comparison with standardised 
colour results on a colour chart. 
2.3.3.5 The Fmoc-test 
To evaluate the coupling of an Fmoc amino acid, and especially the coupling of the first 
amino acid, the characteristic UV absorbance of the liberated Fmoc-fulvene group was 
exploited [10, 17]. For the Fmoc-test a small amount of resin (typically 10 mg) was removed 
after the coupling reaction, washed with ether, dried under vacuum and analytically weighed. 
An accurate volume of 20% piperidine in DMF (200 µL/µmole expected Fmoc-groups) was 
added to the dried resin and then the deblocking reaction was allowed to proceed for 30 
minutes. The absorbance of the deblocking mixture, diluted 10 or 20 times with DMF, was 
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measured at  
290 nm. The coupling efficiency was the calculated from the following relationship: 
% Coupling efficiency of step = (dilution x A290-0.9975) / 0.2848 
Light path = 1.0 cm; resin capacity = typically 0.09 mmoles/1000 mg 
2.3.3.6 Removal of the completed peptides from the resin 
After the final coupling reaction of the tBoc-β-NC14 residue and DMF wash, the resin was 
washed on a sintered glass filter with t-amyl alcohol, acetic acid, t-amyl alcohol and finally 
with peroxide free diethyl ether and then dried under vacuum [6, 9, 10]. The peptides were 
cleaved from the resin with 95% TFA and 5% H2O or 5% phenol as scavenger b. The peptide 
resin was treated for three to six hours with four bed volumes 95% TFA and 5% scavenger. 
After cleavage, the resin was removed by filtration and washed with 50% TFA and water. The 
resin was then washed with t-amyl alcohol, acetic acid, t-amyl alcohol and ether, dried and 
analysed for amino acids to evaluate the extent of peptide cleavage. The filtrate containing the 
peptide was dried under high vacuum on a Buchi Rotavapor at 40oC, resuspended in 50% 
acetonitrile and lyophilised. Because of the lipopeptides insolubility in most solvents, an 
organic solvent/water extraction was not used as initial purification step. 
Small amounts of peptide without the β-amino acid residue, YNQPNS and NYNQPNS, were 
also prepared using the above protocol and resin samples taken before the final coupling step 
in 7-Beta and 8-Beta syntheses. 
2.3.4 Cyclisation of the peptides 
2.3.4.1 Cyclisation using DCC 
Several attempts to cyclise 8-Beta, using DCC, proved to be marginally successful and 
therefore only one protocol is described here. A small quantity of crude 8-Beta (5 µmol) was 
dissolved in 1 mL freshly distilled DMF, after which 20 mL DCM was added. DCC and HOBt 
(2 mmole each) were dissolved in 50 mL DMF. The peptide solution was added slowly (over 
about 30 minutes) to the DCC/HOBt solution while stirring and left to react for 3 days. The 
                                                 
b
 Removal conditions generally include scavengers, which are used to remove reactive by-products such as 
carbonium-ions that may cause unwanted side reactions with the released peptide [7, 9, 10]. 
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reaction mixture was extracted once with 100 mL 50% acetic acid. The acetic acid fraction 
was lyophilised and the residue dissolved in 50% acetonitrile for further HPLC purification . 
2.3.4.2 Cyclisation using PyBOP®  
Method A: A small quantity (15 µmole) of 8-Beta or 7-Beta was dissolved in 3 mL freshly 
distilled DMF, after which 15 mL DCM was added. PyBOP®, HOBt (30 µmole each) and 
DIPEA (60 µmole) in 0.5 mL DMF was added slowly to the peptide mixture while stirring. 
The mixture was left to react for 5 days at room temperature. The reaction mixture was dried 
under vacuum and a N2 stream and dissolved in 3 mL 50% acetonitrile for HPLC purification. 
Method B: The test method was adapted in an attempt to limit polymerisation and improve 
yields. Firstly the peptide solution (15 µmole in 3 mL DMF) was diluted 10 times with DCM 
and titrated with DMF to keep the solution clear. The resultant mixture was subsequently 
cooled to 0oC. PyBOP®, HOBt (30 µmole each) and DIPEA (60 µmole) in 0.5 mL DMF was 
added slowly to the cooled peptide mixture while stirring, and left to react for 5 days at room 
temperature. The reaction mixture was dried under a N2-stream and dissolved in 3 mL 50% 
acetonitrile for HPLC purification. 
2.3.5 Purification of the lipopeptides 
2.3.5.1 Hydrophobic interaction chromatography 
Sephadex LH20 chromatography was used in a trial purification of the crude linear peptides. 
The solubility of the peptides was very poor (<1 mg/mL) in either methanol, ethanol, 
acetonitrile or water alone. Solubility improved in mixtures of water and organic solvent. A 
small quantity of lyophilised crude peptide (4 mg) was consequently dissolved in 600 µL of a 
50% methanol/water mixture. The absorption at 230 and 260 nm was determined and  the 
solution was applied to a column (50 mm X 10 mm). Peptides were eluted using a 50% 
water/methanol mixture at a flow rate of 20 mL/hour. Column eluates were monitored at 230 
nm and 260 nm. The major absorbing fractions were collected and lyophilised. 
2.3.5.2 High performance liquid chromatography 
Semi-preparative HPLC was preferred to purify the crude peptides, because of low yields 
obtained by Sephadex LH20 chromatography. Samples (5 mg/mL) were dissolved in 50 % 
acetonitrile in water and centrifuged for 5 minutes at 1000 g to remove undissolved particulate 
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and subjected to purification on a semi-preparative C18 Polygosil HPLC column (irregular 
particle size, 60 Å pore size, 250 mm x 10 mm). The chromatography system consisted of two 
Waters 510 pumps, MAXIMA software control system, Waters Model 440 detector and a 
WISP 712 sample processor. A linear gradient, at a flow rate of 3 mL/min, was created using 
eluant A (0.1% TFA in water) and eluant B (90% acetonitrile and 10% A) [30] (Table 2.3). 
The separation was monitored at 254 nm with a Waters Model 440 UV-detector. Peptide 
fractions were collected, lyophilised and analysed further. 
Certain  cyclic peptides were purified on a C18 Nova-Pak HPLC column (5 µm particle size, 
60 Å pore size, 150 mm x 3.9 mm). Racemic mixtures of 8-Beta, originating from the 
introduction of a racemic mixture of β-aminotetradecanoic acid, were further purified on an 
analytical C8 Nova-Pak HPLC column (5 µm particle size, 60 Å pore size, 150 mm x 4 mm). 
A linear gradient was created using the same eluants A and B as for the preparative HPLC 
purification. The gradient program, specifically developed for these amphipathic lipopeptides, 
used in both separation procedures is described in Table 2.3. 
Table 2.3    Gradient programs used in the chromatography of the lipopeptides 
 
Time (min) 
Flow 
preparative 
HPLC 
(mL/min) 
Flow 
analytical 
HPLC 
 (mL/min) 
 
% A 
 
% B 
 
MAXIMA curve 
type 
0 3.0 1.0 70 30  
1 3.0 1.0 70 30 linear (6)/curve (5) 
13 3.0 1.0 0 100 linear (6)/curve (5) 
14 3.0 1.0 0 100 linear (6) 
20 3.0 1.0 70 30 linear (6) 
25 3.0 1.0 70 30  
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2.3.6 Analysis of the purified peptides 
2.3.6.1 Thin layer chromatography 
Peptides were analysed with TLC on aluminium backed Kieselguhr 60-F254 TLC-plates 
developed in butan-1-ol:pyridine:acetic acid:water (90:80:60:72) [8]. TLC was also done on 
the hydrolysates of the lipopeptides in a petroleum ether:diethyl ether:acetic acid (90:10:1) 
solvent system. Visualisation was done as described for the TLC under section 2.3.2.1.  
2.3.6.2 Analytical high performance liquid chromatography 
Reverse phase HPLC was used to assess the purity of the synthetic peptides. A C18 Nova-Pak 
HPLC column, or C8 Nova-Pak HPLC column, was used with the system described under 
section 2.3.5.2. The chromatography was monitored at 254 nm. Linear and non-linear 
gradients were created using eluant A (0.1% TFA in water) and eluant B (90% acetonitrile and 
10% A). Elution program 1 was identical to the one shown in Table 2.3 with a flow-rate of 1.0 
mL/minute and the MAXIMA linear gradient no. 6. In elution program 2, a non-linear 
gradient (gradient 5 in MAXIMA control) was run from 1 to 13 minutes. 
2.3.6.3 Amino acid analysis 
Amino acid analyses were done using a pre-column derivatisation with phenylisothiocyanate 
(PITC), according to the Pico-Tag® method [37, 38]. Vacuum-dried samples (peptide 
synthesis resin samples, crude peptide and purified peptide preparations) were analysed for 
amino acid composition after 24 hour gaseous phase hydrolysis at 110oC or after a shortened 
hydrolysis (150oC, 1 hour). Gaseous phase hydrolysis was done under a nitrogen atmosphere 
using 6 N HCl containing 1% phenol. After hydrolysis the acid was removed from the 
samples under high vacuum. In the next step, the so-called "re-drying" step, 10 µL 
methanol:water:TEA (1:2:1) was added to each sample to ensure the optimal pH for 
derivatisation. The samples were thoroughly vacuum-dried before derivatisation with 20 µL 
methanol:TEA:water:PITC (7:1:1:1). The derivatisation proceeded for 20 minutes at room 
temperature. Samples were again vacuum-dried, dissolved in an appropriate amount (50-300 
µL) of Pico-Tag® diluent and filtered through HV 0.45 µm Millipore membrane filters. 
Chromatography was done at 44oC on the Waters HPLC system described under 2.3.5.2 using 
a Nova-Pak C18 HPLC column (150 mm x 3.9 mm). The derivatised amino acids were 
separated with a binary non-linear gradient using eluant A (0.14 M sodium acetate, 10 mM 
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EDTA and 0.5 mL TEA per litre water, titrated to pH 6.40 with acetic acid mixed with  
6% acetonitrile) and eluant B (60% acetonitrile containing 10mM EDTA) (Table 2.4). A 
Pierce standard amino acid mixture (hydrolysis standard) was used to calibrate the analyses. 
Table 2.4      The gradient program used in the chromatography of the PTC amino acids 
[adapted from 38] 
Time (min) Flow 
(mL/min) 
% A % B MAXIMA 
curve type 
0.00 1.0 98.5 1.5  
10.0 1.0 50 50 5 
10.5 1.0 0 100 6 
12.2 1.0 0 100 6 
12.7 1.5 0 100 6 
13.2 1.5 98.5 1.5 6 
20.7 1.5 98.5 1.5 6 
21.0 1.0 98.5 1.5 6 
 
2.3.6.4 Mass spectrometry 
Electrospray ionisation mass spectrometry (ESI-MS) was performed using a Micromass 
Quattro triple quadrupole mass spectrometer fitted with an electrospray ionisation source. The 
carrier solvent was 50% acetonitrile in water, delivered at a flow rate of 20 µL/minute during 
each analysis. Ten µL of the sample solution (2 ng peptide in 50% acetonitrile/water 
containing 0.05% TFA) was introduced into the ESI-MS using a Rheodyne injector valve. A 
capillary voltage of 3.5 kV was applied, with the source temperature set at 80oC. The cone 
voltage was set at 70 V with the skimmer lens offset at 5 V. Data acquisition was in the 
positive mode, scanning the first analyser (MS1), through m/z = 300−1500 or 1200 at a scan 
rate of 100 atomic mass units/second (m/z is defined as the molecular mass to charge ratio). 
Representative scans were produced by combining the scans across the elution peak and 
subtracting the background. 
The FAB-MS was done at the Chemistry Department, University of Potchefstroom by Dr. L. 
Fourie. 
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2.4 Results and Discussion 
2.4.1 Peptide preparation  
2.4.1.1 Synthesis of the peptides 
The successful solid phase peptide synthesis of the amphiphatic iturin A2 analogues 
demonstrated the applicability of the Fmoc-polyamide peptide synthesis protocol. During each 
of the syntheses, negative Kaiser test for amino groups after the coupling steps showed that 
each of the couplings were complete. Positive Kaiser tests, after the removal of the Fmoc 
groups, confirmed successful coupling and deblocking steps. The amino acid analysis on the 
resin samples confirmed that each of the resin bound peptides had the correct amino acid 
composition and that the sequential integrity of the peptides was maintained (Table 2.5). The 
amino acid analysis of the TFA-treated resins showed that the peptide release step was 
successful in each case (results not shown).The amino acids, Asn and Gln, are deaminated 
during the hydrolysis procedure and therefore Asp and Glu are detected during the amino acid 
analysis. The Pro-values, obtained in the amino acid analysis, were slightly higher than 
expected as a result of the unresolved separation of the phenylthiocyanate (PTC) derivative of 
Pro and PTC-NH2 during chromatography. The Ser- and Tyr-values were slightly lower than 
expected because of the oxidative degradation of these hydroxyl-containing derivatives during 
hydrolysis. The PTC derivative of the β-NC14 eluted very late during the amino acid analysis 
chromatography and could not be resolved from contaminating components and was therefore 
not determined.  
The chiral integrity of the residues was not determined, but the use of HOBt as catalyst and 
so-called trapping agent ensures a greater than 99.6% “trapping” of each residue in its original 
configuration during coupling [7, 10, 21]. There was, however, uncertainty about the chiral 
nature of the Nβ-tBoc-aminotetradecanoic acid derivative used during the syntheses. Liquid 
chromatography electrospray mass spectrometry (LC-ESI-MS) and chiral chromatography of 
the Nβ-tBoc-aminotetradecanoic acid was used to investigate this derivative and its 
lipopeptide products (reported in Chapter 3). 
 
 
Stellenbosch University http://scholar.sun.ac.za
 2.26
Table 2.5      Summary of amino acid composition of resin samples taken during one of the 
syntheses of 5-Beta, 6-Beta, 7-Beta and 8-Beta. Values are the ratio between 
picomole residue and picomole Ser. The values of Ser and Tyr were adjusted by 
17% and 13% respectively for oxidative loss that occurred during hydrolysis. (nd 
= not determined)  
                           C-terminal                    Coupling sequence 
Peptide Residue 
coupled 
L-Ser D-Asn L-Pro L-Gln D-
Asn 
D-Tyr L-Asn average 
All L-Ser 1 1 1 1 1 1 1 1 (1) 
All  D-Asn 0.96 1.08 0.79 - - - 0.94 (1) 
All   L-Pro 1.15 1.02 nd 1.04 1.37 1.15 (1) 
All    L-Gln 1.02 nd 1.03 1.03 1.03 (1) 
8-Beta; 7-Beta; 6-Beta   D-Asn nd 1.87 - 1.87 (2) 
8-Beta 7-Beta     D-Tyr 0.88 0.95 0.92 (1) 
8-Beta       L-Asn 3.07 3.07 (3) 
 
2.4.1.2 Purification of peptides 
The purity of the crude peptides, as determined by ESI-MS, was already high with very little 
or no contaminating peptide material (results not shown). It was, however important to ensure 
even higher purity of the peptides for use in the structure-activity studies, as impurities can 
considerably influence bioactivity results. 
Sephadex LH20 chromatography was used in a trial purification of linear 7-Beta and 8-Beta 
(Fig. 2.8). The low yields from this procedure (<50%) were probably due to the use of plastic 
tubing in the chromatography set-up. The highly lipophilic peptides tended to adsorb to the 
hydrophobic plastic surfaces. The use of methanol in the procedure also posed problems. The 
lipopeptides, only partially soluble in this solvent, could form methyl esters between methanol 
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and their carboxyl terminals. This procedure was therefore abandoned for the purification by 
semi-preparative HPLC. 
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Figure 2.8    Sephadex LH20 chromatography of 4 mg each of crude 7-Beta (--) and 8-Beta  
(−). The eluant was 50% methanol in water at a flow rate of 20 mL/hour and the 
bed volume of the column was 4 mL. 
The four different linear peptides (combined products of the different syntheses) were 
subsequently purified using HPLC. In the early stages of the development of purification 
procedures we were unaware that the lipopeptides, especially the shorter analogues, tended to 
aggregate at high concentrations and with time (refer to Chapter 6 for more detail); the ESI-
MS facility was also not available for fast analysis of fractions. Some losses therefore 
occurred because of the aggregation and adherence to plastic as well as membranes used in the 
preparation of the HPLC samples. 
The HPLC gradient program was successful in the purification of 8-Beta and 7-Beta. With a 
linear gradient program using a flow rate of 3 mL/min as depicted in Table 2.3, two peptide 
fractions were collected, named 7-Beta I and 7-Beta II, corresponding to 7-Beta (evaluated by 
TLC, amino acid analysis and ESI-MS; refer to Chapter 3 for more detail) (Fig. 2.9 A). Two 
peak fractions corresponding to 8-Beta (evaluated by TLC, amino acid analysis and ESI-MS; 
also refer to Chapter 3 for more detail), named 8-Beta I and 8-Beta II, were also collected (Fig. 
2.9 B). Other fractions, with significant UV absorbance, did not contain any peptide material 
and were probably residual phenol and side-chain deprotection products. Yields of the 
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purified 7-Beta and 8-Beta were satisfactory, although higher yields were expected (Table 
2.6). 
Table 2.6      A summary of the yields obtained for the synthesis and purification of the  
iturin A2 analogues. Yields were determined on the dry mass of each peptide. 
Peptide % Crude yield 
% Average 
coupling efficiency 
% Yield from 
preparative HPLC 
5-Beta 90 98 24 
6-Beta 99 99.8 44 
7-Beta I,II 94 99 62 
8-Beta I,II 87 98 73 
cyclic 7-Beta I,II - - 47 (Method B) 
cyclic 8-Beta I,II - - 20 (DCC method) 
42 (Method A) 
47 (Method B) 
 
The purification of 5-Beta and 6-Beta was complicated by a number of factors. First, these 
two peptides do not contain any aromatic UV absorbing residues and consequently the 
sensitivity of detection at 254 nm was low. Therefore, instead of 5 mg/mL, a much higher 
peptide concentration (8-10 mg/mL) had to be used. Second, 5-Beta and 6-Beta are strongly 
hydrophobic, with only 4 or 5 slightly polar residues coupled to the highly lipophilic β-NC14 
residue. These peptides readily formed micellular aggregates of different sizes and polarity in 
aqueous solutions. Their hydrophobic nature complicated HPLC purification because the 
formation of aggregates made separations unpredictable (results not shown). Some 5-Beta and 
6-Beta were, however, purified by this means, but yields were low at 24% and 44% 
respectively (refer toTable 2.6). ESI-MS analysis of fractions collected during the 
chromatography of 5-Beta and 6-Beta indicated that fractions throughout the gradient, 
especially the very early eluting fractions, contained peptide material (results not shown). 
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Figure 2.9    HPLC chromatograms of the crude linear lipopeptides (A:7-Beta and B: 8-Beta) 
using a 250 mm X 8 mm C18 Polygosil column. The linear gradient was 
developed over 13 minutes with 0.1% TFA in water as solvent A and 
acetonitrile plus 10% A as solvent B at a flow rate of 3 mL/min. Fractions that 
contained the specific peptide (as evaluated by ESI-MS) are each indicated on 
the chromatograms. 
A 
B 
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The N→C peptide cyclisation procedures with the PyBOP® reagent proved to be more 
successful than any of the DCC procedures. The highest yield of cyclic 8-Beta from a DCC 
procedure, using purified peptide as starting material, was only 20%. FAB-MS analysis 
showed that this preparation contained only the cyclic peptide (results not shown). The main 
solvent used in these procedures was DMF which, because of its ability to participate in 
hydrogen bonds, is a good chaotrophic solvent. However, although the peptides and reagents 
dissolved very well in DMF, the peptides were possibly in an extended conformation with 
non-optimal positioning of the N- and C-terminals. As natural iturin A has intra-peptide 
backbone hydrogen bonds the non-polar dichloromethane was used to facilitate the formation 
of hydrogen bonds and ensure close proximity of the N and C terminals. Combined with the 
highly effective PyBOP® as activation agent, the two peptides 7-Beta and 8-Beta were 
successfully cyclised using the crude peptide mixtures as starting material.  
ESI-MS showed that the PyBOP® cyclisation mixture contained only cyclic peptide after five 
days (Fig. 2.10). By eliminating the linear peptide contamination of the cyclic peptide 
preparation, the problem of overlapping HPLC retention times of linear and cyclic peptides 
was overcome (refer to Figs.2.13, 2.15 in the following section). At this time it was not clear 
which of the two cyclic 8-Beta fractions contained synthetic iturin A2. Cyclisation improved 
the HPLC resolution of the two peptide fractions (named cyclic 7-Beta I & II and cyclic 8-
Beta I & II) and each of the peptides in the cyclisation mixtures could be purified with relative 
ease (Fig. 2.11 A and B).  
The purified yields of cyclic 8-Beta and 7-Beta, using the PyBOP® method B, were 
respectively 33% and 30% both corresponding to a 47% yield from purified peptide 
preparations (refer to Table 2.6). A marginal improvement of 5% in yield of cyclic 8-Beta was 
obtained by improving the solubility and increasing the peptide dilution factor. Bland reported 
in 1996 the synthesis of iturin A2 [39] with a purified product yield of 46% for the cyclic 
peptide. In this synthesis, the cyclisation step involved the use of a linear lipopeptide analogue 
identical to 8-Beta, but with the side-chain groups still protected which accounted for the 
higher yields obtained. The yields could probably be improved by also using a protected 
precursor, a lower reaction temperature to limit polymerisation and a different means of 
activation (PyBOP® has limited stability [10]). 
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Figure 2.10   ESI-MS analysis of A cyclisation mixtures of 7-Beta and 8-Beta. The reaction 
mixture was dried and the residue dissolved in 50% acetonirtile in water 
containing 0.5% NH3. Analyses conditions were as described under 2.3.6.4. 
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Figure 2.11   HPLC chromatograms of the crude cyclic lipopeptide reaction mixture (A: 
cyclic 7-Beta and B: cyclic 8-Beta as synthesised using Method B) using a 250 
mm X  
8 mm C18 Polygosil column. The linear gradient was developed over 13 minutes 
with 0.1% TFA in water as solvent A and acetonitrile plus 10% A as solvent B 
at a flow rate of 3 mL/min. Fractions that contained the specific peptide (as 
evaluated by ESI-MS) are each indicated on the chromatograms. 
A 
B 
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2.4.2 Analysis of purified peptides  
2.4.2.1 Analytical TLC and HPLC of the purified lipopeptides 
To assess the semi-preparative purification of the peptides, analytical TLC and HPLC were 
employed. TLC on the different linear lipopeptides revealed only one ninhydrin-detectable 
spot per linear peptide. The Rf values of all the linear lipopeptides were 0.81, an indication of 
the dominating influence of the β-NC14 moiety on the hydrophobicity of these peptides; the 
two peptides without the fatty acid, namely NYNQPNS and YNQPNS, had Rf values of 0.65 
and 0.54 respectively. TLC of the linear lipopeptide hydrolysates showed that each of these 
peptides contained the β-aminotetradecanoic acid residue. 
During the semi-preparative HPLC of the lipopeptide preparations of 7-Beta, 8-Beta and their 
cyclic analogues it was observed that each contained two peptide fractions with identical 
molecular masses (as shown with ESI-MS) and amino acid compositions, but differing in their 
HPLC properties. The elucidation of this phenomena was accomplished using ESI-MS and it 
was concluded that the introduction of a D/L racemic mixture of the β-NC14 into the peptides, 
lead to two isomeric peptides in each (refer to Chapter 3 for details). 
Analytical HPLC of the purified 7-Beta I and 7-Beta II confirmed their purity, with only a 
small amount of the contaminating diastereomer in each (Fig 2.12). The preparation of  
7-Beta I was particularly pure with only minor contamination of 7-Beta II. Purification of the 
two diastereomers of 8-Beta was exceptionally difficult, because of the low resolution 
between the two diastereomers. Different gradient profiles (linear and non-linear), with either 
analytical C18 or C8 HPLC columns, did not improve the resolution (results not shown). A 
chiral based separation could have been an alternative, but the high cost of chiral columns 
precluded its use at this stage of purification. The purification of 8-Beta I and II were, 
however, successful as evaluated by C18 HPLC (Fig. 2.13) and C8 HPLC (results not shown). 
All these linear preparations were therefore highly enriched with one diastereomer, but not 
chiraly homogeneous. Improved resolution between the cyclic diastereomers enabled the 
isolation of peptides with high chiral purity, especially cyclic 7-Beta I and cyclic 8-Beta I. The 
other diastereomers, cyclic 7-Beta II and cyclic 8-Beta II, had only minor contamination of 
their diastereomers (Figs. 2.14 and 2.15). A peak fraction with Rt of 8.13 in the cyclic  
7-Beta II preparation was probably an aggregate of this diastereomer (Fig 2.14), as no peptide 
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contamination was detected by ESI-MS (Fig. 2.19). The analytical HPLC analyses of 
YNQPNS and NYNQPNS are discussed in Chapter 3. 
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Figure 2.12   HPLC chromatograms of the purified 7-Beta I and 7-Beta II using a  
150 X 3.9 mm C18 Nova-pak column. The linear gradient was developed over 13 
minutes with 0.1% TFA in water as solvent A and acetonitrile plus10% A as 
solvent B. Approximately 4 µg peptide was injected per HPLC analysis. 
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Figure 2.13   HPLC chromatograms of the purified 8-Beta I and 8-Beta II using a  
150 X 3.9 mm C18 Nova-pak column. The linear gradient was developed over 13 
minutes with 0.1% TFA in water as solvent A and acetonitrile plus 10% A as 
solvent B. Approximately 4 µg peptide was injected per HPLC analysis. 
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Figure 2.14   HPLC chromatograms of the purified linear and cyclic lipopeptides using a  
150 X 3.9 mm C18 Nova-pak column. The linear gradient was developed over 13 
minutes with 0.1% TFA in water as solvent A and acetonitrile plus 10% A as 
solvent B. Approximately 4 µg peptide was injected per HPLC analysis. 
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Figure 2.15   HPLC chromatograms of the purified linear and cyclic lipopeptides using a  
150 X 3.9 mm C18 Nova-pak column. The linear gradient was developed over 13 
minutes with 0.1% TFA in water as solvent A and acetonitrile plus 10% A as 
solvent B. Approximately 4 µg peptide was injected per HPLC analysis. 
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2.4.2.2 Electrospray mass spectrometry of the purified lipopeptides 
Only a brief overview of the ESI-MS results will be given as an in depth study of the iturin A2 
analogues with ESI-MS are discussed in detail in Chapter 5. The correct m/z (molecular 
mass/charge ratio) was found for each of the purified linear peptides (Figs. 2.16-2.20, also 
refer to Table 2.1). One of the peptides, 5-Beta, fragmented extensively under the ESI-MS 
conditions used in the analysis (Fig. 2.16). The correct m/z of 5-Beta (670), was however 
observed as was it’s Na and K cationised species. The two major fragments (product ions) 
corresponded to the sequences PNS (y”3 with m/z 317) and β-NC14-Q (b2 with m/z 354), 
confirming the peptide sequence. The correct m/z of 784 was found for 6-Beta and also the 
two product ions PNS (y”3 with m/z 317) and β-NC14-NQ (b3 with m/z 468), confirming its 
sequence (Fig. 2.16). Although the two shorter lipopeptides consisted of diastereomeric 
mixtures, they were chemically pure. 
Increased stability under the ESI-MS conditions was observed for all of the longer 
lipopeptides. The spectra of 7-Beta I and 7-Beta II were near identical in terms of molecular 
ions, Na and K cationised species and limited fragmentation (Fig. 2.17). For both these 
diastereomers the correct m/z of 974, low intensity product ions, such as y”3 (m/z 317) 
corresponding to PNS were detected. The same was true for 8-Beta I and 8-Beta II, also with 
identical spectra (Fig. 2.18). For these peptides the correct m/z of 1061 for the molecular ion 
was found, with the y”3 (m/z 317) and b5 (m/z 744; sequence β-NC14NYNQ) as major product 
ions. The mass spectra of these longer linear lipopeptides confirmed their purity, and identical 
chemical nature and sequence of their diastereomers. 
The ESI-MS analysis of the cyclic peptides confirmed of the cyclic nature of cyclic 7-Beta I 
and II and cyclic 8-Beta I and II, with the m/z of each cyclic peptide differing by 18 Da (Mr of 
H2O) from that of their linear analogues (Figs. 2.19, 2.20, also refer to Table 2.1). 
Fragmentation of the cyclic peptides was limited to only the dehydrated product ions; these 
peptides are exceptionally stable under ESI-MS conditions. According to the ESI-MS analysis 
these preparations did not contain any linear peptide contamination, confirming successful 
cyclisation and purification of each cyclic diastereomer.  
The ESI-MS of YNQPNS and NYNQPNS are reported on in Chapter 3. Refer to Chapter 5 
for more detail on ESI-MS and fragmentation of peptides under ESI-MS conditions. 
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Figure 2.16   Positive mode ESI-MS spectra of the purified linear 5-Beta and 6-Beta. 
Analyses were done as described under section 2.3.6.4. 
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Figure 2.17   Positive mode ESI-MS spectra of the purified linear 7-Beta I and II. Analyses 
were done as described under section 2.3.6.4. 
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Figure 2.18   Positive mode ESI-MS spectra of the purified linear 8-Beta I and II. Analyses 
were done as described under section 2.3.6.4. 
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Figure 2.19   Positive mode ESI-MS spectra of the purified cyclic 7-Beta I and II. Analyses 
were done as described under section 2.3.6.4. 
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Figure 2.20   Positive mode ESI-MS spectra of the cyclic 8-Beta I and II. Analyses were done 
as described under section 2.3.6.4. 
Stellenbosch University http://scholar.sun.ac.za
 2.44
2.4.2.3 Amino acid analysis of purified peptides 
The powerful analytical techniques utilised in the analysis of the synthetic peptides, such as 
HPLC and ESI-MS, already confirmed the chemical purity of each of the peptides. 
Nevertheless, this study would have been incomplete without the traditional amino acid 
analysis (Table 2.7). 
Table 2.7      Amino acid composition of the different HPLC purified peptides. 
(# hydrolysis at 110oC for 18 hours, values of Ser and Tyr were adjusted by 10% 
and 3% respectively; $ hydrolysis at 150oC for 1 hour, values of Ser and Tyr 
were adjusted by 17% and 13% respectively for oxidative loss that occurred 
during hydrolysis; Asx = Asn or Asp and Glx = Gln or Glu. Duplicate analyses 
were done for each peptide.) 
 Amino acid composition 
Peptide β-NC14 Asx Tyr Glx  Pro Ser 
YNQPNS # - 1.97 (2) 0.69 (1) 1.00 (1) 1.20 (1) 0.91 (1) 
NYNQPNS # - 3.00 (3) 0.72 (1) 1.00 (1) 1.20 (1) 0.89 (1) 
5-Beta $ (1) 1.11 (1) - 1.00 (1) 1.05 (1) 0.88 (1) 
6-Beta $ (1) 2.17 (2) - 1.00 (1) 1.02 (1) 0.86 (1) 
7-Beta I $ (1) 2.20 (2) 0.86 (1) 1.00 (1) 1.02 (1) 1.00 (1) 
7-Beta II $ (1) 2.25 (2) 0.95 (1) 1.00 (1) 1.03 (1) 0.93 (1) 
cyclic 7-Beta I $ (1) 2.30 (2) 0.83 (1) 1.11 (1)  1.12 (1) 0.81(1) 
cyclic 7-Beta II $ (1) 2.16 (2)  0.92 (1) 0.91 (1)  1.05 (1)  0.84 (1) 
8-Beta I $ (1) 3.12 (3) 0.88 (1)  1.03 (1) 1.01 (1) 0.87 (1) 
8-Beta II $ (1) 2.99 (3) 0.96 (1) 1.15 (1) 1.23 (1) 0.80 (1) 
cyclic 8-Beta I $ (1) 3.05 (3) 0.93 (1) 1.06 (1) 1.32 (1) 0.60 (1) 
cyclic 8-Beta II $ (1) 3.04 (3) 0.90 (1) 1.18 (1) 1.04 (1) 0.65 (1) 
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The amino acid analyses of the peptide hydrolysates (Table 2.7) confirmed the results from 
the ESI-MS study, but were more useful in the determination of analytical concentrations of 
the peptide solutions used in HPLC, ESI-MS and biological activity discussed in the following 
chapters. Each of the peptides analysed had the correct α-amino acid composition (the  
β-aminotetradecanoic acid was not analysed). The values for Ser and Tyr were lower than 
expected for some of the peptides due to oxidative degradation during hydrolysis. Another 
factor contributing to the low values of Ser and Tyr, especially in the cyclic peptides, may be 
shielding of peptide bonds with respect to hydrolysis. The Pro-value was too high in many of 
the analyses because of interference by PTC-NH2. In all the analyses only the deamination 
products of Gln and Asn, namely Glu and Asp were detected. 
2.5 Conclusions 
Both continuous flow and shake flask solid phase peptide synthesis, and amino acid analysis 
techniques were successfully established in this laboratory. It made possible the synthesis of 
high purity peptides on a regular basis for both commercial and research purposes. Amino 
acid analysis, analytical HPLC and ESI-MS unambiguously confirmed that the correct 
lipopeptides had been synthesised in this study. Lipopeptides of high purity were obtained, 
although synthesis of iturin A2 and some of its cyclic analogues proved to be chemically 
challenging. An N→C cyclisation is in it’s very nature a difficult synthesis step, further 
complicated by ring size and the pronounced amphipathic nature of iturin A2 and some of its 
analogues.  
The synthetic lipopeptides also tended to self-aggregate, especially the shorter peptides, and 
adhere to hydrophobic surfaces, which lead to losses because of handling, and diminished 
biological activity in aggregated peptide samples (discussed in Chapter 6). Natural iturin A is 
a membrane active peptide, and hypotheses have been put forward that the formation of 
aggregates in the membrane is part of its mechanism of action [40]. The polar character of the 
lipopeptides also affected their purification, as we observed a tendency of these lipopeptides 
to associate with Na+ and K+, especially in samples that have been repetitively lyophilised 
(residual Na+ and K+ in water and on glass concentrates in the sample). It has been suggested 
that the affinity of natural iturin for alkali metal ions is part of its mechanism of action [40]. 
An ESI-MS study on the interaction between alkali metal ions and the iturin A2 analogues will 
be discussed in detail in Chapter 5. Other complications arose because iturin A2 also contains, 
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apart from the α-amino acids, a β-NC14 in the absolute R-configuration (D-enantiomer). An 
enantiomerically pure β-D-aminotetradecanoic acid was first synthesised in 1995 by Bland 
[41], only the racemic D/L mixture of β-NC14 was available at the time of our synthesis. 
Consequently two diastereomers of the different lipopeptides were synthesised during each 
synthesis. Even though the insolubility of the iturin A2 analogues in most solvents limited the 
purification possibilities, eight of these diastereomers from the longer lipopeptides could be 
purified with C18-HPLC. These diastereomers probably have different conformations, which 
influence their hydrophobicity and interaction with the C18 stationary phase. The effect of 
these differences on structure and biological activity will be discussed in Chapters 4 and 6. 
The determination of the absolute configuration of the β-NC14 in eight of these peptide 
diastereomers will be addressed in the next chapter. 
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Chapter 3  
Determination of the configuration of the  
β-aminotetradecanoic acid in the iturin A2 analogues  
3.1 Introduction 
Chirality (from the Greek word cheir for hand) in chemistry describes the non-
superimposability of mirror images of otherwise identical chemical compounds. These mirror 
image compounds are also known as stereoisomers or more specifically as enantiomers (from 
the Greek word enantio meaning opposite). Enantiomers are identical in all chemical aspects, 
except for their opposing rotation of polarised light or so-called optical activity. An equimolar 
mixture of enantiomers of a specific compound, also called a racemic mixture, is optically 
inactive. 
Although Van’t Hoff has the distinction of being the founder of stereochemistry [1] in 1874, 
Louis Pasteur, in 1858, used the chiral selectivity of nature to become the very first scientist to 
resolve a racemate [2]. He observed that only the dextro form of ammonium tartate, which 
rotates polarised light to the right, is fermented by Penicillium glaucum. Pasteur had already 
separated the enantiomorphous crystals of ammonium tartate by hand and determined their 
optical activity in 1848. The original D/L nomenclature is based on the optical rotation of 
glyceraldehyde with the enantiomer rotating light to the left (laevo) being L-glyceraldehyde 
and to the right (dextro) being D-glyceraldehyde (Fig 3.1). 
The true orientation of the atoms or groups of enantiomers in space i.e. their absolute 
configuration is very important in the study of biologically active compounds (as will be 
discussed later), although most of the fundamental research of chiral compounds was done 
without this knowledge. It is not always possible to equate the rotation of light to the absolute 
configuration of some other compounds for example, the L-enantiomer of DOPA (3,4-
dihydroxy phenylalanine) rotates plane polarised light to the right. A second assignment was 
thus incorporated in the nomenclature to show the rotation of light of the enantiomer namely 
(−) for rotation of light to the left and (+) for rotation to the right. L-glyceraldehyde was thus 
Stellenbosch University http://scholar.sun.ac.za
 3.2
denoted as L-(−)-glyceraldehyde. Assignment of the D- and L- configuration is still generally 
used in the nomenclature of sugars and amino acids (Fig. 3.1). This system relates compounds 
configurationally to the structure of glyceraldehyde and is limited because it is only applicable 
to compounds having asymmetric carbon atoms. Cahn, Ingold and Prelog [3] developed the 
R/S nomenclature (S stands for sinister and R for rectus) which can be used to assign absolute 
configuration directly to any chiral compound by the sequential arrangement of ligands 
associated with an element of chirality. With this system L-glyceraldehyde is denoted as  
(S)-glyceraldehyde (Fig. 3.1). 
D/L-nomenclature  
HO H2C
D-glyceraldehyde L-glyceraldehyde
1CHO
H OH2C
3CH2OH
1CHO
3CH2OH
most oxidised carbon or 
carbon with lowest number
(α-carbon in amino acids)
bonds 
towards
back
hydroxyl group to right (dextro)
(α-amino group in amino acids) 
bonds 
towards
front
hydroxyl group to left (laevo)
sp3 carbon, 
tetrahedral)
side chain or carbon
with highest number
 
R/S-nomenclature 
CHO
2
H4
OH
1 3
CH2OH
group / atom 
with highest 
atom number
group / atom 
with lowest 
atom number
bonds to
front
direction of rotation from 
lowest to highest numbered 
group - right handed thus 
chirality of carbon is 
denoted as R (rectus)
(R)-glyceraldehyde
(D-glyceraldehyde)
 
Figure 3.1     An illustration of the each of the nomenclature systems with glyceraldehyde as 
example. 
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In our synthetic approach, used to study the structure-function relationship of iturin A, an 
enantiomeric mixture of the β-aminotetradecanoic acid (β-NC14) residue was introduced into 
all the iturin A2 analogues during synthesis. The natural cyclic lipopeptide, iturin A, consists 
of seven α-amino acid residues and a β-amino fatty acid residue in the absolute R-
configuration (D-enantiomer) [4, 5]. The elucidation of the absolute configuration of the β-
NC14 residue in the different iturin A2 analogues proved challenging and several different 
techniques were considered during this study. A summary of available techniques will be 
given as background. The methods generally used in stereoisomer investigations can be 
divided into four categories: methods involving (i) calorimetry, (ii) stereospecific enzymatic 
catalysis, (iii) spectrometry (polarimetry, nuclear magnetic resonance (NMR) and isotopic 
dilution) and (iv) chromatography (chiral gas chromatography (GC) and chiral high 
performance liquid chromatography (HPLC)). 
A calorimetric method, such as differential scanning calorimetry, is based on the energy 
absorbed by a sample as a function of temperature and related to a reference of known 
enantiomeric composition. Data such as melting point, enthalpy of fusion and termination of 
fusion temperature are used to construct a melting point diagram from which enantiomeric 
composition can be determined [1]. This method can only be used if the material is in solid 
form and a reference sample of known composition is available. As with many of the 
techniques under discussion, differential scanning calorimetry is also limited to determination 
of composition and not absolute configuration, that is if standard enantiomer of known 
configuration is not available.  
Stereospecific enzymatic catalysis, however, can be used to determine composition and 
absolute configuration, although general application is limited by the availability of specific 
enzymes. Most enzymes are highly stereospecific and can discriminate completely between 
enantiomers. Many enzymes are commercially available for the determination of enantiomeric 
purity of amino acid and peptide preparations. For example both D- and L-enantiospecific 
amino acid oxidases are available, but only L-enantiospecific proteases and amino acid 
decarboxylases. The presence of the β-amino acid and the D-amino acids in the iturin A2 
analogues prevented the use of an enzymatic method. 
Before the advent of NMR and chiral chromatography, the measurement of the ability of 
chiral compounds to rotate the plane of polarisation of plane polarised light was the only 
means to distinguish between enantiomers. Plane polarised light, with its vibrational plane 
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limited to one direction, is composed of two perpendicular vectors (magnetic and electric). 
The right and left circularly polarised vectors of light will be propagated at different velocities 
when passing through a medium containing optically active compounds. The plane of 
polarisation will be rotated as a result of vector addition and measured in polarimetry as 
optical rotation, symbolised by α. If there is no association between enantiomers, 
enantiomeric purity can be determined, because it is linearly related to optical purity. The 
accuracy of determination can be improved if the isotopic dilution method is used [1]. The 
unknown enantiomeric mixture is mixed with a radioactively labelled racemate of the same 
compound. It is recrystallised and again analysed by polarimetry and either mass spectrometry 
or liquid scintillation counting to determine the optical purity and isotope content from which 
the original optical purity can be calculated. 
In techniques such as optical rotary dispersion (ORD) and circular dichroism (CD) the optical 
activity is plotted as a function of wavelength. ORD and CD are closely related phenomena in 
the same way as absorption and refractive index. With CD, measurement of molecular 
ellipticity ([θ]) is taken as the difference of absorption of left and right polarised light. With 
ORD, the difference of the refractive indices for left and right polarised light is measured and 
denoted as molecular rotation ([φ]) [6, 7]. The sensitivity of ORD and CD improves if an 
aromatic group is part of the compound’s structure, especially if it is near to the chiral atom 
[7]. If an absorption band of the compound falls in the spectral range investigated, the band 
will lead to one or more peaks or troughs. These curve extrema are denoted as either a positive 
or negative Cotton effect and could be correlated with the curve extrema of a structurally 
related compound of known stereochemistry. Thus, as with polarimetry, ORD and CD 
determination of absolute configuration is indirect and depends on the availability of a 
reference standard. Refer to Chapter 4 for more information on CD and ORD. 
Spectrometric methods, such as NMR, do not directly distinguish between enantiomers in 
spectra. Enantiomers must first be transformed into a diastereomeric state with a suitable 
chiral reagent. Prikle [8] introduced chiral solvents to induce a chemical shift difference 
between enantiomers. If enantioselective interaction with chiral solvent takes place, the chiral 
solvent induces a difference in chemical shift leading to peak separation or peak-splitting, 
which can be used to determine enantiomeric composition. With most of the chiral solvents 
the effect is often too small for practical use, but this problem can be overcome by using 
highly effective lanthanide shift reagents (complexes containing Eu3+ or Pr3+) [9]. These 
paramagnetic complexes interact with electron donating groups (such as hydroxyl, carbonyl 
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and carboxyl and amino groups) resulting in a marked downfield shift of nuclei near to loci of 
interaction, consequently improving resolution. The absence of a high purity reference 
standard, however, limits chiral NMR to determination of enantiomeric composition. 
It is obvious that the accuracy with which optical purity can be determined improves when 
enantiomers are already separated. Chromatographic methods such as gas chromatography 
(GC) and liquid chromatography (LC) are therefore feasible alternatives in the determination 
of optical purity and absolute configuration of an enantiomer. The success of these 
chromatographic methods (GC or LC) depends on the type of chiral separation. Optical purity 
can be determined indirectly with chiral derivatisation and separation on conventional GC or 
LC columns. Direct determination is done by separation of enantiomers on chiral stationary 
phases (CSP) in GC and LC or using chiral solvents with conventional LC columns. 
Chiral derivatisation produces diastereomers that can be separated by conventional GC or LC, 
because of their different chemical and physical properties. In GC it is often necessary to 
derivatise the analyte to ensure volatility; if derivatisation leads to diastereomeric analytes, 
determination of enantiomeric composition is possible. In LC much of the early work on 
chiral derivatisation was done on amino acids, because early stereochemical analysis was on 
peptide synthesis products. It was found that LC separation of diastereomeric dipeptides was 
easily accomplished and that activated amino acids are useful derivatisation agents [1]. We 
decided against using chiral derivatisation for determining the enantiomeric composition of β-
NC14, because of several drawbacks in the quantitative analysis. Firstly, contamination of the 
derivatisation agent may lead to formation of enantiomers that are difficult to separate; 
secondly racemisation or epimerisation may take place; and thirdly, the derivatisation reaction 
may be incomplete. More comprehensive information on chiral derivatisation and separation 
can be obtained from [1] and [10]. 
Direct optical resolution by chiral chromatography is clearly preferable to above pre-column 
chiral derivatisation. Chiral chromatography can be accomplished by using a chiral column 
with an achiral mobile phase (GC and LC) or an achiral column with chiral solvent (only LC). 
Optical resolution is obtained by reversible diastereomeric association between chiral selector 
and solute enantiomers. This non-covalent interaction is mostly steric in which dipole-dipole, 
charge transfer, hydrogen bonding, electrostatic, and hydrophobic interaction are very 
important. Achiral stationary phases are converted to liquid chiral stationary phase in LC, if 
the chiral constituent in chiral solvent adsorbs on the stationary phase. If the interaction 
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between the chiral mobile phase constituents and the analytes are more favourable, non-
covalent diastereomeric complexes are generated. In most cases separation of enantiomers is 
accomplished by both interaction with the liquid chiral stationary phase and formation of 
mobile phase non-covalent diastereomeric complexes. Some experience with this type of 
chromatography, using a C18 stationary phase and N’,N-dimethyl-L-phenylalanine in copper 
acetate as chiral mobile phase, was gained in the analysis of enantiomeric purity of residues in 
a synthetic 23 residue peptide [11]. Although highly repeatable results were obtained, this 
separation method was found to be somewhat unpredictable because of its absolute 
dependence on equilibration in coating the achiral stationary phase, or the prerequisite of 
formation of stable diastereomeric complexes. An alternative, not limited to LC, is the use of 
permanent chiral stationary phases (CSP). Most of the early work on CSPs was done in the 
field of chiral GC. Chiral stationary phases were functionalised with an amino acid such as  
L-Pro (due to the limited racemisation of this residue) and have been successfully applied in 
chiral GC and LC. The LC mode, however, also exploits the ability of amino acids to form 
chelates with metal such as copper as in the previous example (Fig. 3.2 C, Table 3.1). The 
difference in dissociation constants of the diastereomeric complexes with the metal ions can 
then be used to obtain chiral resolution.  
Chiral recognition in other types of CSP’s depends on various types of interaction between the 
chiral selector and the chiral compounds. Dalgliesh [1] proposed a three-point interaction 
model to explain the chiral separation of some aromatic amino acids by paper 
chromatography. He proposed that hydrogen bonds are formed between the hydroxyl groups 
of the cellulose and the carboxyl and amino groups of the amino acid, while the third point of 
interaction was due to the aromatic ring substituents (Fig. 3.2 A, Table 3.1). Three-point 
interaction was also proposed by Prikle and Finn [12] for enantioselection by the charge-
transfer or so-called Brush chiral selectors (Fig. 3.2 A, Table 3.1). This type of 
enantioselection requires at least the interaction of pi-electron systems. Additional polar 
interaction (hydrogen bonding or dipole interactions) leads to very efficient LC chiral 
selectors (Fig. 3.2 A, Table 3.1). An important feature of these selectors is their 
reciprocityenantioselectivity is independent of which chiral partner is immobilised. 
Another type of chiral selection depends on the chiral inclusion or insertion of the enantiomer 
in a so-called chiral cavity. Crown ethers and polymers such as starch, cellulose derivatives, 
polyacrylamides and cyclodextrins have been widely used as inclusion or insertion chiral 
selectors (Fig. 3.2 B) [13]. The chiral cavity can either be hydrophilic (as in chiral GC and 
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LC) or hydrophobic (only in chiral LC) to respectively include hydrophilic and hydrophobic 
analytes (Fig 3.2 B; Table 3.1.). Reversed-phase LC in combination with hydrophobic 
interaction, with steric effects from substituents in the chiral selector, is thought to lead to 
enantioselection by some of the chiral cavity selectors [13].  
The potential for chiral selectivity is obvious from the selective nature of protein-ligand 
interaction. Despite this potential only albumin and α1-acid glycoprotein [1], and recently 
cellobiohydrolase I [19], have been used as LC chiral selectors, with the best results obtained 
when these proteins were immobilised on silica (Fig. 3.2 D, Table 3.1) [1]. Because of the 
complex nature of the proteins, the mechanism of chiral selection is unknown. It is, however, 
influenced by pH, ionic strength and organic modifier. 
The principle of complex chiral selection, using various modes of interaction, has been 
exploited in the LC chiral selectors developed by Armstrong et al. [15, 16] in 1994. They used 
silica-bonded macrocyclic peptide antibiotics, teicoplanin and vancomycin, as chiral selectors 
in HPLC (marketed as ChirobioticTM columns) (Table 3.1). 
Table 3.1 Classification of chiral stationary phases 
Type Chiral selector Interaction Enantioselection  Ref. 
Brush 
(Prikle) 
various small chiral 
selectors e.g. amino 
acid derivatives; 
nitroaromatics 
H-bonding; dipole 
stacking; charge transfer 
(pi−pi interaction) 
Dalgliesh or Prikle 
type of chiral 
selective interaction 
(Fig 3.2 A) 
1, 12 
Chiral 
cavities 
crown ethers and 
polymers e.g. 
cellulose derivatives  
polyacrylamides 
cyclodextrins  
inclusion/insertion 
complexes 
hydrophobic 
interaction and steric 
interference  
(Fig. 3.2 B) 
1, 13 
Metal co-
ordination 
amino acid-metal 
complexes 
diastereomeric metal 
complexes 
diastereomeric 
ligand exchange (Fig 
3.2 C) 
1, 14 
Protein ligand specific 
protein e.g. bovine 
serum albumin, 
orosomucoid 
selective ligand binding stereospecific ligand 
binding  
(Fig 3.2 D) 
1 
Antibiotic amphoteric 
glycopeptide e.g. 
teicoplanin (Fig 3.3); 
vancomycin 
combination of chiral 
cavity and brush type 
interaction 
various 
enantioselective 
mechanisms 
(Fig 3.3) 
15-17 
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A
B
C
silica
achiral
spacer
chiral moiety
Type of interactions:
dipole/ dipole
/
hydrogen bonding
steric hindrance
    
A'
B'
C'
A
B'
C
A
B
C
     solute
enantiomers
chiral
selector
three point
interaction
 
 
chiral
selector -
cyclodextan
chiral 
compound 
in cavity
chiral 
pore
chiral
selector -
dextran or 
dextran derivative
 
Me
O
HH
O
HH
R
R2
R1
 solute
enantiomer
chiral solid
phase
 co-ordinated 
metal ion
 
Protein Protein
chiral
selector
chiral
binding
equilibria
 
Figure 3.2     Enantioselective mechanisms: Brush chiral selection as described by Prikle and 
Dalgliesh’s three point interaction model (A); chiral cavities (inclusion and 
insertion) (B); chiral metal co-ordination complexes (C); and, protein as chiral 
selector (D). [1,18] 
B 
C 
D 
A 
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Teicoplanin (Fig 3.3) and vancomycin contain multiple chiral centres, which include chiral 
cavities, pi-electron systems, hydrogen donor and acceptor sites and several other polar 
interaction sites. These columns have been shown to be highly selective for several neutral 
molecules, amides, acids, esters and cyclic amines and possess many of the separation 
characteristics of protein-based CPS’s [17]. The ChirobioticTM columns, especially the 
teicoplanin type, are also very versatile in both reversed phase and normal phase solvents. 
This is of great importance for this study where the insolubility of the non-polar β-NC14 
limited the choice of type of chiral LC. Chiral GC was not readily available although it would 
have been a more feasible alternative, because of the availability of chiral columns developed 
for the separation of aliphatic enantiomers. The use of reverse phase solvents also made the 
combination of chiral chromatography with electrospray mass spectrometry possible. It was 
therefore decided to use the teicoplanin chiral selector (ChirobioticTM T) linked to ESI-MS to 
elucidate the absolute configuration of the β-NC14 residue in the iturin A2 analogues. 
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Figure 3.3     Macrocyclic peptide antibiotics teicoplanin as silica-bound chiral selector in 
HPLC (marketed as ChirobioticTM  T column) [17]. 
If the retention time of one of the enantiomers is known, it is possible to determine absolute 
configuration with chiral chromatography. If it is assumed that an enantiomer and a related 
reference standard are separated by the same chiral mechanism, absolute configuration can 
also be determined, but with some uncertaintythe compound’s absolute configuration is 
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deduced solely from the enantioselectivity mechanism of the chromatographic method. In the 
case of complex interactions, and sometimes more complex compounds, this latter technique 
alone is not reliable, and data must be supported by independent techniques such as NMR or 
CD.  
In this study of the function-structure relationship of iturin A, it was important that the 
synthetic products be of high chemical purity. The adaptability of electrospray ionisation mass 
spectrometry (ESI-MS) to HPLC and chiral LC was used to verify the optical purity of the 
synthetic peptide preparations. A reference standard of the D-enantiomer of β-NC14 was 
available, therefore the absolute configuration of the β-NC14 residue, introduced in each 
peptide, could be elucidated by using chiral LC linked to ESI-MS. 
3.2 Materials 
The four linear lipopeptides (7-Beta I, II and 8-Beta I, II), their cyclic analogues (cyclic 7-Beta 
I, II and cyclic 8-Beta I, II) and the two peptides without the β-NC14 (NYNQPNS and 
YNQPNS) were synthesised using the Fmoc-polyamide peptide synthesis protocol and 
purified using semi-preparative HPLC (described in Chapter 2). The HCl salt of racemic  
β-aminotetradecanoic acid (β-NC14.HCl) was donated by Dr. R. Levitt, previously from Fine 
Chemicals, South Africa. The t-butyloxycarbonyl derivative from racemic β-NC14.HCl was 
synthesised as described in Chapter 2 under 2.3.2.1. The enantiomerically pure  
t-butyloxycarbonyl derivative of β-D-aminotetradecanoic acid ((R)-(+)-tBoc-iturinic acid) was 
synthesised by the department of Chemistry, University of Stellenbosch, according to the 
method of Bland [20]. D-phenylalanine was from Aldrich Chemical Co. (Gillingham, UK).  
L-phenylalanine, trifluoroacetic acid (TFA, 99.5%), constant boiling hydrochloric acid (HCl) 
(30%), phenol (99.5%) and absolute ethanol (99.8%) were from Merck (Darmstadt, 
Germany). Nitrogen gas (N2) and liquid nitrogen were from Afrox, South Africa. Acetonitrile 
(HPLC-grade, UV cut-off 190 nm) and methanol (HPLC-grade, UV cut-off 205 nm) were 
from Romil LTD (Cambridge, UK). Nova-Pak C18 analytical HPLC columns (150 x 3.9 mm, 
60 Å, 5 micron particle size), 0.45 micron HV membrane filters were from Millipore-Waters 
(Milford, USA). Polygosil C18 packing material, Inertsil microbore C4 and C8 HPLC columns 
(150 x 2 mm, 60 Å, 5 µ particle size) were from Macherey-Nagel (Düren, Germany) and 
Chirobiotic TTM chiral HPLC column (150 x 4.6 mm) from Advanced Separation 
Technologies Inc. (Whippany, USA). Analytical grade water was prepared by filtering glass 
distilled water through a Millipore Milli Q® water purification system. 
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3.3 Methods 
3.3.1 High performance liquid chromatography  
Reverse phase high performance liquid chromatography, using a C18 Nova-Pak HPLC column 
with the system described under section 2.3.6.2, was used to evaluate the lipopeptides. The 
chromatography was monitored at 254 nm. Linear gradients were created using eluant A 
(0.1% TFA in water) and eluant B (90% acetonitrile and 10% A). (Refer to Chapter 2, section 
2.3.5.2 for more detail.) 
Isocratic liquid chromatography ESI-MS (LC-ESI-MS) was performed using an inline Inertsil 
C8 microbore (150 x 2 mm) HPLC column for the lipopeptides and Inertsil C4 microbore (150 
x 2 mm) HPLC column for the Nβ-t-butyloxycarbonyl-β-aminotetradecanoic acid preparation. 
Isocratic chromatography was done with 50% acetonitrile in water at a flow rate of 70 µL/min 
using a Pharmacia LKB 2249 gradient pump for solvent delivery. 
3.3.2 Chiral liquid chromatography 
Chiral LC-ESI-MS of the β-NC14 was done on an enantiomeric mixture and a chiraly pure 
preparation of the β-D-aminotetradecanoic acid. The preparation of the t-butyloxycarbonyl 
(tBoc) derivative of β-NC14 was treated with TFA (10 mg/100 µL) for 30 minutes to remove 
the tBoc group and liberate β-NC14. The TFA was removed using a nitrogen stream followed 
by further drying under high vacuum and the residual material dissolved in 10 mL 50% 
acetonitrile for chiral LC-ESI-MS analysis. Chiral liquid chromatography (chiral LC) was 
performed using a Chirobiotic TTM column (150 x 4.6 mm) inline with ESI-MS described 
hereafter under 3.3.3. Isocratic conditions, with either 30%, 40%, 50% methanol or 30% 
ethanol in water at a flow rate of 500 µL/min using a Pharmacia LKB 2249 gradient pump for 
solvent delivery, were used in chromatography of β-NC14. A stream-split was used allowing  
60 µL/min to enter the electrospray ionisation chamber. Chromatography of standard D/L-Phe 
was accomplished with 40% methanol in water as eluant. The column was regenerated with 
20-50 bed volumes isopropanol followed by 20-50 bed volumes 50% acetonitrile to remove 
retained β-NC14 and other components. 
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The chiral identity of the β-NC14 residue in each of the purified lipopeptide preparations was 
determined by analysing the peptide hydrolysates. A small amount (0.2 to 1 mg) of each of the 
peptides was hydrolysed according to the protocol outlined in Chapter 2 section 2.3.6.3. The 
shortened hydrolysis procedure (150oC, 1 hour) was performed if possible immediately before 
ESI-MS analysis. Gaseous phase hydrolysis was, as before, accomplished under a nitrogen 
atmosphere using 6 N HCl containing 1% phenol. After hydrolysis the acid was removed from 
the samples under high vacuum and the residual material dissolved in 100 µL 50% 
acetonitrile/water for chiral LC-ESI-MS analysis. The samples were then diluted 10 times 
with the 40% methanol/water and 10 µL was analysed per run. Because room temperature 
storage leads to deamination of the β-NC14, samples were either directly analysed or stored at 
−80oC until analysis. Isocratic conditions, with 30% ethanol in water at a flow rate of 500 
µL/min., were used in chromatography of the peptide hydrolysates. 
3.3.3 Electrospray mass spectrometry 
ESI-MS, using a Micromass triple quadrupole electrospray mass spectrometer fitted with an 
electrospray source, and LC-ESI-MS was employed to investigate the synthetic components. 
The 50% acetonitrile in water carrier solvent was delivered at a flow rate of 20 µL/minute 
during each analysis. Ten µL of the sample solution (2 ng peptide in 50% acetonitrile/water 
containing 0.05% TFA) was introduced into the ESI-MS using a Rheodyne injector valve. A 
capillary voltage of 3.5 kV was applied, with the source temperature at 80oC. The cone 
voltage was 70 V and the skimmer lens offset 5 V. Data acquisition was in the positive mode, 
scanning the first analyser (MS1), through m/z = 300−1300 or 1500 at a scan rate of 100 
atomic mass units/second. Representative scans were produced by combining the scans across 
the elution peak and subtracting the background. Product ions were detected in MS1 after cone 
voltage decomposition between 70 and 100 V or in MS2 after decomposition at collision 
energy between 10 eV and 40 eV with cone voltage at 70 V and the argon pressure in the 
collision cell at (2.5 ± 0.3) x 10-3 millibar. 
LC-ESI-MS and chiral LC-ESI-MS were performed using an inline column (described under 
3.3.1 and 3.3.2). The rest of the conditions and settings for both types of chromatography were 
as above. Single ion recording (SIR) at 243.5, the Mr of β-NC14, was used to visualise the 
chiral chromatography of β-NC14. 
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3.4 Results and discussion 
During the purification of the four longer linear lipopeptides (discussed in Chapter 2) two 
fractions corresponding to each lipopeptide were collected (Figs.3.4 A, 3.5 A). These peptide 
fractions were identical in terms of the TLC behaviour, amino acid composition and mass 
spectra.  
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Figure 3.4    A. Preparative HPLC profile of the peptide preparation of 7-Beta obtained on a 
C18 Polygosil column (250 x 10 mm). The gradient was developed over 13 
minutes from 30% A (0.1% TFA in water) to 100% B (90% acetonitrile, 10% A) 
using a flow rate of 3.0 mL/min. B. The ESI-MS spectra of the two partially 
resolved components (7-Beta I and II) of 7-Beta. 
B 
A 
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Figure 3.5     Analytical HPLC profiles of the peptide preparation of 8-Beta on a C18 Nova-
Pak column (150 x 3.9 mm). The gradient was developed over 13 minutes from 
30% A (0.1% TFA in water) to 100% B (90% acetonitrile, 10% A) using a flow 
rate of 1.0 mL/min. B. The LC-ESI-MS profile (total ion count, TIC) of the 8-
Beta peptide preparation and mass spectra of the two resolved components. 
Chromatography was done on an inline Inertsil C8 column (150 x 2.0 mm) with 
50% acetonitrile in water as mobile phase and a flow rate of 70 µL/min. C. Cone 
voltage-induced product ions of the two resolved components, 8-Beta I and 8-
Beta II. 
The two HPLC purified fractions of the linear 7-Beta preparation were analysed by ESI-MS 
and it was found that the spectra of these two fractions were identical (Fig. 3.4 B). The HPLC 
behaviour (Fig 3.4 A) of these two compounds could not be explained by differences in 
peptide sequence, as their amino acid composition is also identical (see Chapter 2). The two 
components in the 8-Beta preparation differed very little in their HPLC behaviour (Fig 3.5 A) 
and it was thus difficult to prepare a homogenous peptide. LC-ESI-MS analyses with its high 
resolving power again revealed two components of the 8-Beta preparation with identical 
molecular ions (Fig. 3.5 B). Fragmentation by cone voltage-induced dissociation produced 
identical fragments from both components, indicating identical amino acid sequences (Fig. 3.5 
C). 
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Analytical HPLC and ESI-MS of the purified hexapeptide (YNQPNS) and purified 
heptapeptide (NYNQPNS) confirmed the purity of the peptide moieties of 7-Beta and 8-Beta 
(Fig. 3.6).  
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Figure 3.6    Analytical HPLC profiles and the ESI-MS-spectra of YNQPNS hexapeptide (A), 
and NYNQPNS heptapeptide (B). Chromatography was done on a C18 Nova-Pak 
column (150 x 3.9 mm). The gradient was developed over 15 minutes from 95% 
A (0.1% TFA in water) to 100% B (90% acetonitrile, 10% A); flow rate 1.0 
mL/min. 
The fact that the second HPLC peak appeared only after coupling the β-amino fatty acid to the 
peptide indicated that the introduction of this residue was the cause of the appearance of two 
compounds, which could be either enantiomers or conformers. The synthesis method limits 
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racemisation of the amino acids during coupling to a maximum of 0.4% [21]. The two 
peptides observed in each preparation were probably the consequence of the introduction of a 
racemic mixture of the N-terminal β-NC14 residue. Most of the peptide synthesis work was 
completed before Bland [20] in 1995 successfully synthesised enantiomerically pure β-D-
amino-tetradecanoic acid. A product synthesised with the protocol of Levitt [22], which 
produced a racemic mixture of β-NC14, was incorporated into the iturin A2 analogues. LC-
ESI-MS of the t-butyloxycarbonyl derivative of β-NC14, used in the syntheses, revealed two 
components, with identical molecular ions, confirming that the preparation was a racemic 
mixture (Fig. 3.7). 
Repeated crystallisation of the Nβ-t-butyloxycarbonyl-β-aminotetradecanoic acid from 
acetonitrile resulted in an enriched preparation of one of the isomers. The isomeric 
composition of the enriched preparation could not be accurately determined using normal 
reverse phase LC-ESI-MS (Fig. 3.7) because of insufficient resolution. The percentage 
enriched isomer was determined by chiral chromatography linked to ESI-MS as 60% of the 
total (Fig. 3.8). 
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Figure 3.7    LC-ESI-MS profile (TIC) of the enriched preparation of Nβ-t-butyloxycarbonyl-
β-aminotetradecanoic acid and mass spectra of the two components. 
Chromatography was done on an inline Inertsil C4 microbore column (150 x 2.0 
mm) with 50% acetonitrile in water as mobile phase and a flow rate of 70 
µL/min. 
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The results, obtained during the development of a chiral separation method for β-NC14 using 
different isocratic conditions (30%, 40% and 50% methanol in water), are depicted in Fig. 3.8. 
It was not possible to obtain baseline separation with any of the methanol mixtures or if the 
methanol was substituted with ethanol. Addition of 0.1% TEA/acetate in 30% methanol 
resulted in total depression of the ESMS signal (results not shown). Other solvent mixtures 
such as 40 to 50% acetonitrile in water, sometimes containing a small percentage of 
isopropanol, did not resolve the enantiomers. The best separation (sufficient resolution with a 
short elution time) between the two enantiomers was obtained by using the general α-amino 
acid isocratic LC conditions (40% methanol in water) (Fig. 3.8 B)[17]. 
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Figure 3.8    Chiral LC-ESI-MS profiles of the enriched Nβ-t-butyloxycarbonyl-β-
aminotetradecanoic acid preparation after treatment with TFA to liberate β-
NC14. Chromatography was done on an inline Chirobiotic TTM column (150 x 
5.0 mm) with mobile phases (A) 50% methanol in water; (B) 40% methanol in 
water, and (C) 30% methanol in water. The flow rate was 0.5 mL/min and single 
ion recording (SIR) at 243.5, the Mr of β-NC14, was used to visualise the 
chromatography. (D) Chromatography of standard D-Phe and L-Phe with 40% 
methanol in water as eluant and SIR at 165.2, the Mr of Phe. 
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The absolute configuration of components in the Nβ-t-butyloxycarbonyl-β-aminotetradecanoic 
acid preparation, after treatment with TFA to liberate β-NC14, could not be deduced from only 
chiral chromatography without using the pure enantiomer with known chirality as a reference 
standard (Fig. 3.8). It was, however, observed during the chiral separation of L-Phe and  
D-Phe that the L-enantiomer eluted first and the D-enantiomer second on the Chirobiotic TTM 
column (Fig. 3.8). These results were in accordance with the elution profiles observed for all 
of the 20 α-amino acids on the teicoplanin type chiral selector as shown by Armstrong et al. 
[15, 16].  
Cyclisation of the 7-Beta and 8-Beta lipopeptide preparations produced the cyclic 7-Beta and 
cyclic 8-Beta diastereomers (refer to Chapter 2). To ascertain the absolute configuration of the 
β-NC14 residue in each of the eight lipopeptide preparations, the β-NC14 in each of the peptide 
hydrolysates was identified by chiral chromatography (chiral LC-ESI-MS) (Figs. 3.9, 3.10, 
Table 3.2). During the first analysis of the peptide hydrolysates, using 40% methanol in water 
as eluant, extensive peak retention drift occurred from elution at about 20 minutes to elution 
after more than an hour (Fig. 3.9). This drift coincided with the total loss of resolution. This 
method probably failed because of column coating by β-NC14, effectively converting the 
chiral stationary phase to a reverse phase. The column was washed with different organic 
solvents and revived to such an extent that base line separation of L- and D-Phe (Fig. 3.8 D) 
was again obtained. The separation of the enantiomers of β-NC14 was, however, not regained. 
Because of the enormous expense of chiral LC columns it was not possible to replace the 
item. An alternative chromatographic technique such as chiral GC, which would have been a 
better option, was not available to us. Alternative solvents were again investigated and some 
resolution, with less drift in retention volume, was obtained between the β-NC14 enantiomers 
using 30% ethanol in water as mobile phase (Fig. 3.10). This resolution was not adequate for 
chiral purity assessment, but sufficient for identification of the major enantiomer in each 
preparation (Fig. 3.10). 
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Figure 3.9     Example chiral LC-ESI-MS profiles of β-NC14 (A, B) and a hydrolysate of 8-
Beta II (C, D) illustrating the retention time drift experienced with 40% 
methanol in water as eluant. Chromatography was accomplished by using a 
Chirobiotic TTM column (150 x 5.0 mm) with flow rate of 500 µL/min. 
Chromatography was visualised using SIR of β-NC14 (m/z 243.5). 
If the β-NC14 chiral separation took place via the same mechanism as with the α-amino acids 
it could be hypothesised that the L-enantiomer is the first eluting component and the  
D-enantiomer the second eluting component, although this could only be verified with the use 
of a β-NC14 reference standard of known chirality. Biological activity in the cyclic 8-Beta II 
preparation was, however, similar to that of natural iturin A [5] (refer to Chapter 6). If cyclic 
8-Beta II is the synthetic iturin A2 analogue it must contain the D-enantiomer of β-NC14; 
therefore we cannot deduce that the elution order of the enantiomers of β-NC14 is the same as 
 A 
 C 
 B 
 D 
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that of α-amino acids. It was therefore necessary to synthesise a pure enantiomer of  
β-NC14. A t-butyloxycarbonyl derivative of β-D-aminotetradecanoic acid was synthesised 
according to Bland [20], with some adaptations, and used as the reference standard (Fig. 3.10 
B).  
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Figure 3.10   Example chiral LC-ESI-MS profiles of (A) the β-NC14 preparation used in 
syntheses; (B) enantiomerically pure β-D-NC14 , and hydrolysates of (C) cyclic 
8-Beta I and (D) cyclic 8-Beta II. Chromatography was done one an inline 
Chirobiotic T TM column (150 x 5.0 mm) with 30% ethanol in water as mobile 
phase and a flow rate of 500 µL/min. Chromatography was visualised using SIR 
of β-NC14 (m/z 243.5). 
We were able to obtain separation of the eight HPLC purified lipopeptides using analytical 
HPLC (refer to Chapter 2, section 2.4.2.1), facilitating the determination of the chiral purity of 
the peptide samples (Table 3.2).  
 B 
 A 
 C  D 
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Table 3.2 A summary of the data (duplicate analyses) obtained from analytical RP-HPLC, 
chiral-LC-ESI-MS and CD for β-NC14 and the 8 purified lipopeptide isomers (# 
refer to Chapter 2, section 2.4.2.1; retention times were corrected for * +5% and 
$
 −3% drift). 
 
Peptide 
RP-HPLC 
Rt (min.) 
of 
 peptide #  
Chiral LC 
Rt (min.) 
of  
β-NC14 
Absolute 
configuratio
n of β-NC14 
Chiral 
purity 
(%) 
Revised 
name of peptide 
Std β-D,L-NC14 − 52.5; 54.4 D, L − − 
Std β-D-NC14 − 52.8$ D − − 
7-Beta I 9.60 54.9 L 89 7-Beta I (L) 
7-Beta II 9.80 52.3 D 84 7-Beta II (D) 
8-Beta I 8.90 52.8* D 79 
8-Beta I (D) 
(linear iturin A2) 
8-Beta II 9.03 55.1* L 83 8-Beta II (L)  
cyclic 7-Beta I 9.13 52.5* D 100 cyclic 7-Beta I (D) 
cyclic 7-Beta II 9.27 55.7 L 82 cyclic 7-Beta II (L) 
cyclic 8-Beta I 8.70 54.5 L 100 cyclic 8-Beta I (L) 
cyclic 8-Beta II 8.90 52.8 D 84 
cyclic 8-Beta II (D) 
(iturin A2) 
 
The difference in HPLC retention of the peptide diastereomers is the result of the chiral 
difference between the incorporated β-NC14 residues. The chiral purity of all the HPLC 
purified peptides was greater than 80%, except 8-Beta I (D) at 79%. Two of the cyclic 
peptides were virtually 100% pure in terms of HPLC and enantiomeric purity. 
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3.5 Conclusions 
The peptides synthesised in this study were found to be isomeric mixtures with the mixed 
chiral centre located at the β-carbon of the β-NC14 residue. The racemic nature of the 
synthetic lipopeptides complicated purification and decreased yields. The HPLC behaviour of 
the peptides was influenced by the β-NC14 residue, as the conformation of the diastereomers 
in solution is probably different, resulting in different hydrophobicities. Purification of the 
diastereomers to greater than 80% chiral purity in all but one preparation was accomplished. 
The inclusion of the racemic β-amino fatty acid in the peptides, however, introduced a new 
structural aspect in this investigation. 
Chiral and reverse phase LC-ESI-MS proved powerful tools to resolve chiral composition 
(optical purity) of the lipopeptides in this study. Using standard β-D-NC14, the absolute 
configuration of the β-NC14 residue in each peptide preparation was determined. This is the 
first time that the combination of chiral LC, using a Chirobiotic TTM column, and ESI-MS was 
successfully used to elucidate the composition and chiral identity of a β-amino acid residue. 
This method may prove useful for future investigation of chirality in peptides. 
The influence of deviation from the constant cyclic DLDDLLDL chiral sequence of iturin A 
on its structure, as studied with NMR, CD and molecular modelling of the four 
octalipopeptides, will be discussed in Chapter 4. In Chapter 5 the influence of chirality and 
peptide structure on the association of the lipopeptide with alkali metal ions will be reported. 
The importance of stereoselectivity on the bioactivity of the lipopeptides will be addressed in 
Chapter 6. 
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Chapter 4  
A structural study of the octalipopeptide analogues 
of iturin A2 
4.1 Introduction 
An range of physical methods, that make use of some part of the electromagnetic spectrum 
(Fig. 4.1), is available for the structural analysis of simple molecules. The highly complicated 
structures of peptides and proteins challenged the physical chemistry field to such an extent 
that many of these methods evolved to accommodate even the most complicated structure. 
This challenge also extended into the realm of computer science: molecular modelling 
programs for the prediction of molecular structure were developed and are still evolving along 
with the accumulation of physical data, such as covalent bond distances and angles, group 
planarity, van der Waals radii and other inter atom distances in chemical groups. A short 
summary of some of the main techniques for the study of molecular structure, such as nuclear 
magnetic resonance, spectroscopic methods based on the chromatophoric properties of 
molecules, and the ultimate method for three-dimensional (3D) structure determination 
namely, X-ray crystallography, will be given in this chapter.  
1 10 10 10 10 10 102 3 4 5 6
X-rays UV
visible infrared microwave
electronicType of 
transition
vibrational rotational nuclear
inner shell outer shell
Means of
study X-ray diffraction
Absorption
spectroscopy Infrared and Raman spectroscopy
Nuclear
magnetic
resonance
Wavelength (nm)
 
Figure 4.1    The relevant part of the electromagnetic spectrum in structure determination with 
spectroscopic methods [adapted from 1]. 
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The determination of the 3D structures of small proteins and peptides became possible with 
the development of two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopy 
and more recently 3D and 4D techniques. NMR is the result of the absorption and re-emission 
of radio-frequency radiation by atomic nuclei, when placed in a strong magnetic field, and 
depends on the charge and spin of nuclei. NMR spectroscopy can also give the position of 
individual hydrogen atoms, which is beyond the scope of X-ray crystallography. Because of 
the differences between the resonance frequency of isotopes in a given magnetic field, only 
one isotope is studied directly in an NMR experiment. NMR studies in biochemistry utilised 
nuclei with spin number (I) of ½, namely 1H, 13C, 15N, 19F and 31P. In a stationary magnetic 
field only one energy transition is possible for a nucleus with I = ½ and the transition is the 
result of absorption of electromagnetic radiation with a specific frequency (v). The shielding 
of nuclei from the external magnetic field by their electrons differ in different chemical 
groups. These atoms will therefore resonate at different frequencies or will have different 
chemical shifts (symbolised by δ in parts per million; ppm), which will facilitate 
identification. The resonance intensity of a chemical group is directly proportional to its 
quantity. NMR spectra often contain multiplets of two or more clustered spectral lines, 
exceeding the number of chemically different nuclei. The splitting of resonance lines into 
multiplets is not due to chemical shift, but the result of electron-coupled interactions between 
spins of covalent bonded nuclei (spin-spin coupling). The molecular structure and 
stereochemistry, including electron distributions and bond angles, can be correlated to the 
observed coupling constants. Two dimensional correlation spectroscopy (2D-COSY) provides 
connectivity between spins through, for example, scalar coupling. The interproton distances 
through space are determined by the nuclear Overhauser effect spectroscopy (NOESY). Refer 
to [1-3] for more information on NMR spectrometry. 
An NMR study in 1978 of iturin A dissolved in pyridine was the first attempt to elucidate the 
3D structure of iturin A [4]. It was proposed that the characteristic constant LDDLLDL chiral 
sequence of the seven α-amino acid residues and the β-D-amino fatty acid (iturinic acid) in 
the peptide ring included two hydrogen-bonded β-turns. Garbay-Jaureguiberry et al. [4] 
proposed that one turn, a type II β-turn, is formed by L-Gln5-L-Pro6-D-Asn7-L-Ser8 and the 
second, a type I’ β-turn, by Asn2-D-Tyr3-D-Asn4-L-Gln5. This structure of iturin A in pyridine 
was refined by Marion et al. [5] using NMR combined with molecular modelling (Fig. 4.2). 
The two tetrapeptide units, β-amino fatty acyl-Asn2-D-Tyr3-D-Asn4 (turn A) and L-Gln5-L-
Pro6-D-Asn7-L-Ser8 (turn B), were classified as type II β-turns with distorted hydrogen bonds. 
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A third turn is formed by Asn2-D-Tyr3-D-Asn4-L-Gln5 (turn C), as originally proposed [4], 
and could be classified as a type I’ or III’ β-turn or the beginning of a 310-helix. The existence 
of these β-turns in the iturin A structure may be of importance in the interaction of the peptide 
with the monovalent cations, Na+ and K+. Our investigation into interaction with Na+ and K+ 
is reported in Chapter 5.  
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Figure 4.2    The structure of iturin A2. This drawing is an adaptation from the structure 
deduced by Marion et al. [5] from nuclear magnetic resonance spectrometry data 
and molecular modelling of natural iturin A. The dashed lines represent 
hydrogen bonds that stabilise the structure. 
The physical phenomena on which light spectroscopic methods are based, namely absorption, 
refraction, circular dichroism (CD) optical rotary dispersion (ORD), are closely related, 
because of their dependence on the properties of light. Light may be described as an 
oscillating electric vector that is affected by the electric dipole moment of an absorbing unit 
(chromophore) and vice versa [6] (Fig 4.3). Light is circularly polarised if the electric vectors 
of two electromagnetic waves are 0.25 λ out of phase. The resulting molecular ellipticity ([θ]; 
the difference in absorbance of left and right circularly polarised light) is measured with CD 
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and molecular rotation ([φ]; the difference in refractive index of left and right circularly 
polarised light) with ORD (Fig. 4.3; also refer to Chapter 3). 
direction of propagation
wavelength (λ )
E
(oscillating electric field)
H
(m agnetic field)
A
B
E 1
E 2
E 1
E 1
E 2
 
Figure 4.3    A. Propagation of an electromagnetic wave. The thick line follows the path of the 
E-vector and the thin line that of the H-vector. These vectors are perpendicular 
and mutually perpendicular to the direction of propagation.  
B. Generation of circularly polarised light. If the E-vectors of two 
electromagnetic waves are 0.25 λ out of phase, circularly polarised light is 
generated [adapted from 1]. 
Beer’s Law states that the absorbance of a solution is directly proportional to the 
concentration of the chromatophores. This law is no longer valid if the chromatophores 
aggregate or are within one large molecule such as a peptide or a protein. The absorption band 
of the chromatophore can undergo a blue shift to shorter wavelengths, a red shift to longer 
wavelengths, split into two bands, increase in intensity (hyperchromism) or decrease in 
intensity (hypochromism) [6]. These changes can be related to the conformation and 
interactions of the polymer. The major absorbing units, generally exploited in the 
spectrophotometry of protein and peptides, are the amide bonds (peptide bonds) and the 
aromatic side-chain groups of Tyr, Trp and Phe. These chromatophores and their interaction in 
the protein structure can be analysed by CD and ORD to elucidate the secondary conformation 
of a solvated protein. ORD and CD curves of model polypeptides with a single conformation 
were used to construct “standard” curves for α-helical-, β-sheet-, β-turn- and random coil 
conformation (Fig. 4.4) [1]. It is assumed that no other conformation exists and the percentage 
of secondary structure is predicted from the “standard” curves [1]. These predictions are fairly 
accurate, but not exact. 
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Figure 4.4    A comparison between ORD and CD spectra of a protein [adapted from 1]. 
The secondary structures of antimicrobial peptides in synthetic membranes (liposomes) such 
as melittin [7], selected melittin analogues [8], and gramicidin S analogues [9] have been 
determined with CD. The design and analysis of model membrane active peptides also 
depended extensively on CD [10]. Only one study by Besson et al. [11] on iturin A, using CD, 
has been reported to date. The CD spectra of iturin A were recorded in tetrahydrofuran (THF) 
and water and indicated that iturin A conformation in water was vastly different from that in a 
hydrophobic environment (as simulated with THF). The existence a type II β-turn 
conformation in THF was again indicated. 
Infrared (IR) spectroscopy utilises the absorption of light in the infrared region (103-105 nm), 
which causes transitions between vibrational levels of a molecule. IR spectra are consequently 
generated by the vibrational motions of functional groups, motions such as bond stretching 
and bond bending. IR absorption spectra are plotted against wave numbers (1/λ) or frequency 
(v). The amide I band, characteristic of the peptide bond, is of enormous value in the study of 
protein and peptide structure. Its absorption frequency depends on environment of the bond 
such as in an α-helix (1/λ =1650 cm-1), β-sheet (1/λ =1632; 1685 cm-1) or random coil (1/λ 
=1658 cm-1)[1]. The relative proportion of the amino acids in any of the three conformations 
can be determined from the intensity of the absorption of the bands. IR-spectroscopy can also 
be used to investigate hydrogen bonding in a macromolecule. An infrared study of iturin A 
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confirmed the existence of hydrogen bonded type II β-turns in the peptide ring, with a 
characteristic amide component band in the range of 1638-1646 cm-1 [11]. It was also 
concluded from the IR study that different solvents induced significant conformational 
changes in iturin A. 
Raman spectroscopy is related to IR-spectroscopy as it also monitors the vibrational motions 
of atoms. It does, however, not have the disadvantage of the strong interference of water in the 
IR spectrum that makes the analysis in aqueous solution virtually impossible [1]. The Raman 
spectrum is generated when the wavelength of a small fraction of the incident monochromatic 
light increases (frequency decreases) because of vibrational transitions. Raman scattering has 
a very low probability and therefore produces low line intensity. Highly concentrated samples 
must be used and this may lead to aggregation, which may complicate the interpretation of the 
spectra. With improved laser technology and the powerful computerised data analyses this 
technique is gaining ground in the investigation of macromolecules such as proteins and 
peptides in membrane environments. For more information refer to [13]. 
Technological and theoretical advances in macromolecular X-ray crystallography, since the 
first X-ray photograph of a protein crystal was obtained by Bernal and Crowfoot [12] in 1934, 
made possible the elucidation of well over 200 protein crystal structures. The structural detail 
provided by X-ray crystallography allows atomic models to be built for larger molecules than 
those handled by NMR spectroscopy. In X-ray crystallography a crystal of a molecule is 
exposed to a collimated beam of monochromatic X-rays and the resultant diffraction pattern is 
recorded on photographic film. The X-rays, with wavelengths of the same order as covalent 
bond lengths (~1.5  ), are scattered by the electrons that surround atoms. The position and 
intensities of diffraction maxima (dark spots on the film) allow the construction of an electron 
density map that is used to form a 3D image of the crystal. For more information refer to [14]. 
We synthesised diastereomers of iturin A2 analogues by incorporating an enantiomeric 
mixture of the β-aminotetradecanoic acid (β-NC14) residue during synthesis (refer to Chapters 
2 and 3). The absolute configuration of the β-NC14 residue in each of the lipopeptides was 
determined with chiral liquid chromatography linked to electrospray ionisation mass 
spectrometry (refer to Chapter 3). The diastereomers differed in HPLC retention, suggesting 
that their hydrophobicity and therefore structures in solution must be different. The deviation 
from the constant DLDDLLDL chiral sequence of the iturin A2 analogues at the chiral centre 
at the β-carbon of the β-NC14 residue consequently has an influence on their physical 
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properties. This influence of the β-NC14 residue and cyclisation on the structures of the four 
purified octalipopeptides (8-Beta I (D), 8-Beta II (L), cyclic 8-Beta I (L) and cyclic 8-Beta II 
(D)) was investigated by employing NMR, CD and molecular modelling. 
Limited quantities of purified octalipopeptides (cyclic and linear peptides) precluded a full 
investigation with NMR, but it was possible to do 13C NMR and 1H NMR on a mixture of  
8-Beta I (D) and II (L). CD was used for determining the influence of a lipidic environment on 
the structure of each of the four octalipopeptides. The structures of the octalipopeptides, 
especially backbone structures, were predicted using a personal computer based molecular 
modelling program HyperChem®4.5 [15]. The predicted structures were compared with the 
iturin A structure proposed by Marion et al. [5] and with structural data from our NMR and 
CD studies. 
4.2 Materials 
The two linear octalipopeptides (8-Beta I (D) and II (L)) and their cyclic analogues (cyclic 8-
Beta I (L) and cyclic 8-Beta II (D)) were synthesised using the Fmoc-polyamide peptide 
synthesis protocol and purified using semi-preparative HPLC (described in Chapter 2).  
HEPES (2-[4-(2-hydroxyethyl-1-perazinyl]-ethane sulphonic acid), dimyristoyl-L-α-
phosphatidylcholine (DMPC) were from Sigma Chemical Co. (St. Louis, USA). Acetonitrile 
(HPLC-grade, UV cut-off 190 nm) was from Romil LTD (Cambridge, UK). Chloroform 
(99%), NaCl and Triton X100 were from Merck (Darmstadt, Germany). Nitrogen gas was 
supplied by Afrox, South Africa. Analytical grade water was prepared by filtering glass 
distilled water through a Millipore Milli Q® water purification system. 
4.3 Methods 
4.3.1 Structural investigation using spectroscopy 
4.3.1.1 Nuclear magnetic resonance spectrometry 
NMR spectra were recorded at 25±0.1oC with a Varian VXR 300 pulsed FT NMR 
spectrometer operating at 299.1 MHz and at 75.42 MHz for the observation of 1H and 13C 
respectively. A diastereomeric mixture of 8-Beta (1 mg) was dissolved in 650 µL 50% 
CD3CN in D 2O (neutral pH) as this lipopeptide is soluble in very few solvents. 1H spectra 
were calibrated by using the residual proton multiplet of CD3CN at 1.91 ppm as a secondary 
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reference. 13C spectra were calibrated using the CD3CN multiplet at 1.28 ppm as secondary 
reference. To enhance the sensitivity for the protonated carbons, a pulse angle of 60 degrees 
and a repetition time of 0.41 seconds were used. In the 1H experiments 45 degree pulses were 
used with a repetition time of 4.1 seconds. 
4.3.1.2 Circular dichroism 
Stock solutions (5 mg/mL) of the octalipopeptides were prepared in 50% acetonitrile/water. A 
20 µL aliquot of these solutions was diluted to 6 mL with 20 mM HEPES containing 150 mM 
NaCl (pH 7.4) to give a final concentration of 1.5 µM. A second 20 µL aliquot was mixed 
with 500 µL of a 2.5 mg/mL dimyristoyl-L-α-phosphatidylcholine liposome preparation and 
then diluted to 6 mL. The peptide to lipid ratio was 1.5:25 in the final preparation. CD spectra 
were measured, from 260 to 180 nm, with 0.1 nm intervals over 1200 seconds (50 nm/min.) 
and a 4 second response time in a cuvette with a 20 mm path length in a Jasco 720 
spectropolarimeter. The CD spectra of the buffer and buffer-liposome mixture (where 
appropriate) were subtracted from that of the sample. 
4.3.1.3 Preparation of DMPC-vesicles 
Small unilamellar vesicles were prepared by dissolving 10 mg dimyristoyl-L-α-
phosphatidylcholine (DMPC) in 2 mL chloroform in a detergent-free glass test tube. The 
chloroform was evaporated either under a stream of N2 or under vacuum (rotary evaporator) to 
leave a thin film of lipid on the glass. The lipid was resuspended in 4 mL 20 mM HEPES, pH 
7.4 containing 150 mM NaCl, and flushed with N2. The lipid-buffer mixture was sonicated (2 
mL per tube) in a sonic bath, half filled with 0.1% (v/v) Triton X100, until the solution was 
translucent. Because the transition temperature of DMPC is 24oC, liposomes were prepared at 
35-37oC. The duration of sonication was 60±10 minutes. (Refer to Chapter 6 for more detail.) 
4.3.2 Molecular modelling using HyperChem ®4.5 
In vacuo structure modelling of the octalipopeptide structures was done with the 
HyperChem®4.5 from HyperCube® [15]. Structural geometry was optimised with the Polak-
Ribiere (conjugate gradient) general algorithm for molecular mechanics with non-varying 
dielectric constant and convergence limits of the RMSa gradient for the molecular system set 
                                                 
a
 The RMS gradient is the rate of change (first derivative) of energy of a molecular system as a function of atomic 
positions. A gradient of zero indicates a conformation with minimum energy (a local of global minimum or a 
Stellenbosch University http://scholar.sun.ac.za
 4.9
as 0.0001 kcal/  mole. The method used for chemical calculations, also known as a molecular 
mechanics force field, was AMBER 90b. 
Geometric optimisation started with the model build function of HyperChem®4.5. The β-NC14 
residue was substituted with a β-NC5 residue (indicated with a star *) to simplify the structure 
modelling experiments. No constraints were placed on the structure, but structures that did not 
settle into a stable backbone conformation were rejected if the molecular orbital energy did 
not decrease in subsequent experiments. Optimised structures were further refined by 
geometry optimisation after a molecular dynamic experiment performed over 0.3 ps with 
starting temperature of 100 K and final temperature 300, 400 or 500 K. If the three molecular 
dynamic experiments, followed by geometry optimisation, gave identical energy minima and 
similar structures, it was accepted that a local or global minimum had been reached. These 
low energy structures were also tested with other molecular mechanics force fields such as 
BIO+ and OPLS (both developed for proteins) followed by a geometry optimisation with 
AMBER 90. These structures were accepted to be “final” after again being subjected to 
molecular dynamic experiments as described above, their backbone conformation remained 
the same. 
4.4 Results and discussion 
4.4.1 Structural investigation using spectroscopy 
4.4.1.1 Nuclear magnetic resonance spectroscopy 
13C and 1H NMR of the diastereomeric mixture of 8-Beta was originally done to assess the 
purity of one of the 8-Beta synthesis products after HPLC purification. NMR confirmed the 
purity, but at the same time revealed interesting aspects concerning the conformation of 8-
Beta in that the spectra revealed “two” tyrosine chemical shift patterns (Table 4.1). This 
preparation contained only the diastereomeric mixture of 8-Beta as confirmed with HPLC, 
amino acid analysis, HPLC and ESI-MS (refer to Chapters 2 and 3). Assignments of 13C NMR 
chemical shift values (δ) observed for 8-Beta correlated well with amino acid δ-values in 
                                                                                                                                                        
transition state). The absolute quantity of the calculated molecular orbital energy has no physical implication, 
except as an indicator of progress in optimisation during modelling experiments. 
b
 AMBER 90 force field was developed specifically for proteins and nucleic acids and provide representation for 
individual atoms and united atoms (groups). 
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literature (Table 4.1) [16]. The shaded column in Table 4.1 shows the assignments for D-Tyr3, 
with δ of the β-carbon as 37.52 and 37.40 and that of C5/C9 as 131.34 as 131.30. The δ-value 
assignment of the α- and β-carbons of the Asn residues also revealed four chemical shift 
values, instead of the expected three (Table 4.1). 
The observation of two separate sets of signals (characteristic for a para-disubstituted aromatic 
ring and assigned to the aromatic protons of tyrosine) in the aromatic region of the 1H 
spectrum suggested a slow conversion between two conformations of the peptide. In each 
conformation the tyrosine aromatic protons experience a different chemical environment, 
giving rise to two sets of chemical shifts (Fig 4.5). Harnois et al. [17] observed, using time-
resolved fluorescence of the Tyr residue of iturin A, that a slow exchange between two Tyr-
rotamers (χ1 = -60o and +180o) takes place in water. This may also happen to the Tyr-residue 
in 8-Beta. This structural aspect will be addressed using molecular modelling later in this 
chapter. 
Table 4.1      13C chemical shift (δ) assignment of the amino acid carbons in the 8-Beta 
preparation as analysed in 50% acetonitrile (T=25±0.1oC) compared to that of 
literature values [16] (the latter is shown in brackets). 
 L-Asn2  
D-Asn4  
D-Asn7  
 
D-Tyr3 
 
L-Gln5 
 
L-Pro6 
 
L-Ser8 
 
 β-NC14 
Cα 51.72, 51.46 
51.15, 51.07  
(52.4) 
56.25 
(57.3) 
56.25  
(55.4) 
63.39 
(62.4) 
56.25 
(56.4, 57.4) 
49.7 
 
Cβ 37.24, 37.15, 
37.05, 36.54 
(35.7) 
37.52; 37.40 
(37.5) 
27.13 
(27.4) 
31.49 
(30.3) 
63.08 
(62.3, 61.3) 
 
not detected 
Cγ − not detected 
(138) 
33.02 
(32.1) 
25.62 
(25.0) 
− 
30.09, 29.87, 
29.82, 29.70 
(C4-11) 
Cn − 131.34; 131.30 
(C5, C9,130.5)  
116.26; 
(C6, C8 117.5) 
156.44 
(C7, 156.3) 
− 
48.75  
(C5, 47.4) 
− 
32.39 
(C12) 
23.18 
(C13) 
14.34 
(C14) 
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Figure 4.5     1H-NMR spectrum in the region of 6.6 to 7.4 ppm of the Tyr residue in 8-Beta at 
299.1 MHz in 50 % CD2CN in D 2O (neutral pH) at 25±0.1oC.  
4.4.1.2 Circular Dichroism 
Results obtained in another study (reported in Chapter 6) confirmed the association of the 
linear octalipopeptides with DMPC; DMPC liposomes formed a hydrophobic environment 
suitable for CD spectrometry experiments. The octalipopeptides in this study have the 
characteristic iturin LDDLLDL chiral sequence for the α-amino acid residues. The CD spectra 
of peptides containing D and L amino acids have not been as well studied as those of 
polypeptides and proteins containing just L-amino acids [18]. Nevertheless, it was possible to 
deduce some structural information from spectra of these peptides in buffer and in DMPC 
liposomes. One important result was that the CD spectra of the octalipopeptides in water and 
in liposomes were significantly different, indicating that solvent-induced conformational 
changes of each of the octalipopeptides do occur (Figs. 4.6, 4.7). Each of the four lipopeptides 
showed a negative mean ellipticity in the region between 199 and 201 nm, which is 
reminiscent of a random coil in protein samples in water [6, 18]. A similar result was obtained 
by Besson et al. [11] for iturin A in water with the negative Cotton effect centred around 198 
nm. The principal Cotton effect for peptides and proteins occurs around 200 nm, the 
wavelength range in which the peptide bond absorbs [1]. 
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The spectra of the linear 8-Beta diastereomers in buffer differed to a large extent (Fig. 4.6).  
8-Beta I (D) showed a positive Cotton effect centred around 203 nm, whereas 8-Beta II (L) 
showed a negative Cotton effect at 201 nm indicating different backbone conformations. 
Association with liposomes induced in both the structures of 8-Beta I (D) and II (L) a 
conformation that gave a strong positive Cotton effect centred round 201 nm (Fig. 4.6). The 
spectra of the 8-Beta diastereomers in liposomes were remarkably similar, except for a small 
difference in the region centred around 190 nm, but both displayed an overall negative 
ellipticity in this region. Small negative effects at 216 nm and 226 nm were also observed for 
these diastereomers. The CD spectra of 8-Beta diastereomers in liposomes resembled that of 
the tetrapeptide, VPGG, which contains a type II β-turn. This peptide displayed negative 
Cotton effects at both 216 nm and 190 nm and a strong positive Cotton effect at 203 nm [6]. 
The cyclic lipopeptide pair displayed similar spectra in buffer (Fig. 4.7), except in the region 
of 203 nm and 207 nm, where cyclic 8-Beta II (D) showed a positive and negative Cotton 
effect respectively. The 203 nm maxima could be because of to a small amount of linear 8-
Beta I (D) contamination in the cyclic 8-Beta II (D) preparation. A conformation leading to 
strong positive Cotton effects centred around 197 nm and 207 nm and a strong negative effect 
centred around 205 nm was introduced in the peptide structures of both cyclic 8-Beta I (L) and 
II (D) in liposomes (Fig 4.8). The ellipticity of cyclic 8-Beta II (D) at 207 nm was not as high 
as that of its diastereomer. A minimum at 209 nm was also observed for cyclic 8-Beta II (D). 
Spectra of both peptides in liposomes had a shoulder between 210 and 215 nm. The cyclic  
8-Beta spectra resembled to some extent the type II β-turn spectrum of cyclo-(VPGVG)2 with 
a positive ellipticity centred around 205 nm [6]. The spectra of another β-turn peptide, 
cyclo(D-Phe-L-Pro-ω-aminocaproyl) [19], showed a strong negative minimum at 206 nm and 
a shoulder at 213 nm. Further resemblance was observed to the spectra of poly L-Ser. This 
peptide has an antiparallel β-pleated sheet conformation and displayed negative Cotton effects 
at 214 nm and 222 nm and a strong positive Cotton effect at 197 nm [6]. 
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Figure 4.6     Circular dichroism spectra of the linear octalipopeptides, 8-Beta I (D) and 8-
Beta II (L), in 20 mM HEPES buffer (pH 7.4) containing 0.15 M NaCl incubated 
with or without DMPC-liposomes. The arrows indicate the significant Cotton 
effects observed for the peptides in liposomes (solid line) and buffer (dashed 
line). 
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Figure 4.7     Circular dichroism spectra of the cyclic octalipopeptides, cyclic 8-Beta I (L) and 
II (D), in 20 mM HEPES buffer (pH 7.4) containing 0.15 M NaCl incubated 
with or without DMPC-liposomes. The arrows indicate the significant Cotton 
effects observed for the peptides in liposomes (solid line) and buffer (dashed 
line). 
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Besson et al. [11] found that the average CD spectrum of iturin A in tetrahydrofuran (THF) 
displayed positive mean ellipticity values at 190 and 210 and a negative value at 200 nm. The 
disagreement between these ellipticities and those of our cyclic peptides can be attributed to 
the differences between THF and hydrophobic membrane environment in which the two 
experiments were done. There was, however, a general correlation between the two spectra of 
the cyclic 8-Beta pair and that of iturin A. According to Besson et al. [11], their spectra 
showed similarities with that of a β-turn peptide in the region between 195 to 230 nm [20]; it 
is therefore possible that the cyclic 8-Beta diastereomers also contain such a turn (as discussed 
in above).  
The spectra of the cyclic peptides in liposomes differed significantly from spectra of the linear 
peptides in liposomes in the 190 to 210 nm region, suggesting different backbone 
conformations. These differences could explain the limited bioactivity observed for the linear 
peptides (reported in Chapter 6). As for the linear peptides, the spectra of the cyclic 8-Beta 
pair in liposomes were similar, except for a small difference in the region centred around 190 
nm, with cyclic 8-Beta I (L) showing a positive Cotton effect and cyclic 8-Beta II (D) a 
negative effect (Fig. 4.7). The relationship between the configuration of the β-NC14 and this 
observation could be of some significance. The difference in the peptide structures, observed 
with NMR and CD, was further investigated empirically with structure modelling. 
4.4.2 Structure modelling using HyperChem®4.5 
The structure modelling of the four octalipopeptides, using HyperChem®4.5 [15], suggested a 
probable turn conformation in each of the two tetrapeptide sequences, β-NC5NYN and QPNS 
(Figs. 4.8-4.12). The predicted models therefore indicated a tendency to adopt conformations 
with two turns in the backbone structure. 
Two types of stable backbone conformations for the linear octalipopeptides, 8-Beta*L and 8-
Beta*D, called the W-structure (distorted W) and S-structure (twisted S), evolved from the 
soup of structures with molecular orbital energy raging between 285 and 292 kcal/  mole 
(Fig. 4.8). The S-type of backbone conformation was the only one observed in structure 
modelling including the C11 aliphatic chain, but it complicated the optimisation process to 
such an extent that it was substituted with C2 aliphatic group (β-NC14 substituted with a β-
NC5). The modelled backbone conformations of the linear lipopeptide diastereomers were 
similar in both the S-structure (Fig. 4.9) and W-structure (Fig. 4.10). Differences were 
confined to the  
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β-carbon of β-NC5 and backbone of the β-NC5-L-Asn2 dipeptide moiety. As described in 
section 4.4.1.2, the CD spectra of the 8-Beta diastereomers in buffer did show a large 
difference. The predicted conformations in vacuo showed no such difference, but suggested 
the possibility of two extreme conformations. An S  W equilibrium could be possible 
with hinging at D-Asn4-L-Gln5. The equilibrium distribution between the two forms could 
also be strongly influenced the longer aliphatic chain through steric interference, but this was 
not investigated. The predominance of different structures in each of the 8-Beta diastereomer 
preparations could explain the differences in CD spectra found for these diastereomers in 
water. NMR revealed a difference in the chemical shift patterns of the Tyr-residue in 8-Beta 
(refer to Table 4.1 and Fig. 4.5), which could also be explained by the slow conversion 
between two conformations such as the W- and S-structures. 
 
 
 
 
Figure 4.8     Representative low energy stick structures of 8-Beta*D, as modelled with 
HyperChem®4.5 [15] showing the two typical backbone conformations, the  
S-structure (left) and W-structure (right). (The white lines depict the hydrogen 
bonds, dark blue the amino groups and the red the oxygen containing groups.)  
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Figure 4.9     Stereotypgraphs of the “S” low energy stick structures of the two linear 
octalipopeptides, 8-Beta*L and 8-Beta*D as modelled with HyperChem®4.5 
[15]. The minimum energy and convergence gradient of each structure are given 
in brackets. 
8-Beta*L  
(-298.853 kcal /  mole; 
gradient 0.00001) 
8-Beta*D 
(-300.575 kcal / mole; 
gradient 0.000009) 
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Figure 4.10   Stereotypgraphs of the “W” low energy stick structures of the two linear 
octalipopeptides, 8-Beta*L and 8-Beta*D as modelled with HyperChem®4.5 
[15]. The minimum energy and convergence gradient of each structure are given 
in brackets. 
8-Beta*D 
(-296.492 kcal / mole; 
gradient 0.000009) 
8-Beta*L 
(-295.340 kcal / mole; 
gradient 0.0001) 
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In the S-structure there are two turns, β-NC5NYN and QPNS, that approximate true β-turns. 
The correct hydrogen bond pattern, however, was not demonstrated. Hydrogen bonding in the 
S-structure occurs between the β-amino group of the β-NC5 residue and the D-Tyr3 carbonyl 
oxygen, and also between some of the side-chains (Fig. 4.9). The six polar side-chain groups, 
namely the four acid amides of the Asn residues and Gln and the two hydroxide groups of Ser 
and Tyr, can all participate in a hydrogen-bond network stabilising the peptide structure. Many 
of these groups participated in hydrogen bonding in the observed low energy structures of  
8-Beta*. Freedom of movement of the amino acid side-chains was observed except for the 
side-chain of D-Tyr3 and the naturally rigid pyrrolidine ring of L-Pro6 in all the 8-Beta* 
structures. 
The conformation of the modelled backbones of the cyclic octalipopeptides appears to be 
rather rigid, with the side-chains having a larger degree of freedom (Figs. 4.11, 4.12). This 
rigid backbone structure was found regardless of the conformation and carbon length of  
β-amino acyl residue (β-NC14, β-NC7 or β-NC5). Backbone rigidity of the iturin A structure 
was also reported by Marion et al. [5]. The backbone NH-CαH bonds were also, as in their 
structure, in a trans conformation including a trans conformation for L-Pro5.  
 
 
Figure 4.11   Representative low energy stick structures of cyclic 8-Beta*D, as modelled with 
HyperChem®4.5 [15] showing the typical backbone conformations. The left 
hand structure was obtained by substituting the β-D-NC14 with a β-D-NC7 
residue. (The white lines depict the hydrogen bonds, dark blue the amino groups 
and the red the oxygen containing groups.) 
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Figure 4.12   Stereotypgraphs of low energy ball-and-stick structures of the two different 
cyclic octalipopeptides cyclic 8-Beta L and D as modelled with HyperChem®4.5 
[15]. The calculated minimum energy and convergence gradient of each 
structure are given in brackets. 
Cyclic 8-Beta*L 
(-307.437 kcal / mole; 
gradient 0.000009) 
Cyclic 8-Beta*D 
(-306.573 kcal / mole; 
gradient 0.000009) 
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Three turns were observed in the modelled structures: turn A in β-NC5NYN, turn B in QPNS 
and turn C in NYNQ (Fig. 4.12). These turn conformations resembled the two type II β-turns 
and the type I’ or II’-turn observed from NMR and modelling data of iturin A [5], but the 
predicted pattern hydrogen bonding was not correct. The side-chains protruded from the 
peptide ring cavity, similar to the iturin A structure [5], except for the side-chains of L-Ser8 
and L-Gln5. Marion et al. [5] found that the L-Gln5 side-chain is stabilised by a hydrogen 
bond between the side-chain amino group and amide carbonyl group of D-Tyr3. In our models 
we, however, found that the Gln4 side-chain amino group is hydrogen bonded with the amide 
carbonyl group of D-Asn2 (refer to Figs. 4.11 and 4.12). A slight difference was observed 
between the relative positions of the tyrosine ring in the optimised structures of the cyclic 
octalipopeptide structures (Fig. 4.11). From the work of Marion et al. [5] it was deduced that 
the 60o rotamer of the tyrosine ring is the optimum conformation in iturin A. The side-chain of 
Tyr in the cyclic peptide models also tended to settle into a similar position (χ1= 49.3-52.3o). 
Very little information on the three Asn side-chains is available except that those of L-Asn2 
and D-Asn7 (and also L-Ser8), flip-flop between extreme conformations stabilised by 
hydrogen bonding to the backbone [5]. The modelled structures contained a hydrogen bond 
between the side-chains of L-Ser8 and D-Asn4 and backbone hydrogen bonding between L-
Ser8 carbonyl, amino or hydroxyl group and L-Gln5 peptide bond. The D-Asn7 flip-flop was 
also observed between different models (Fig 4. 11). 
The W-structure of the linear octalipopeptide somewhat resembles that of the cyclic 8-Beta* 
in that the L-Gln5 side-chain and L-Asn2 (participating in hydrogen bonds) are located in the 
peptide cavity with the other amino acid side-chains protruding from the peptide ring. The two 
turns, turn A (β-NC5NYN) and turn B (QPNS) in the S-structure, also resemble the turns 
found in the cyclic structure. There is, however, a marked difference between the predicted 
cyclic and linear structures, but limited differences between the peptide diastereomers. These 
results substantiated the results obtained with NMR and CD. 
4.5 Conclusions 
NMR spectra of the diastereomeric mixture of 8-Beta confirmed the chemical integrity of the 
peptide preparation (synthesis discussed in Chapter 2). NMR results also suggested a slow 
conversion between two conformations in which the Tyr-residue side-chain and possibly one 
or more of the Asn residues are influenced. The existence of two backbone conformations was 
also predicted by structure modelling. CD spectra also revealed a difference between the 8-
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Beta diastereomers in buffer. The CD spectra of the 8-Beta pair did not differ much in 
liposomes, thus a single backbone conformation, possibly a β-type II turn(s), exists if these 
peptides are associated with a hydrophobic environment. This backbone conformation is, 
however, different from that of the cyclic 8-Beta pair and iturin A [5, 11]. An induction of a 
secondary structure in liposomes, similar to that observed for iturin A in THF, from a possible 
random aqueous conformation, was observed for the cyclic 8-Beta diastereomers. This 
conformation of the cyclic peptides in the lipid membrane may be important in the biological 
activity of the peptide. There is also some resemblance between the CD spectra obtained for 
an antiparallel β-pleated sheet of poly L-Ser [6] and that of the cyclic 8-Beta pair. This could 
be an indication of ordering of the peptide aggregates, stacked to form β-sheets, in the 
membranes. Aggregation in the membrane is thought to be part of iturin A’s mechanism of 
action [21]. 
The low energy peptide structures of the cyclic octalipopeptide (Fig. 4.8), predicted by 
HyperChem®4.5, corresponded to some extent to structures obtained from the NMR studies of 
iturin A in pyridine [5]. However, the two predicted backbone structures of linear peptide, 
namely the W- and S-structure, differed markedly from that of the cyclic octalipopeptides (and 
iturin A) and substantiated the results obtained with CD and NMR. The predicted linear 
octalipopeptide structure of particular interest is the so-called S-structure. Because it is 
difficult to relate empirically derived in vacuo structures with structures that exist in an 
aqueous environment, we can only ask whether it is possible that the so-called S-structure, 
with its two turns, predominates in the 8-Beta I (D) diastereomer leading to the strong positive 
Cotton effect observed at 203 nm. The S-structure of 8-Beta* also does not contain the 
“hydrophobic hub”, formed by the β-NC14 residue and D-Tyr3 side-chain in the cyclic iturin A 
molecule. If the S-structure does exist, this absence of the hydrophobic hub may help to 
explain the low bioactivity of the linear octalipopeptides (refer to Chapter 6). The low yields 
obtained during cyclisation could also be explained if the S-structure is the predominant 
conformation, as the W-structure would probably cyclise easier (refer to Chapter 2). The 
probability of β-turns in the S-structure and the position of the L-Gln4 side-chain are also of 
important for the ESI-MS study of the association of this octalipopeptide with alkali metal 
ions (discussed in Chapter 5). 
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Chapter 5  
An electrospray ionisation mass spectrometry study of the 
interaction between iturin A2 analogues and alkali metals 
5.1 Introduction 
Some of the interactions between metal ions and biomolecules are essential for life processes. 
Metal ions, such as Mg2+ in nucleotide complexes, have an important structural function 
whereas Zn2+ participates in the catalytic mechanism of many enzymes, for example 
carboxypeptidase A. As secondary messenger in cells, Ca2+ interacts with several proteins, 
whereas the redox pair Fe2+/Fe3+ is utilised in electron transfer. The alkali metal ions, Na+ and 
K+, are very important in the osmoregulation of cells, in which Na+/K+-ATP-ases play a major 
role. Any disruption of essential ion-biomolecule interactions or new “foreign” interactions 
will thus have an influence on the functioning of the cell as a live unit. This has been 
exploited in the development of some antibiotics such as chloroquin and analogues that 
interrupt iron detoxification of the malarial parasite. Ionophores, such as the cyclic antibiotic 
dodecapeptide, valinomycin, disrupt the osmotic balance by specifically complexing with K+ 
and transporting it over the cell membrane [1]. The single ion is coordinated by six carbonyl 
oxygens in the interior of the cyclic peptide. Valinomycin is a perfect example of a biological 
counterpart of the crown ethers. Crown ethers are known to complex alkali metal ions in their 
cyclic cavity with oxygens as the chelating atoms [2]. Gramicidin S, a cyclic decapeptide with 
a β-pleated sheet conformation [3] and one cyclic octalipopeptide in this study, iturin A2, both 
contain two type II’ β-turns [4]. The biological action of these peptides on membranes leads to 
the leakage of the alkali metal ions, Na+ and K+. Iturin A’s action initially leads to a 
continuous increase, in contrast to a stepwise increase, of the K+ and Na+ permeability and ion 
conductivity of the target membrane, followed by the release of cellular contents [5]. 
Although iturin A has been under investigation for about 50 years, the precise mechanism of 
action of this peptide still remains unclear. Iturin A shows an affinity for alkali metal cations 
such as Na+ and K+ [6], but precipitates in the presence of divalent cations such as Mg2+ and 
Ca2+ [7]. It has been suggested that specific interaction between iturin A and alkali metal ions 
may be an important feature of its mechanism of action [6]. Other cytolytic peptides such as 
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the linear α-helical gramicidin A [8] also transport both Na+ and K+ over target cell 
membranes by the formation of ion channels. A myriad of antimicrobial peptides, the 
magainins [9], defensins [10], cecropins [11], and tachyplesin [12], all anion selective ion 
channel forming peptides [13], and many others [14] have been discovered and shown to be 
cytotoxic for a wide range of microorganisms. The activity of many of these membrane active 
peptides is partially or totally dependent on inducing leakage of the alkali metal ions, Na+ and 
K+, over target cell cytoplasmic membranes. The investigation of these antibiotic peptides and 
their interaction with alkali metal ions at an atomic level, is therefore important to elucidate 
their structure-function relationship and mechanism of action. 
Nuclear magnetic resonance (NMR), ion selective electrodes and conductive methods have 
been used to assess peptide-ion complexation [15]. The use of mass spectrometry as a tool to 
probe gas-phase peptide-ion complexation became possible with the development of new 
desorption and ionisation techniques. These techniques include fast atom bombardment (FAB) 
[16], matrix-assisted laser desorption/ionisation (MALDI) [17] and electrospray ionisation 
(ESI) [18-20]. Mass spectrometry (MS) in general, with specific emphasis on ESI-MS, will be 
discussed briefly as background to the ESI-MS investigation of peptide-ion interaction. 
A mass spectrometer (Fig 5.1) is an analytical instrument that measures the molecular mass of 
chemical compounds by the separating ions according to their mass-to-charge ratio (m/z) in a 
mass filter/analyser such as quadrupoles, magnetic sector, time-of-flight or ion trap. The ions 
are then detected by either an electron multiplier or a scintillation counter. Ions are generated 
in the ionisation source for example by either electron impact ionisation, fast atom 
bombardment, matrix assisted laser desorption/ionisation or electrospray ionisation. The ions 
include molecular ions ([M]) or parent ions, product ions or daughter ions and ions complexed 
to metal ions, water, solvent or other molecules (adducts). Samples can be introduced in 
several ways: using a solid probe inserted into the mass spectrometer, direct infusion without 
pre-analysis separation of analytes or direct infusion using gas chromatography (GC), high 
performance liquid chromatography (HPLC), solid phase extraction (SPE) or capillary 
electrophoresis (CE) linked the mass spectrometer. The last three methods are used only in 
electrospray ionisation mass spectrometry. 
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Figure 5.1     Components in mass spectrometers [adapted from 21]. 
Ions, the molecular products detected in mass spectrometry, are created in various ways such 
as through electron ejection, electron capture, transfer of a charged molecule from a 
condensed phase to a gas-phase, protonation, deprotonation or cationisation (Fig. 5.2). 
 Ion transfer 
[M] + solution   [M]+ gas 
Electron ejection 
[M]   [M]− +  e−  
Electron capture 
[M]  +  e−   [M] − 
Protonation/Deprotonation 
[M]  +  H+   [MH]+  
[M]  −  H+   [M]− 
Cationisation 
[M]  +  Cation+   [MCation]+ 
[MH]+  +  Cation+   [MCation]+ + H+ 
 
Figure 5.2    Different mechanisms of ionisation in mass spectrometry [adapted from 21]. 
Until the 1980’s electron impact ionisation (EI) was the primary ionisation mode available for 
mass analysis, but due to harsh ionisation conditions its use was limited to the analysis of 
small volatile molecules. EI commonly depends on electron ejection to give a net positive 
charge. Pioneers such as M. Barber, F. Hillenkamp, M. Karas, M. Dole and J. B. Fenn 
developed the techniques of FAB, MALDI and ESI. These new ionisation processes extended 
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mass spectrometry into the realm of biology by allowing the analysis of large biomolecules 
[21]. 
In FAB and MALDI, ions are liberated from analytes imbedded in a solid matrix by ion beam 
bombardment and laser beam respectively. Electron capture occurs in FAB and MALDI by the 
absorption of an electron to give a net negative charge to the analyte. Protonation and 
deprotonation also form ions that may be detected by FAB and MALDI. Cationisation, which 
occurs by the association of a small cation, such as the alkali metal cations, with a neutral 
complex, is also commonly observed in FAB and MALDI spectra. 
In the ESI process ions are liberated from solvent droplets by desolvation, making this the 
mildest ionisation process currently available (Fig. 5.3). Gaseous ionised molecules are 
created when a fine spray of highly charged droplets are introduced into a strong electric field 
and the solvent is removed by heat, vacuum and dry gas. Protonation, deprotonation, 
cationisation and transfer of charged molecules from the aqueous phase are frequently 
observed in ESI. 
        water 
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ions observed
gas and /or heat
cause droplets
to decrease
in size
charged droplet
Taylor cone
Charged Droplet Ion Injection
solvent evaporation
budding
droplet 
fission at 
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further 
droplet 
fission and 
desolvation
 
Figure 5.3     Process of electrospray ionisation [adapted from 20, 21]. 
The use of solvent in the ESI-MS makes it feasible to link it to liquid chromatography systems 
such as HPLC and SPE, therefore increasing its analytic capability. The mild electrospray 
ionisation, wide mass detection range (up to 200 000 Da) and femtomole sensitivity made it 
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possible to study large biomolecules and weak non-covalent interactions. ESI-MS 
spectrometry is therefore the most versatile mass analytical technique. A detailed diagram of 
an electrospray ionisation mass spectrometer, similar to the one used in this study, is given in 
Fig. 5.4. For more technical detail, specific applications and coverage of early ESI literature 
other reviews should be consulted [19, 20]. 
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Figure 5.4     Diagrammatic representation of the Micromass Quattro Triple Quadrupole 
electrospray ionisation mass spectrometer [adapted from diagrams provided by 
Micromass]. 
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As with ESI-MS, FAB-MS permits the study of peptide-ion interactions in the gas-phase, but 
because of the nature of ionisation, these studies may exclude some interactions that depend 
on the prior aqueous conformation of the peptide. Electrospray ionisation makes it possible to 
also observe weak non-covalent interactions that depend on native conformation [21, 22]. 
Solution and ESI-MS instrument parameters can be optimised to balance the processes 
occurring in solution as well as in the gas-phase. Assessment of peptide interactions is 
facilitated by the disassembling or fragmentation of the peptide complexes into discernible 
units. Regardless the mode of ionisation (EI, FAB, MALDI or ESI), fragmentation is 
dependent on the lability of the chemical bonds and therefore energy input in the mass 
analyser. 
Fragmentation of peptides in FAB-MS, MALDI-MS and ESI-MS generally occurs at the 
peptide (amide) bonds (b and y product ions), but some other types of product ions from 
backbone fragmentation are also observed. The nomenclature of Roepstorff and Fohlmann 
[23], as revised by Biemann [24], was used to denote the product ions from fragmentation of 
peptide molecular ions described in this chapter (Fig. 5.5). 
In an instrument with a triple quadrupole mass analyser the fragments are generally generated 
in the collision cell after selection of the parent ion in MS1 (Fig. 5.4). The fragments are then 
detected in MS2.The fragment or product ions (also called daughter ions) can be separated into 
two classes: (i) an, bn and cn and dn product ions from the N-terminal, and (ii) xn, yn, zn, vn and 
wn product ions from the C-terminal (Fig. 5.5). The subscript n indicates the number of amino 
acid residues in the positively charged fragment. The fragmentation pattern depends on the 
location of protons (and other associated cations) within the peptide and possibly also the 
conformation of the peptide. The characteristic N-terminal bn and its complimentary C-
terminal yn product ion series is commonly observed for peptides, especially in low-energy 
collision induced decomposition/dissociation (CID) [25]. This fragmentation pattern occurs 
because of charge separation processes [26] and points to protonation at various positions 
along the peptide backbone. The yn ions are more predominant in spectra, because bn ions are 
susceptible to further degradation to e.g. the an ions formed by the loss of CO [27]. Sequence 
related fragmentation is observed for peptides containing proline and or basic amino acid 
residues such as arginine, lysine and histidine [25]. The peptide bonds flanking a Pro residue 
are particularly susceptible to cleavage [28]. This is possibly the result of the combination of 
conformational constraints induced by proline on the peptide backbone and favourable 
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protonation of the secondary amine group of proline [25]. Bonds in the vicinity of a 
protonated amino acid or a basic site are very labile and likely to be broken, but protonation 
and subsequent cleavage close to an already protonated site will be unlikely due to Coulomb 
repulsion [29]. A strongly basic amino acid residue, such as arginine, will thus influence the 
fragmentation pattern. 
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Figure 5.5     Fragmentation patterns of a peptide during mass spectrometry and nomenclature 
according to Roepstorff and Fohlmann [23], as revised by Biemann and Martin 
[24]. 
The fragmentation pattern changes dramatically if cationisation of a peptide by metal ions, 
such as the alkali metal cations, occurs. The long range Coulomb interaction of the cation with 
the peptide influences the chemistry of distant sites on the peptide [30]. This effect is more 
pronounced in the gas-phase where the shielding effects of surrounding solvent are absent 
[31-39]. The differences in fragmentation patterns reveal the nature of the interaction of the 
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metal ion with the peptide on the molecular and even atomic level. Teesch et al. [31, 32], used 
FAB-MS to study the interaction of various peptides with alkali metal ions. They concluded 
that alkali metal ions tend to complex to sites with basic carbonyl groups, such as the amide 
oxygen in Asn and Gln side-chains, and to the amide oxygen in the peptide bond. Other 
investigators, using FAB-MS [33-35], proposed that the alkali metal ion is complexed to the 
deprotonated carboxylate terminus. Mallis and Russel [36] suggested complexation to amide 
nitrogen, and were the first to note that the fragmentation of peptide-ion adducts also revealed 
additional information on the primary sequence. In an ESI-MS study of peptaibols, Kanai et 
al. [37] were able to deduce complete sequence information by fragmentation of sodium 
containing peptide complexes. Their study showed that fragmentation of the sodium adducts 
produced mainly N-terminal (bn-type) product ions, a common phenomenon observed for 
peptide-alkali metal adduct decomposition. The C-terminal fragments contained sodium, but it 
was generated by the same bond cleavages found in CID of the non-complexed peptide. They 
did not investigate specific interaction between sodium and the peptides. Wang et al. [38] 
studied the association between sodium and nine different glycine containing tripeptides with 
the aid of ESI-MS. They proposed that the metal ion was complexed to one of the carboxy 
terminal oxygens (including the possibility of a salt-bridge between the carboxylate and 
sodium) and the nitrogens in the two amide bonds and amino terminal. Giogi et al. [39] again 
illustrated that cations tend to associate with the basic groups in peptides in their ESI-MS 
study of the complexation properties of (histidyl-glycyl)2 with alkali metal ions. They 
concluded that the metal ion interacted with either the carboxylate anion or with the amide 
bonds. Consequently it is clear that many different types of gas-phase interactions between a 
peptide and an alkali metal ion are possible; some interactions are due to “non-specific” ionic 
interaction, while others depend on peptide length, specific amino acids or a specific 
sequence. Those interactions between biologically active peptides and alkali metal ions such 
as Na+ and K+, that are highly sequence specific and probably dependent on peptide 
conformation, may be biologically significant. 
Many parameters affect ion formation during electrospray ionisation [40-46], and in our study 
the ESI-MS instrument settings and solvent composition had to be carefully optimised. When 
dissolved analyte is introduced into the mass spectrometer it is accompanied by solvent 
molecules and electrolytes. The characteristics of the solution are firstly important in the 
ionisation of the analyte and secondly in the electrospray process. The ionisation of the analyte 
is highly dependent on the pKa values of its dissociating groups and therefore also on the pH 
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of the solution [40, 41]. It is also known that the actual pH in the ionisation chamber of the 
mass spectrometer can differ markedly from the pH in bulk solution [41, 42]. Not only is the 
pH of the analyte solution of great importance in ionisation, but also the concentration of 
electrolytes. Strong acids and salts in the analyte solution may lead to diminished sensitivity 
due to ion-pairing and “masking” of the ions (ion suppression) [40, 43-45]. The formation of 
the droplets during the electrospray process is also influenced by solution properties, such as 
surface activity of analytes and electrolytes, surface tension, dielectric constant and volatility 
of the solvent [40, 46]. Instrument settings such as the source temperature in the ionisation 
chamber and parameters relating to acceleration of ions in the mass spectrometer (thus energy 
charge) will also influence the ion current and the non-covalent complex. 
The linear analogue of iturin A2, 8-Beta with the β-aminotetradecanoic acid (β-NC14) as  
N-terminal residue and L-Ser8 as C-terminal residue, was used as model peptide and Na+ as 
model ion to determine the maximum ion current (signal intensity) conditions and influence 
on ion current and cationisation. Parameters such as cone voltage (∆V between sample cone 
and skimmer lens, refer to Fig. 5.3), carrier solvent composition, sodium concentration in the 
sample, pH (including the influence of different acids and bases), solvent composition in the 
sample and pre-incubation time of the lipopeptide with sodium were investigated. ESI-MS 
was also used to investigate the interaction between alkali metal ions, Na+, K+ and Rb+, and a 
series of iturin A2 analogues in which one of the β-turns was sequentially eliminated. The 
structure of iturin A, discussed in Chapter 4, includes a type II β-type turn in each of the 
tetrapeptide moieties: β-NCn-L-Asn2-D-Tyr3-D-Asn4 and L-Gln5-L-Pro6-D-Asn7-L-Ser8. In 7-
Beta and cyclic 7-Beta the L-Asn2 residue was omitted, in 6-Beta the L-Asn2-D-Tyr3 dipeptide 
unit, and in 5-Beta the L-Asn2-D-Tyr3-D-Asn4 tetrapeptide unit (structures are given in 
Chapter 2, Table 2.1). 8-Beta was again used as model peptide for stability and structural 
investigations, because it includes the two intact sequences containing the β-turns. This linear 
analogue of iturin A2 was investigated, because cyclic peptides give a much more complex 
fragmentation pattern than linear peptides. 
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5.2. Materials 
HPLC grade trifluoroacetic acid (TFA, 99.5%), NaCl (99.9%), KCl (99.9%), HCl and NaOH 
were from by Merck (Darmstadt, Germany). Acetonitrile (HPLC-grade, UV cut-off 190 nm) 
and methanol (HPLC-grade, UV cut-off 205 nm) were from Romil LTD (Cambridge, UK).  
Triethylamine (TEA) and RbCl were from Sigma Chemical Co. (St. Louis, USA). Analytical 
quality water was prepared by filtering glass distilled water through a Millipore Milli Q® 
water purification system. Synthetic gramicidin S was donated by Dr. R. Levitt, previously 
from Fine Chemicals, South Africa. The synthetic iturin A2 analogues were synthesised with 
the Fmoc-polyamide peptide synthesis protocol and purified by RP-HPLC and characterised 
as described in Chapters 2 and 3. 
5.3 Methods 
5.3.1 Sample preparation for ESI-MS 
Lyophilised HPLC purified 8-Beta (a racemic mixture of 8-Beta I (D) and II (L)) was 
dissolved in a mixture of 50% acetonitrile in analytical quality water (glass-distilled, de-
ionised) to a concentration of 5.0 mg/mL. This stock solution was diluted to 0.2 mg/mL (±0.2 
µmole/mL) with 50% acetonitrile modified with 0.05% TFA in water, except when stated 
otherwise. To determine the influence of sodium concentration, a NaCl concentration range 
from 0.1 µM to 80 mM was used. Samples in the remaining investigations contained 10 mM 
NaCl. The influence of TFA and TEA was determined by varying their concentration from 
0.01% to 0.5% in the sample solutions. To investigate the influence of the pH of the sample 
solution, the 0.2 mg/mL of 8-Beta was dissolved in analytical grade water and the pH adjusted 
with standardised HCl (pH 0, 1.0, 2.0, 3.0 and 4.0), TFA (pH 5.1), TEA (pH 7.0 and 8.9) and 
standardised NaOH (pH 10.0, 11.0 and 12.0). The sodium concentration was kept constant at 
10 mM in all these samples. To determine the influence of the solvent polarity, different 
solvent compositions (25%, 50% and 80% acetonitrile in water) were used in the sample and 
carrier solvent. All samples were freshly prepared before analysis, except in the one case when 
the influence of cold storage on cationisation of the peptide was examined. To investigate the 
structures of the cationised 8-Beta and the effect of cationisation with sodium on its stability, 
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0.2 mg/mL peptide in 50% acetonitrile/water modified with 0.05% TFA and 10 mM of NaCl 
was used (this optimum solvent composition was determined as reported below). 
To investigate the influence of primary structure on cationisation, the purified diastereomers 
of 8-Beta, 7-Beta, cyclic 8-Beta and cyclic 7-Beta and the isomeric mixtures of 6-Beta and 5-
Beta were analysed in the presence of different alkali metal ions (Na+, K+ and Rb+). As in the 
other analyses 0.2 mg/mL HPLC purified peptide in 50% acetonitrile, modified with 0.05% 
TFA in water, was incubated with NaCl, KCl and RbCl. In this competition assay all three of 
the alkali metal ions (10 mM of each chloride salt) were used.  
5.3.2 Electrospray ionisation mass spectrometry 
ESI-MS was performed using a Micromass triple quadrupole mass spectrometer fitted with an 
electrospray ionisation source (refer to Fig. 5.4). The carrier solvent was 50% acetonitrile in 
water, except in the investigation of solvent influence where 25% and 80% acetonitrile were 
also used. The solvent was delivered at a flow rate of 20 µL/minute during each analysis using 
a Pharmacia LKB 2249 gradient pump. Ten µL of the sample solution (2 nmole peptide) was 
introduced into the ESI-MS using a Rheodyne injector valve. A capillary voltage of 3.5 kV 
was applied and the source temperature was set at 800C. The skimmer lens offset was 5 V and 
the cone voltage was set at 70 V, except during the investigation of cone voltage influence 
when it was changed in increments from 20 V to 150 V. Triplicate analyses were done at each 
cone voltage value, using 10 µL 8-Beta sample solution per analysis. Analyses of other 
peptides were done at 70 V using 2 nmole peptide per analysis.  
Data acquisition was in the positive mode, scanning the first analyser (MS1), through m/z = 
300 to1300 or 1500) at a scan rate of 100 atomic mass units/second. Representative scans 
were produced by combining the scans across the elution peak and subtracting the 
background. Signal intensity of each of the ions under investigation was determined by 
integrating the ion specific chromatographic peaks detected during analysis. 
5.3.3 CID of peptides and product ions 
The stability of each of the molecular species of 8-Beta was determined using collision 
induced decomposition/dissociation (CID) with multiple reaction monitoring (MRM; static 
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selection of specific ion in MS1 and static monitoring of product ions in MS2). These 
experiments were conducted using the same ionisation parameters as before, except that the 
solvent flow was increased to 50 µL/min and argon was introduced into the collision cell at 
(2.5 ± 0.3) x 10-3 millibar. Collision energy settings ranging from 10 to 100 eV were used, 
with an injection of 2 nmole peptide at each value. The resulting chromatographic peaks were 
integrated to obtain the intensity of the measured ion at the set collision energy. 
To determine the influence of cationisation on 8-Beta fragmentation patterns, each of the 8-
Beta molecular species was selected in MS1 and subjected to identical CID conditions to 
obtain product ion scans. The same ionisation parameters as before were used, but with 
continuous infusion at 5 µL/min using a Harvard Apparatus syringe pump. The argon pressure 
in the collision cell was as for the MRM experiments, and the collision energy was set at 30 
eV. Data was acquired in continuum mode scanning MS2 from m/z = 100 to 1200 at 100 
atomic mass units/second for precisely six minutes.  
Verification of the fragment identity was afforded by multiple injections of 10 µL sample or 
continuous flow injection at 5 µL/min and subjecting the peptide to cone voltage 
decomposition between 90 V and 110 V. The selected fragment ion was further fragmented by 
CID in MS2 (“MS3”). Data was acquired in the so-called MCA mode (cumulative 
acquisitions) through an m/z range of 10 to 50 atomic mass units above the mass of the 
selected ion. 
5.4 Results and discussion 
5.4.1 Optimisation of solvent composition for ESI-MS analysis 
5.4.1.1 Incubation of the lipopeptide with NaCl 
The influence of incubation of 8-Beta with 10 mM NaCl on the ESI-MS spectra is shown in 
Fig. 5.6. Cationised species containing one sodium ([M+Na]+) and two sodiums ([M+2Na-
H]+), with signal intensities between 60% and 90% of that of the free peptide ([M+H] +), were 
observed in fresh samples (compare  Fig. 5.6 A and B). Molecular species associated with 
three sodiums ([M+3Na-2H]+; [M+3Na-H]2+) were also observed at very low signal 
intensities. 
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Figure 5.6     ESI-MS spectra of 8-Beta before (A) and after incubation with NaCl where (B) 
is the spectrum obtained with freshly prepared sample and (C) after 3 months 
cold storage. Spectra were obtained at 70 V cone voltage using 50% acetonitrile 
in water as carrier solvent. The sample consisted of 0.2 mg/mL peptide (without 
(A) or with 10 mM NaCl (B and C)) dissolved in 50% acetonitrile containing 
0.05% TFA. The spectra were obtained using optimised conditions described in 
this study. 
The singly charged specie [M+3Na-2H]+ was absent in some of the spectra. After a long 
sample incubation (three months of storage at −10oC), a substantial increase in the signals of 
the cationised species was observed (compare Fig. 5.6 B and C). A large increase in the signal 
of [M+3Na-H]2+, to about 50% of the free peptide signal, and a specie associated with 4 
sodiums [M+4Na-2H]2+ (m/z=575) were observed. This change in spectrum is an indication 
that time-dependent cationisation of 8-Beta occurs in solution. 8-Beta also has a tendency to 
aggregate in solution with time and that this may influence solution equilibrium between 
sodium and the lipopeptide.  
5.4.1.2 Influence of salt concentration in sample solvent 
As in any type of ligand binding study it was also important to investigate the influence of 
ligand concentration on complex formation. At a NaCl concentration of 10 mM, background 
interference in the ESI-MS analyses was negligible (Fig. 5.7; also refer to Fig. 5.6 B). The 
binding curves depicted in Fig. 5.7 show that the peptide is almost saturated with sodium at  
C 
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10 mM NaCl. Analyses done at 40 mM and 80 mM NaCl exhibited very high background 
interference due to ion clustering [47] and signal suppression as a consequence of the counter 
anion effect [43-45] (results not shown). Signal suppression by 10 mM NaCl was also 
observed, with the total signal amounting to only 74% of the signal obtained without added 
NaCl. These results indicated that the optimum NaCl concentration to study the interaction of 
8-Beta with either one or two sodium ions was10 mM. 
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Figure 5.7    Influence of NaCl concentration on cationisation of 8-Beta with sodium as 
observed by ESI-MS at a cone voltage of 70 V. Results were calculated as a 
percentage of the sum of the signals of the four species under consideration. The 
signal values of [M+2Na-H]+ was corrected with a factor of 1.7 for comparison. 
The influence of NaCl concentration on total signal is also depicted with the 
100% signal taken as the total ion current of the spectra obtained with no added 
NaCl. 
5.4.1.3 Influence of TFA and TEA concentration in sample solvent 
To ensure the ionisation and positive ion detection of 8-Beta and its cationised species, TFA 
was used as solvent modifier. The optimum percentage TFA in 50% acetonitrile was 
determined as 0.05% (indicated with an arrow in Fig. 5.8 A). The decrease in signal intensity 
at 0.5% TFA was probably a result of the counter anion effect [43-45]. As expected, TEA in 
the sample solvent eradicated the positive ion signal of 8-Beta and its cationised species and 
no improvement of cationisation or adduct formation because of ionic interaction was seen 
(Fig. 5.8 B). 
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Figure 5.8     Influence of percentage TFA (A) and percentage TEA (B) in the sample solvent 
on cationisation of 8-Beta with sodium as observed by ESI-MS at a cone voltage 
of 70 V. Duplicate samples were analysed and SEM (standard error of mean) is 
shown for each value. 
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5.4.1.4 Influence of sample solvent pH 
It is known that the use of solvent modifiers in high concentrations, in this case to adjust the 
pH, complicates the interpretation of the results [43-45]. In this study it was found that 
varying the sample solvent pH from 0 to 4 had a significant influence on the signal intensities 
of the major molecular species (Fig. 5.9 A). Signal depression at the lower pH values was due 
to the high counter anion concentration in the sample, eradicating the improved ionisation at 
lower pH values. Depression of the signal by the high chloride ion concentration is the 
consequence of ion-paring whereby masking of the positive ions takes place. The effect of 
chloride concentration is illustrated in Fig. 5.9 B. Low signal intensity at the high pH values 
was also the result of high counter anion concentration. The deprotonation of the peptide, 
however, is a major factor in the loss of signal (Fig. 5.9 A). 
All species showed a maximum signal at pH 4. A negligible influence on the signal intensity 
of the sodium adducts of 8-Beta was observed in varying the sample solvent pH from 4 to 11, 
whereas the signal for the free peptide decreased substantially over this range (Fig. 5.9 A). 
The relatively constant signal intensity observed for the sodiated 8-Beta species over this 
range indicated contribution of the associated sodium ions to the overall positive charge of 
these species (Fig. 5.9 A). The eradication of the free peptide signal was expected at a much 
lower solvent pH due to the deprotonation of the free peptide. To explain this, the influence of 
the instrumentation must be considered. The metal capillary used to introduce the electrospray 
carries a 3.5 kV charge, thus redox reactions taking place in the capillary will result in a 
change of the initial solution composition entering the spray-capillary. Van Berkel et al. [41] 
showed that oxidation of water in the ESI-MS capillary actually lowered the pH of the 
solution with up to two units under certain conditions. This is therefore an explanation for the 
detection of the free peptide over an apparently broad pH-range (Fig. 5.9 A).  
An 8-Beta molecular specie containing four sodiums ([M+4Na−3H]+) was detected at pH 12 
albeit at very low signal intensity (results not shown). The detection of this specie was 
probably because of the contribution of the extra sodium ion to the overall positive charge of 
the molecular species, illustrating the role of cationisation in detection of positive ions at high 
pH. From this data it could be deduced that there are at least four binding sites on the peptide 
of which only two, the C-terminal carboxylate group and the tyrosyl residue side-chain 
(phenolate group), can take part in ionic association with sodium. The specific interaction 
between sodium and 8-Beta will be addressed later on in this chapter. The strong influence of 
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counter ions in the sample solvent on detection was again confirmed. These results also 
supported the decision to use 0.05% TFA, which gave an apparent sample pH between 3 and 
4, as modifier in the sample solvent. 
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Figure 5.9     A. Influence of pH of the sample solvent on detection and cationisation of 8-
Beta with sodium using ESI-MS at 70 V cone voltage. All samples contained 10 
mM sodium. Duplicate samples were analysed and SEM is shown for each 
value. B. The influence of chloride ion concentration on ion current (deduced 
from the data in graph A (pH 0-4)) 
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5.4.1.5 Influence of carrier solvent composition  
To determine the influence of sample and carrier solvent on ion current and cationisation,  
8-Beta and its cationised species were analysed using different percentages of acetonitrile in 
the solvent system. Acetonitrile was chosen as carrier solvent because of its high volatility and 
low background interference in the ESI-MS. A mixture of acetonitrile and water was also 
suitable for dissolving the lipopeptide, 8-Beta, which is insoluble in most organic solvents 
including methanol. It was found that the influence of acetonitrile concentration, and therefore 
also solvent polarity, on the signal intensity and cationisation was negligible (Fig. 5.10). The 
slight suppression of the signal intensities using 80% acetonitrile was probably due to 
solubility factors or weaker ionisation. 
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Figure 5.10   Influence of percentage acetonitrile in the carrier solvent and sample solvent on 
cationisation of 8-Beta by sodium as observed by ESI-MS at a cone voltage of 
70 V. Duplicate samples were prepared using the same solvent composition as in 
carrier solvent, but including 0.05% TFA and 10 mM NaCl. SEM is shown for 
each value. 
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5.4.2 ESI-MS signal intensity and stability of the lipopeptides 
5.4.2.1 Influence of cone voltage on 8-Beta and its cationised species 
A concern in the study of the interaction of synthetic iturin A2 analogues with alkali metal 
ions is the differences in signal intensity and therefore also the difference in stability between 
the different molecular species. If there were significant differences in the signal intensities of 
the different molecular species at a certain instrument setting, quantitative comparisons would 
be complicated. Cone voltage in the ESI-MS is one of the parameters that determines the 
acceleration of the sample particles in the ionisation source and has a large influence on 
detection and fragmentation of sample molecules. To select the best cone voltage for 
sensitivity and minimum fragmentation, 8-Beta and its cationised species (refer to Fig. 5.6) 
were analysed at different cone voltages. 
For 8-Beta and its cationised species, spectra obtained at higher cone voltages (setting >50 V) 
produced less background noise and fewer multiple charged species, thereby facilitating  
interpretation. As expected in ESI-MS analyses, the doubly charged species were detected at 
the lower cone voltages, albeit at very low signal intensities, whereas the singly charged 
species were detected at the higher cone voltages. A bell-shaped relationship was found 
between signal intensity of any of the molecular species of 8-Beta and cone voltage over the  
20 V to 150 V range (Fig. 5.11). The weaker signal at lower cone voltages was probably due 
to impairment of detection of the peptide ions. The sharp decrease in signal intensities at cone 
voltages higher than the "optimum cone voltage" were the result of peptide ion fragmentation. 
The highest signal for free 8-Beta ([M+H]+) was found at 70 V, while the peptide fragmented 
extensively at higher cone voltages causing a rapid decrease of its signal (Fig. 5.11 A). The  
8-Beta molecular specie(s) containing one sodium ([M+Na]+) was detected at maximum 
intensity over a broad cone voltage range, showing two maxima, namely at 70 V and at 100 V 
(Fig. 5.11 B). This may be explained by the existence of two or more different complexes of  
8-Beta with one sodium, differing in their detection and stability. The maximum signal 
intensity of [M+2Na−H]+ at 100 V was in the order of 1.7 times higher than the intensity of 
[M+H]+ at 70 V, and [M+Na]+ at both 70 V and 100 V (Fig. 5.11 A-C). Complexes of 8-Beta 
to three sodium ions were also observed at 10 to 17 times lower signal intensities than that of 
the other sodiated species. The signal for [M+3Na−H]2+ was detected with maximum intensity 
at 70 V and at a comparable intensity to the [M+3Na−2H]+  signal with its maximum at 100 V 
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(Fig. 5.11 D). It was concluded that 70 V is the optimum cone voltage to do comparative 
studies of [M+H]+, [M+Na]+ and [M+3Na−H]2+, but in the case of [M+2Na−H]+ and 
[M+3Na−2H]+  values must be adjusted in comparative analyses. At 100 V all the singly 
charged sodiated species of 8-Beta could be compared, but at this cone voltage no or very 
little free peptide was observed. 
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Figure 5.11  Correlation between cone voltage and the signal intensity of the 8-Beta molecular 
species. The values were calculated from data obtained in triplicate analyses and 
SEM is shown for each value. A. [M+H]+ and [M+2H]2+; B. [M+Na]+ and 
[M+Na+H]2+ (Data for [M+Na+H]2+ are only shown to 90 V due to the 
interference of a peptide fragment with the same m/z at the higher cone 
voltages.); C. [M+2Na−H]+ and [M+2Na]2+; D. [M+3Na-2H]+ and  
[M+3Na-H]2+. (Note: Cone voltage = setting of instrument ± 2V) 
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5.4.2.2 Signal intensity and stability of the lipopeptides and their cationised species 
The optimum solvent composition for 8-Beta, namely 50% acetonitrile in water containing 
0.05% TFA and 10 mM NaCl, was used for the other peptides, because this composition 
minimised the counter anion effect. 
Very little fragmentation of 8-Beta,7-Beta and their cyclic analogues (with and without 10 
mM NaCl) was observed at 70 V cone voltage. The shorter peptides were much more 
sensitive to fragmentation at 70 V. Some stabilisation of the shorter peptides by sodium was, 
however, observed with 20% less fragmentation (35% vs. 53%) of 5-Beta and 5% less 
fragmentation (5% vs. 10%) of 6-Beta in the presence of 10 mM NaCl. The peptide backbone 
in the sodiated species was therefore protected from cone voltage dissociation. These 
observations substantiated the “cone voltage profiles” found for 8-Beta and its cationised 
species. The specific stabilisation and protection of the peptide backbone by sodium were 
studied in detail with 8-Beta as model peptide and will be discussed later in this chapter. 
Comparative analyses of all the lipopeptides were possible at 70 V, if the fragmentation of the 
two shorter peptides is also considered in the calculations. 
These results suggested that the possible existence of specific interaction between iturin A2 
analogues and alkali metal ions at binding cavities or sites. Peptide size and the N-terminal 
sequence would be important for this interaction. 
5.4.3 Interaction of the iturin A2 analogues with alkali metal ions  
In this part of the study the influence of increased hydrophobicity of the peptides, resulting 
from the elimination of one of the type II β-turns, was considered in the analysis of interaction 
with alkali metal ions. The influence of the peptide ring size and blocking of the N- and 
specifically the C-terminal on peptide-ion interaction were investigated using the cyclic 
analogues of the peptides 7-beta and 8-Beta. To probe the specificity and interaction cavity 
size, the alkali metal ions, Na+, K+ and Rb+ which increase in radius, were incubated with the 
different peptides. The antimicrobial cyclic decapeptide, gramicidin S, was used as control 
peptide in some of these studies. 
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5.4.3.1 Cationisation of iturin A2 analogues by sodium 
Stable sodiated molecular ions (cationised species) in all the peptide samples, modified with  
10 mM NaCl, were detected using positive mode ESI-MS (Figs. 5.6, 5.12, 5.13). The ESI-MS 
signal of the sodiated species of the linear lipopeptides ranged between 55% and 70% and that 
of the cyclic lipopeptides between 90% and 95% of the total peptide signal (Figs. 5.12, 5.13).  
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Figure 5.12   Relationship between molecular mass of the linear (o) or cyclic peptides (•) and 
percentage sodiated molecular specie detected in ESI-MS. The average of 
quadruplicate values with SEM is shown for each peptide. 
It was generally found that association with sodium increased with length (molecular mass) of 
the linear lipopeptides, although a linear relationship was not demonstrated (Fig. 5.12). 
Specifically, a greater association with sodium for 6-Beta and less association for 7-Beta than 
expected was observed. The latter observation may be the result of steric interference by the 
Tyr residue side-chain on association of sodium with the basic carbonyl groups (e.g. in 
peptide bonds, Asn and Gln acid amide side-chains) in 7-Beta. Because the Tyr residue is not 
present in 6-Beta, more carbonyl groups are possibly exposed. It was also observed that the 
deletion of an N-terminal Asn residue from 8-Beta and from 6-Beta, resulting respectively in 
7-Beta and 5-Beta, impaired the sodium interaction of these latter two peptides. Very little 
difference in sodium association between the two diastereomers of 7-Beta was found, but the 
differences between the diastereomers of 8-Beta were substantial (4%) and may be due to 
greater influence of the β-NC14 residue on the longer peptide’s conformation or to two distinct 
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backbone conformations, as was indicated by molecular modelling and NMR (refer to Chapter 
4). 
The four cyclic peptides, derived from 7-Beta and 8-Beta, differed very little from each other 
in their tendency to associate with sodium. An inverse relationship between peptide molecular 
mass and sodium association was found, with the sodium association of cyclic decapeptide 
gramicidin S, used as control, the lowest of the cyclic peptides and more in line with that of 
the linear peptides (Fig. 5.12). It seems as if the shorter cyclic peptides, cyclic 7-Beta I (L) and 
II (D) bind sodium with higher affinity than the longer peptides, suggesting that the sodium 
ion binds within the cyclic peptide’s cavity (“tighter” binding in a smaller cavity). The cyclic 
peptide, valinomycin, is such an example, with a non-solvated alkali metal ion (especially 
potassium) co-ordinated to the carbonyl oxygens in the cyclic cavity [1]. 
All the linear peptides, with almost equal distribution, associated with either one or two 
sodium ions as detected at a cone voltage of 70 V (Fig. 5.13). The longest linear peptides, 8-
Beta I and II, also formed substantial complexes with a third sodium ion. Higher abundance of 
the mono-sodiated species was detected in the longer peptides, whereas the di-sodiated 
species of the shorter peptides predominated. This is attributed to differences in signal 
intensity and/or the stability of the different sodiated species under ESI-MS conditions. 
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Figure 5.13   Preference of each of the iturin A2 analogues and gramicidin S to either 
associate with one, two or three sodium ions as observed under ESI-MS 
conditions. Quadruplicate values and SEM for each of the detected molecular 
peptide species are shown. 
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The ESI-MS detection of the neutral free cyclic peptides was improved by the cationisation by 
sodium and the singly sodiated species of the four cyclic peptides was predominated (>90% of 
total signal) in spectra (Figs. 5.13, 5.14 B). The low abundance or absence of di-cationised 
complexes suggests possible association of the cation in the interior of the peptide ring. 
Electrostatic repulsion would restrict the inclusion of a second cation. The spectra of cyclic 8-
Beta II (D) with and without 10 mM NaCl are given in Fig. 5.14 as example. The longer 
cyclic gramicidin S, used as control, bound to either one or two sodium ions resembling the 
sodium association pattern of the linear lipopeptides (Fig. 5.13). A previous study [48] of the 
alkali metal association of gramicidin S indicated that the alkali metal ion is bound to the 
exterior of  peptide ring, therefore avoiding the charge repulsion of two cations in the interior 
of the peptide ring. 
Because of the polar nature of the interaction between sodium and peptides it was predicted 
that sodium would preferentially associate with the more polar peptides. The polarity of each 
of the lipopeptides is influenced by their conformation in solution and the differences in 
polarity can be equated to retention by the hydrophobic matrix during HPLC, with the 
apparently less polar peptides eluting later than the polar peptides. 
The dependence on polarity is illustrated by the relationship between HPLC retention time 
(refer to Chapter 2) and percentage sodiated species detected (Fig. 5.15). This is not a linear 
dependence, indicating that not only polarity, but primary structure (also refer to Fig. 5.13) 
and the specific solution conformation contributed to the interaction with sodium. The shorter 
less polar linear peptides tended to associate less with sodium. The difference of sodium 
association between the diastereomers of 8-Beta was substantial, when compared to the other 
diastereomers. Two low energy conformations, the so-called S- and W-structure were 
predicted using HyperChem®4.5 (refer to Chapter 4). It is proposed that the S-structure may 
be the more favourable structure in sodium association. If this S-structure is predominant in 
the 8-Beta II (D) preparation this may explain its better complexation to sodium. 
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Figure 5.14   Positive ESI-MS spectra of cyclic 8-Beta II (D) before (A) and after incubation 
with NaCl (B). The sample consisted of 0.2 mg/mL peptide (without (A) or with 
10 mM NaCl and 0.05 % TFA (B)) dissolved in 50% acetonitrile/water. The 
spectra were obtained using optimised conditions described in this study. 
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Figure 5.15   Relationship between RP-HPLC retention time of the iturin A2 analogues and 
percentage sodiated molecular specie detected in ESI-MS. Average of triplicate 
values with SEM is shown. (All the HPLC analyses were done under identical 
conditions.) 
5.4.3.2 Alkali metal ion selectivity 
It has been observed that natural iturin A has a tendency to associate with cations, such as the 
alkali metal ions sodium and potassium [4]. The different lipopeptides were incubated with 
the chloride salts of sodium, potassium and rubidium in a competition assay. Difference in 
abundance of complexes between iturin A2 analogues and the alkali metal ions Na+, K+ and 
Rb+ can be related to the accessibility of the interaction sites. A range of cationised peptide 
species associated with either one or two alkali metal ions was found for all the linear 
peptides, but only mono-cationised species were detected for the cyclic peptides. Spectra of 7-
Beta and cyclic 7-Beta, in Fig. 5.16, illustrate these observations. 
The dominant species detected for all the lipopeptides, linear and cyclic, was the mono-
sodiated species. Abundance of the mono-cationised species decreased with increase in size of 
the cation for all the peptides, indicating at least a size limitation in the “interaction cavity” 
(Fig. 5.17). This was further demonstrated by the fact that only mono-cationised species were 
detected for all the cyclic lipopeptides and also gramicidin S (Fig. 5.17). In the case of the 
cyclic peptides it was clear that only one alkali metal ion “interaction cavity” is accessible. All 
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the lipopeptides showed an identical gas-phase selectivity for the alkali metals namely: 
Na+>K+>Rb+, which is the inverse of that observed for the longer valinomycin in methanol 
[49]. 
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Figure 5.16  ESI-MS spectra of 7-Beta (A) and cyclic 7-Beta (B) incubated in the presence of 
NaCl, KCl and RbCl. The sample consisted of 0.2 mg/mL peptide dissolved in 
50% acetonitrile/water modified with 0.05% TFA and 10 mM of each of the 
salts. The spectra were obtained using optimised conditions described in this 
study. 
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Figure 5.17   Relationship between the abundance of cationised peptide species and cation 
radii. The data points are the average of duplicate sample analyses. (Cation radii 
were taken from [50]; Na+ = 0.95 C; K+ = 1.33 C; Rb+ =1.48C)  
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A substantial amount of di-cationised species, containing either two Na+ or Na+ and K+, were 
detected for the longer linear peptide pairs of 8-Beta and 7-Beta (Figs. 5.16 A, 5.17). These 
results indicated that at least two “interaction cavities” are present in the linear hepta- and 
octalipopeptides. Di-cationisation of the shorter 5-Beta and 6-Beta was greatly impaired (Fig. 
5.17), whereas di-cationised species of the cyclic peptides were virtually absent (Figs. 5.16 B, 
5.17). The residues NY were omitted in 6-Beta and NYN in 5-Beta indicating that one of the 
cavities is probably situated in the C-terminal tetrapeptide moiety, QPNS. It can therefore be 
hypothesised that a second cavity is situated in the N-terminal tetrapeptide moiety,  
β-NC14-NYN. 
5.4.4 Investigation of specific interaction with alkali metal ions  
ESI-MS-MS was also employed in the detailed investigation of the specific interaction 
between sodium, as model cation, and peptide moiety of iturin A. The peptide preparation 
used in this study was a diastereomeric mixture of 8-Beta I (D) and 8-Beta II (L). A difference 
in total sodium adduct signal intensity was observed between the diastereomers, but no 
distinctive difference in fragmentation patterns was observed (refer to Chapter 3). Using this 
preparation was still feasible because both diastereomers contain exactly the same α-amino 
acid peptide chain with similar backbone conformation as determined by in vacuo structure 
modelling (refer to Chapter 4). 
5.4.4.1 CID Stability of 8-Beta and its sodium cationised species 
To select the best condition for fragmentation by CID, the effect of increasing collision energy 
on the stability of 8-Beta and sodium cationised species was investigated (Fig. 5.18) The order 
of stability was found to be 8-Beta+1Na > 8-Beta+2Na > 8-Beta+3Na > 8-Beta. Under the 
specific experimental conditions used to obtain data in Fig. 5.18, the collision energy needed 
to reduce the signal by 50% (defined as I50) increased in the order of 10 eV when one sodium 
was complexed to 8-Beta, whereas the I50 collision energy requirement decreased in the order 
of  
2 eV for each further sodium complexed to the peptide after the first sodium. These results 
corroborated the cone voltage stability data (refer to Fig. 5.11) which showed that 
fragmentation of the 8-Beta occurred at cone voltages higher than 70 V, whereas sodiated 
species only fragmented at cone voltages higher than 100 V. Results from both CID and cone 
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voltage decomposition of 8-Beta and its cationised species indicated that complexation of 
sodium to 8-Beta afforded protection against fragmentation. 
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Figure 5.18  Correlation between signal intensity of the four different singly charged 8-Beta 
molecular species and collision energy at cone voltage of 70 V. The values were 
normalised using the signal obtained at 10 eV as 100%. The arrows indicate the 
collision energy at which the signal intensity of each of the species decreased by 
50% defined as I50. Data were collected using MRM with both MS1 and MS2 
static at the parent ion m/z. The results of one of four similar experiments are 
shown. 
The current hypothesis is that fragmentation reactions are induced by a protonated site; the 
location of these sites has therefore a considerable influence on the fragmentation of the 
peptide [25, 29, 52]. It is possible that the association of the sodium with basic sites in the 
peptide might lead to protection of bonds in its neighbourhood. In this study it was, however, 
shown with CID that cationised peptides containing more than one sodium were more inclined 
to fragment. This complicated the picture, indicating that binding of each additional sodium 
after the first increased the lability of some of the bonds in the peptide. This may be due to 
conformational changes in the peptide structure exposing new basic sites or as a direct result 
of Na+ attachment. If the Na+ is attached to carbonyl oxygens in peptides, as suggested by 
some authors [31-35, 52], it could have opposing effects. Tang et al. [52] proposed that the 
sodium attachment increases the double bond character of the peptide bond stabilising it, but 
conversely activates the carbonyl carbon making it more electrophilic and a target for 
nucleophilic attack. The overall stability of alkali metal cationised peptides in the mass 
I50 
Stellenbosch University http://scholar.sun.ac.za
 5.34
spectrometer has not specifically been addressed by other investigators. The subsequent study, 
was focused on the sequence specific protection afforded by the association of the model 
lipopeptide, 8-Beta, with sodium. 
5.4.4.2  Fragmentation of 8-Beta and its cationised species 
Fragmentation of each of the sodium cationised molecular species was greatly impaired under 
identical CID conditions used for the free peptide (Fig. 5.19), confirming the results obtained 
in the collision energy stability experiments. In this study it was also found, as in others [31-
39, 51], that the fragmentation patterns were markedly different from that of the free peptide 
and that the sodium is retained in most of the product ions (Figs. 5.20, 5.22, Tables 5.2, 5.3). 
A neutral loss of 1 mass unit, from parent ions and some product ions, was also observed in 
spectra generated by CID. This could be explained by one or more of the following: 
rearrangement in the N-terminal β-aminotetradecanoic acid residue, neutral loss of a proton 
from the Tyr3 side-chain or another acidic group, and the inherent low resolution of 
electrospray ionisation mass spectrometry at low signal intensity (imprecise centroid 
determination because of poor counting statistics). For these reasons we relied primarily on 
secondary product ion fragmentation (“MS3”) and previous interpretations in literature to 
assist us in product ion assignment. The nomenclature of Roepstorff and Fohlmann [23], as 
revised by Biemann [24], used in the product ions assignment was described earlier in this 
chapter (refer to Fig. 5.5). 
Fragmentation of free 8-Beta (expected m/z 1062.2, observed MS2 m/z 1061.3) occurred at all 
the peptide bonds, producing most of the expected b- and y-type product ions and ynbm-
internal fragments (Figs. 5.6 A, 5.19, Table 5.1). Product ions b5 (m/z 744.4; 728.1) and y3 
(m/z 317.5), from L-Gln5-L-Pro6 bond cleavages, were the major fragments of 8-Beta. It is 
known that the N-terminal peptide bond in which Pro participates is highly susceptible 
towards low energy fission [28]. A high abundance of internal fragments (m/z 212.3; 284.6) 
corresponding to L-Pro6-D-Asn7 indicated the lability of the L-Gln5-L-Pro6 bond, as well as 
that of the D-Asn7-L-Ser8 amide bond. A wa4 product ion (m/z 371.2), formed as a result of the 
loss of the Gln-side-chain from y4, and the immonium ion of L-Gln5 were also observed. This 
further indicated the lability of bonds in the neighbourhood of the L-Gln5 residue. The low 
abundance product ion m/z 634.5 was attributed to b4+OH (according to Teesch et al. [31, 
32]) although this is relatively uncommon for non-cationised peptides. Internal fragments (m/z 
278.5; 249.8) corresponding to D-Tyr3-D-Asn4 or L-Asn2-D-Tyr3 and the immonium ion of  
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D-Tyr3 (m/z 136.5) were observed at relatively high abundance indicating the lability of the 
amide bonds in the neighbourhood of D-Tyr3.  
Table 5.1      Summary of the observed product ions generated by CID of the free peptide 
specie of 8-Beta. Only product ions detected at signal intensities equal to or 
above 45000 were taken into account. (* = loss of side-chain; fi = internal 
fragment; ? = inconclusive results from product ion fragmentation; C-terminal 
product ions are indicated in italics) 
m/z 
observed 
intensity relative 
intensity 
(%) 
proposed  
fragment type 
m/z 
calculate
d 
sequence 
1061.3 727488 100.0 [M]+ 1061.2 β-NC14NYNQPNS 
744.4 52712 7.2 b5 744.9 β-NC14NYNQ 
728.1 59016 8.1 b5-NH3 727.9 β-NC14NYNQ 
711.5 47224 6.5 b5-2NH3 710.9 β-NC14NYNQ 
634.5 54584 7.5 b4+OH 633.8 β-NC14NYN 
561.8 61788 8.5 a4-CO 561.6 β-NC14NYN 
544.2 56504 7.8 a4-CONH2 543.5 β-NC14NYN* 
503.3 56628 7.8 b3 502.7 β-NC14NY 
450.8 62092 8.5 2(b1) ? 450.8 β-NC14  ? 
433.4 83136 11.4 (b1-NH3; b1) ? 433.8 β-NC14 ? 
426.4 70372 9.7 fi-CO 426.5 NQPN 
416.4 81472 11.2 2(b1-NH3) ? 416.8 β-NC14  ? 
405.0 45424 6.2 fi-H 405.6 YNQ 
371.2 45708 6.3 w4a 371.4 QPNS 
323.3 55256 7.6 fi-NH3 323.3 NQP/QPN 
320.2 75228 10.3 ?  ? 
317.5 245472 33.7 y''3 317.3 PNS 
278.5 81868 11.3 fi 278.3 YN/NY 
249.8 57768 7.9 fi-CO 250.3 YN/NY 
220.6 55164 7.6 y''2 220.2 NS 
212.3 80636 11.1 fi 212.2 PN 
184.6 192752 26.5 fi-CO 184.2 PN 
136.5 93876 12.9 i3 136.2 Y 
101.4 50948 7.0 i5 101.1 Q 
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The N-terminal β-NC14 residue complicated the interpretation of the fragmentation results, as 
it has a tendency to form adducts with itself (see b1-product ion assignments in Table 5.1). 
CID produced mostly smaller product ions and internal fragments from the 8-Beta molecular 
ion, whereas larger product ions and very little internal fragments were produced from the 
cationised parent ions. The product ion with m/z 320.2 was not assigned after inconclusive 
product ion fragmentation results. 
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Figure 5.19   CID spectrum of [M+H]+ at a collision energy of 30 eV and cone voltage of  
70 V. Selection of the parent ion took place in MS1 and fragmentation data was 
acquired by continuum mode scanning MS2 from m/z=100 to 1200 at 100 atomic 
mass units/second for precisely six minutes. 
Close inspection of fragments generated by CID revealed the specific interaction between 8-
Beta and sodium. The major product ions from sodium cationised molecular species were N-
terminal an-m, bn-m and bn-m+OH ions (n=7, m=0...6). Refer to Figs. 5.20 and 5.22, and Tables 
5.2 and 5.3, for detailed product ion assignment. The pattern of predominantly N-terminal 
product ions from sodium adducts was also found by Teesch et al. [31, 32], in FAB-MS 
studies of alkali metal adducts of various peptides, and by Kanai et al. [36] in ESI-MS studies. 
Assignment of bn-m+OH, rather than cn-m, to some of the observed ions was favoured due to 
convincing evidence in literature describing the formation of this type of ion as a result of 
alkali metal cationisation [31-35, 52, 53]. Tang et al. [52] was the first to suggest that alkali 
metal  cationisation leads  to  hydroxyl  transfer  from  the  C-terminal  carboxyl  to  form  
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bn-m+OH+Na product ions and not c-type ions as previously reported [36] (Fig. 5.21 A). Some 
an-m+Na−H product ions in the CID spectra of the cationised 8-Beta, as well as in the spectra 
from the bn-m+OH+Na precursor ions, were also observed. Teesch et al. [31, 32] proposed the 
formation of an-m+Na-H product ions from precursors with the alkali metal ion complexed 
towards the N-terminal of the peptide with no involvement in an ionic bond with the C-
terminal carboxylate. 
Fragmentation of 8-Beta+1Na (m/z 1084.1, m/z expected 1084.2), under the CID conditions 
used, produced mostly only very low abundance product ions with relative intensity of 1-2% 
of the parent ion (Table 5.2, Fig. 5.20). The three major product ions were a dehydrated parent 
ion (m/z 1065.9) at 6.5% relative intensity, b7+OH+Na−H (m/z 996.7) at 3.2% and b7+Na−H 
(m/z 978.5) at 2.2%. The formation of b7+Na−H product ion (probably via 1,2 elimination of 
OH from b7+OH+Na [10]) indicated that the binding site of Na+ is to the N-terminal side of 
the cleavage site. We also observed an-m+Na−H product ions in the CID spectra of m/z=996.7 
product ion, in accordance with the evidence presented by Teesch et al. [31, 32]. This again 
indicates that the alkali metal ion is bound to the N-terminal side of the cationised 8-Beta.  
Table 5.2      Summary of the observed product ions generated by CID of the singly cationised 
specie(s) of 8-Beta, namely 8-Beta + 1Na. Only product ions detected at signal 
intensities equal to or above 40000 were taken into account. (* = loss of side-
chain to form m-ion; # = assignment confirmed by selection and fragmentation 
of product ion; C-terminal product ions indicated in italics) 
m/z 
observed 
 
intensity 
relative 
intensity (%) 
proposed  
fragment type 
m/z 
calculated 
 
sequence 
1084.1 2853376 100.0 [M+Na-H]+ 1084.2 β-NC14NYNQPNS 
1065.8 185056 6.49 [M +Na-H2O-H]+ 1065.2 β-NC14NYNQPNS 
1022.7 43200 1.51 m8+Na-CO-3H 1023.2 β-NC14NYNQPNS* 
996.7 97188 3.41 b7+OH+Na-H # 996.1 β-NC14NYNQPN 
978.5 63724 2.23 b7+Na-H 979.1 β-NC14NYNQPN 
898.8 41684 1.46 a7-CO-2H 899.1 β-NC14NYNQPN* 
880.8 40516 1.42 b6+OH+Na-H # 881.0 β-NC14NYNQP 
739.6 50740 1.78 a5+Na-H # 739.9 β-NC14NYNQ 
639.0 52448 1.84 b4+Na-H # 639.8 β-NC14NYN 
580.5 <40000 <1.4 y”5+Na-# 580.5 NQPNS 
187.8 41908 1.47 z’2-NH3 187.1 NS 
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Figure 5.20   CID spectrum of [M+Na]+ at a collision energy of 30 eV and cone voltage of  
70 V. Selection of the parent ion took place in MS1 and fragmentation data was 
acquired by continuum mode scanning MS2 from m/z=100 to 1200 at 100 atomic 
mass units/second for precisely six minutes. 
According to the mechanism depicted in Fig. 5.21 A, the C-terminal carboxyl (that of L-Ser8 
in 8-Beta) does not partake in an ionic interaction of the precursor ion with sodium, that is if 
no migration of the sodium took place. It is, however, possible that the formation of 
b7+OH+Na−H was because of interaction with the C-terminal carboxyl group and the adjacent 
carbonyl oxygen of the peptide bond. Such a reaction mechanism, describing the loss of the C-
terminal residues from alkali metal cationised peptides to form a “new peptide”, was 
originally described by Renner and Spiteller [33] and endorsed by Thorne et al. [52] and 
Grese et al. [34, 35] (Fig. 5.21 B). In our studies the participation of C-terminal Ser8 was 
indicated by a low abundance sodium adduct of x1-type (m/z 154.1) observed in some of the 
CID spectra.  
In contrast with the free peptide only very low abundance product ion from L-Gln5-L-Pro6 
bond cleavages were detected, namely a5+Na-H (m/z 739.6), indicating that the amide bond in 
this dipeptide unit is highly protected. This is of particular significance due to the well-
characterised MS lability of the N-terminal peptide bond in which Pro residues participate 
[25, 28]. In an ESI-MS study of the fragmentation of alkali metal cationised peptaibols 
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(containing sub-sequences of α-aminoisobutyryl-prolyl) by Kanai et al. [37] such a protection 
of the N-terminal peptide bond of Pro by cationisation was not reported. We propose that the 
L-Gln5 carbonyl oxygen in the peptide bond and the side-chain of L-Gln5 participate in 
cationisation of 8-Beta. The participation of L-Gln5 is also indicated by the absence (or very 
low abundance) of the w4a product ion and the Gln immonium ion observed in the CID spectra 
of free 8-Beta.  
The interpretation of these results is in accordance with that of Teesch et al. [31, 32] who used 
high resolution FAB-MS to study the interaction of various peptides with alkali metal ions. 
They concluded that alkali metal ions tended to complex to sites with basic carbonyl groups, 
such as the amide oxygen in Asn and Gln side-chains, and to the amide oxygen in the peptide 
bond. Further evidence of the association of sodium towards the N-terminal of 8-Beta is the 
observation of b6+OH+Na−2H (m/z 880.8) and a5+Na-H (m/z 739.6) and very low abundance 
b4+OH+Na−H (m/z 656.9).  
If the C-terminal carboxyl group participates in the reaction to form a bn+OH product ion, it is 
important that the particular electrophilic carbonyl-carbons must be in close proximity to the 
nucleophilic group, which is either the hydroxyl group as in the Tang mechanism (Fig. 5.21 
A) or carboxylate oxygen as in the Thorne mechanism (Fig. 5.21 B). In the case of 8-Beta, 
proximity of the peptide bond carbonyl of the dipeptide moiety, D-Asn4-L-Gln5, to the C-
terminal carboxyl group, such as in a β-turn, would explain the observation of b4+OH in the 
spectra of free and mono-sodiated 8-Beta. The structure of natural iturin A (as determined 
with NMR) includes a type II β-turn in each β-NC14NYN and QPNS [4]. Molecular modelling 
studies on 8-Beta using HyperChem®4.5 (refer to Chapter 4), suggested two turns in the so-
called S-structure, approximating β-turns, with a turn each in the N-terminal tetrapeptide (β-
NC14NYN) and C-terminal tetrapeptide (QPNS). These turn conformations place some of the 
peptide bond atoms in close proximity to the C-terminal carboxyl group and will also be 
conducive to multidentate and intrinsic binding of the alkali metal ions. The smallest 
fragments from the 8-Beta+1Na parent ion still associated with sodium were b4 (m/z 639.0) 
and low abundance y”5 (m/z 580.5) product ions corresponding to β-NC14NYN and NQPNS 
respectively (Fig. 5.20, Table 5.2). The presence of sodiated N- and C-terminal product ions 
may be explained by the presence of two intrinsic binding sites (possibly two β-turns) for 
sodium in 8-Beta and at least two types of singly cationised parent ions. The existence of two 
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such cationised species may also explain the two “cone voltage maxima” observed for mono-
sodiated 8-Beta (Fig. 5.11). 
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Figure 5.21   Mechanisms describing the bn+OH+Na−H product ion formation: (A) Tang 
mechanism [51] (B) Thorne mechanism [52]. 
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The multi-sodiated 8-Beta species were more inclined to fragment than the mono-sodiated  
8-Beta. The CID of di-sodiated 8-Beta (expected m/z 1106.2, observed MS2 m/z 1105.4) again 
produced sodiated bn-m+OH, and an-m type product ions, a deaminated parent ion (m/z 1088.1) 
and a high abundance (17.5%) of m8+2Na-2H product ion (m/z 1075.4, produced by the loss 
of the Ser-side-chain) (Fig. 5.22, Table 5.3). The smallest fragment, still associated to two 
sodiums, was b7+OH+2Na−2H (m/z 1017.8) at 2.7% intensity. The corresponding low 
abundance a7 product ion (m/z 949.8) contained only one sodium, which is an indication that 
at least one sodium is bound towards the N-terminal side of the peptide. Other N-terminal 
product ions, identical to that found for mono-sodiated 8-Beta, namely b6+OH+Na-2H (m/z 
881.7) at 3.6% intensity and a5+Na-2H (m/z 739.1) at 2.1% intensity were observed. No 
product ions corresponding b4+OH+Na were observed, which could possibly be the result of a 
subtle conformational change. A product ion with m/z 384.1, observed at 7.9% intensity, was 
assigned to [x6+Na−H]2+ after exhaustive secondary product ion CID. This assignment was 
also substantiated by the observation of other C-terminal product ions of sodiated x6-type (m/z 
769.6; 735.7) and the a2 (m/z 313.3) N-terminal product ion. The formation x6-type ions 
would require increased lability and/or exposure of the bond between the Cα of D-Asn2 and 
the amide bond carbonyl carbon. The participation of the D-Asn2 amide oxygen in interaction 
of the C-terminal side of the peptide with sodium may increase the stability (by increased 
double bond character) of the amide bond and/or expose the neighbouring bond. The 
participation of other amide bond atoms (amide bond oxygens of L-Gln5, D-Asn4 and D-Tyr3) 
and basic groups (L-Gln5 side-chain) with sodium are indicated by the absence (or very low 
abundance) of certain product ions, such as L-Gln5 and D-Tyr3 immonium ions, wa4 and 
sodiated b4-type product ions. The smallest fragments bound to one sodium, from CID of di-
sodiated 8-Beta, were a5+Na-H (β-NC14NYNQ; m/z 739.1) and y”5 +Na−NH3−H (NQPNS; 
m/z 566.1) (Fig. 5.22, Table 5.3). These results indicated that the major binding sites for 
sodium in di-sodiated 8-Beta are similar to those proposed for the mono-sodiated 8-Beta, and 
probably multidentate in both cases.  
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Table 5.3      Summary of the observed product ions generated by CID of the di-cationised 
specie(s) of 8-Beta, namely 8-Beta + 2Na. Only product ions detected at signal 
intensities equal or above 40000 were taken into account. (* = loss of side-chain 
to form m-ion; #  = assignment confirmed by selection and fragmentation of 
product ion; ? = inconclusive results from product ion fragmentation; C-terminal 
product ions are indicated in italics) 
m/z 
observed 
 
intensity 
relative 
intensity (%) 
proposed  
fragment type 
m/z 
calculate
d 
 
sequence 
1105.4 2270464 100.0 [M+2Na-3H]+ 1105.2 β-NC14NYNQPNS 
1088.1 58940 2.60 [M +2Na-NH2-2H]+ 1088.2 β-NC14NYNQPNS 
1075.4 397632 17.51 m8+2Na-2H 1075.2 β-NC14NYNQPNS* 
1017.8 60808 2.68 b7+OH+2Na-2H # 1018.1 β-NC14NYNQPN 
949.8 <40000 <1.8 a7+Na-H # 950.2 β-NC14NYNQPN 
881.7 81256 3.58 b6+OH+Na-H # 881.0 β-NC14NYNQP 
739.1 46580 2.05 a5+Na-H # 738.9 β-NC14NYNQ 
735.7 40820 1.80 x6+Na-2NH3-H # 735.7 YNQPNS 
563.9 < 40000 <1.8 y”5+Na-H-NH3 # 563.5 NQPNS 
555.4 68656 3.02 [M+2Na+2H]2+ # 554.6 β-NC14NYNQPNS 
458.3 44000 1.94 a3-NH2 457.6 β-NC14NY 
384.1 179008 7.88 (x6+Na-H)2+ # 385.4 β-NC14NYNQ 
362.3 40636 1.79 b2+Na-H ? 362.5 β-NC14N ? 
322.4 74964 3.30 b2-H2O ? 322.5 β-NC14N ? 
313.3 55312 2.44 a’2 313.5 β-NC14N 
 
The fragmentation pattern of 8-Beta+3Na changed with pre-incubation time (age of sample) 
and because of this unpredictability and its very low abundance it was decided not to study 
this cationised specie in detail. It is, however, possible to predict from the data presented that 
the third binding site is probably due to ionic interaction between the carboxyl group of L-Ser8 
and sodium. This explains the low abundance of the 8-Beta+3Na molecular specie. Under the 
experimental conditions used in this study, it was not possible to show interaction between D-
Tyr3 and sodium, a putative binding site of the fourth sodium that was observed in aged 
samples and at high pH. The fragmentation patterns obtained with 8-Beta as model peptide 
and sodium as cation substantiated previous results (Figs. 5.13, 5.18). 
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Figure 5.22   CID spectrum of [M+2Na−H]+ at a collision energy of 30 eV and cone voltage 
of 70 V. Selection of the parent ion took place in MS1 and fragmentation data 
was acquired by continuum mode scanning MS2 from m/z=100 to 1200 at 100 
atomic mass units/second for precisely six minutes. 
5.5 Conclusions 
The stable nature and ease of detection of 8-Beta and its cationised species allows the use of 
ESI-MS to study the specific interactions of 8-Beta and alkali metals. The cationisation of 8-
Beta with sodium takes place in the solution and the complexation equilibrium is slow. 
Furthermore, under ESI-MS conditions, the lipopeptide-sodium interaction is not influenced 
by solvent polarity and is also independent of pH over a broad range. From the pH study it 
was further deduced that there are at least four binding sites for sodium to 8-Beta of which 
two, the C-terminal carboxylate and the side-chain of tyrosine, can take part in ionic 
interaction with sodium. Results from the pH study also showed that the pH is not as 
important as the concentration of the counter anions in the sample solvent. We also found, as 
did other investigators [43-45], that the influence of solvent counter ions on ionisation during 
the electrospray process must not be underestimated. 
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The optimum ionisation conditions for this study was determined with 8-Beta as model 
peptide and Na+ as model ion. It was decided to conduct future studies with cone voltage set at 
70 V,  the apparent optimum from “cone voltage profiles” for comparative studies of the 
singly charged molecular species [M+H]+ and [M+Na]+. At this cone voltage, however, the 
signals of [M+2Na−H]+ and [M+3Na-2H]+ are somewhat underestimated. A carrier solvent of 
50% acetonitrile in water was found to be suitable for dissolving the lipopeptide and for the 
ESI-MS analyses of the peptide sodium complexes. The same sample solvent composition, 
modified with 0.05% TFA and 10 mM NaCl, was chosen as the reference sample solvent for 
subsequent studies in which the stability and structures of the sodiated 8-Beta species were 
determined. 
The interaction with sodium was influenced by the primary structure of the linear peptides, as 
a higher abundance of sodiated species of the longer peptides was observed. This is probably 
the result of the sequential elimination of the N-terminal β-turn in the shorter peptides. The 
cyclic peptides only bound to one sodium with a slightly higher abundance observed for 
sodiated cyclic 7-Beta, having a smaller cyclic cavity, than the sodiated cyclic 8-Beta. This is 
an indication of a cation binding site inside the peptide ring.  
Very little fragmentation of 8-Beta and 7-Beta and the cyclic lipopeptides (with and without 
10 mM NaCl) was observed at 70 V cone voltage. The shorter peptides fragmented 
substantially at 70 V, but some stabilisation by sodium was observed with 20% less 
fragmentation of 5-Beta and 5% less fragmentation of 6-Beta in the presence of 10 mM NaCl. 
This complexation to sodium therefore protected some of the very labile peptide bonds from 
cone voltage induced dissociation. Stability was specifically conferred by protection of the 
very labile L-Gln-L-Pro
 
peptide bond in the sodiated peptide species. The difference in lability 
between the mono-sodiated and di-sodiated species in 8-Beta is possibly the result of better 
stabilisation of the labile D-Tyr3-D-Asn4 bond in the mono-sodiated specie. The fragmentation 
patterns observed for each of the sodiated species of 8-Beta were in accordance with the 
findings of Teesch et al. [31, 32], although these results did indicate limited interaction 
between the C-terminal carboxylate and sodium. Fragmentation of 8-Beta and its cationised 
species revealed two intrinsic binding sites for non-solvated sodium ions situated in the N-
terminal peptide moiety, β-NC14NYN(Q) and C-terminal peptide moiety, NQPNS (Fig. 5.23). 
The structure of natural iturin A includes a type II β-turn in each β-NCnNYN and QPNS [50]. 
This type of turn conformation in the linear peptides could position the peptide chain in such a 
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way that multidentate binding of ions and the formation of bn-m+OH ions are facilitated. The 
interaction of alkali metal ions with the two peptide moieties was also confirmed by the 
observed association between alkali metal ions and the shorter lipopeptides. The alkali metal 
ion selectivity sequence of all the lipopeptides was Na+> K+> Rb+, indicating a size limitation 
in the interaction cavity or cavities. It is proposed that interaction of non-solvated sodium with 
most of the amide bond oxygens in the predicted turns, specifically that of β-NC14, Asn2 and 
Tyr3 in turn A (β-NC14NYN) and that of Gln5 and Pro6 in turn B (QPNS), and with the Gln5 
side-chain,
 
provide the protection against low energy fragmentation of sodiated 8-Beta species 
during ESI-MS (Fig. 5.23). 
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Figure 5.23   Proposed association between 8-Beta and sodium. All the interaction 
possibilities with 8-Beta predicted from CID fragmentation patterns of the 
mono-sodiated and di-sodiated 8-Beta. 
One of the low energy structures of 8-Beta*D (*indicates the substitution of β-NC14 residue 
with a β-NC5 residue for modelling purposes) predicted by HyperChem®4.5 is a backbone 
structure in the shape of a twisted S (S-structure) which includes two turns approximating β-
turns (refer to Chapter 4). A model of this structure complexed to two sodium ions is depicted 
in Fig. 5.24. The proposed interaction is between one sodium and the carbonyl oxygens of β-
NC14, Asn2 and Tyr3 in turn A and between the second sodium and the carbonyl oxygens of 
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Gln5 and Pro6 in turn B. The atomic distance between the turn B carbonyl oxygens of Gln5 and 
Pro6 in the model is 3.56  . The triangular distances in turn A is 2.94  between the carbonyl 
oxygens of β-NC14 and Tyr3, 4.15  between carbonyl oxygens of β-NC14 and Asn2, and 3.36 
 between chain carbonyl oxygens of Asn2 and Tyr3. These gaps are adequate to allow the 
interaction of two or more of the oxygens with a alkali metal ion in the turn cavities. 
 
Figure 5.24  Stereotypgraphs of the predicted S-structure of 8-Beta*D showing the one of the 
possible structures including two sodium ions. 
It is clear that each of the predicted turns in the so-called S-structure may serve as interaction 
cavities. The omission of amino acid residues in these cavities, as in 5-Beta an 6-Beta, leads to 
a diminished capacity to bind a second larger cation. Association of the cation in the interior 
of the peptide ring of the cyclic peptides is proposed from the absence of or observation of 
only low abundance di-cationised complexes, and the slightly better association of the cyclic 
heptalipopeptides. The inclusion of a second cation may be unfavourable because of 
electrostatic repulsion. This resembles valinomycin accommodating a single cation in its 
cyclic cavity [49] and not gramicidin S which binds the alkali metal cations on its exterior 
[48]. It is therefore hypothesised that alkali metal ions can bind in either one of the two β-
turns in the peptide ring of natural iturin A molecule, with the carbonyl oxygens as chelating 
atoms. The specific interaction of the iturin A2 analogues with alkali metal cations may point 
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to some role of this interaction with its biological activity which will be addressed in Chapters 
6 and 7. 
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Chapter 6  
Hydrophobic properties and biological activity 
of iturin A2 analogues 
6.1 Introduction 
The interaction of antimicrobial peptides with membranes and hydrophobic environments is 
crucial for their biological activity. Knowledge about the hydrophobicity of an antimicrobial 
peptide would be of great help in an understanding of their interaction with membranes. The 
retention of peptides by the hydrophobic octadecanoylsilane matrix (ODS or C18), commonly 
used as packing material in HPLC, can be used as a measure of the peptides' solution-phase 
hydrophobicitythe more hydrophobic the peptide, the longer it will be retained. In assessing 
the purity of the synthetic iturin A2 analogues (Chapter 2) it was observed that primary 
structure influenced HPLC behaviour. This chapter describes the analysis of the HPLC 
behaviour of the iturin A2 analogues in terms of their hydrophobic nature and interaction with 
membranes. 
Peptides that are membrane-active are amphipathic because interaction occurs at the interface 
between the hydrophobic aliphatic chains and the hydrated polar head groups of the 
membrane lipids. Accordingly, most antimicrobial peptides are amphipathic, for example, 
when interacting with membranes, the cationic magainins adopt an amphipathic α-helical 
conformation [1] and the cationic defensins an amphipathic β-sheet conformation [2]. Iturin 
A2 is amphipathic because of the inclusion of the hydrophobic β-aminotetradecanoic acid (β-
NC14) in its otherwise polar structure [3]. The omission of the aliphatic chain destroys all 
biological activity [4]. 
After interaction with the membrane, many antimicrobial peptides form characteristic ion 
channels [5, 6] by self-aggregation and self-assembly in the membrane [7]. Aggregation of the 
iturin A2 analogues was observed during purification and general handling (Chapter 2). In this 
chapter the aggregation of some of the linear iturin A2 analogues will be discussed. Induction 
of secondary structures, possibly β-pleated sheet structures, caused by self-assembly of the 
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synthetic iturin A2, was observed upon interaction with dimiristoylphosphatidylcholine 
(DMPC) liposomes (Chapter 4). The natural iturin A also tends to aggregate in membranes [8, 
9], forming complexes with an ion-pore character [10-12]. The precise structure and 
composition of ion-conducting pores are as yet unknown. It was previously found that the 
iturin A aggregates or complexes in DMPC membranes consisted of only iturin A molecules 
[13], but in the presence of membrane sterols these complexes included cholesterol (1:1) or 
ergosterol (2:3) [13] (also refer to Chapter 1 and [3]). Maget-Dana and Peypoux [3] proposed 
the binding of cations in the iturin A ion-pores to explain their weak anion selectivity. In this 
study the synthetic iturin A2 and the other analogues showed sequence specific interaction 
with alkali metal ions with higher selectivity for Na+ than for K+ (Chapter 5). 
The target cell specificity of antimicrobial peptides depends on recognition of the target 
membrane. Some antimicrobial peptides can recognise specific lipids; for example, the cyclic 
antibiotic peptide, Ro09-0198, recognises phosphatidylethanolamine (PE) [14]. Magainins 
preferentially interact with bacterial membranes that contain lipopolysaccharides and mainly 
neutral PE and acidic phosphatidylglycerol in the outer monolayer of the membrane [15]. 
Melittin on the other hand has an affinity for erythrocyte membranes containing cholesterol 
and zwitterionic (neutral) phospholipids such as phosphatidylcholine (PC) and sphingomyelin 
[15]. This peptide also possesses antibacterial activity. Iturin A interacts with membranes 
containing PC and membrane sterols, such as cholesterol or ergosterol [13, 16-18]. 
Consequently, iturin A possibly recognises cholesterol or ergosterol and PC in eukaryotic 
target cells such as erythrocytes [8, 18, 20] and fungi [16, 17, 19, 21]. The recognition 
mechanism of one of the few prokaryotic target cells of iturin A, Micrococcus luteus [22-24], 
is unknown because it does not contain PC or membrane sterols in its membrane [25]. The 
precise role of iturin A’s primary structure in the recognition of target cell membranes is 
unclear. The influence of iturin A’s peptide moiety on the interaction with DMPC liposomes 
will be discussed in this chapter. 
Living organisms are usually selective with respect to the chiral configuration of compounds, 
but the recognition of their membranes by most antimicrobial peptides does not seem to be 
stereoselective. Wade et al. [26] found that D-enantiomers (exact mirror images) of cecropin 
A, magainin 2 amide, melittin and some cecropin-melittin hybrids retained their antimicrobial 
activity. These enantiomeric D-peptides retained their amphipathic structure, but as left 
handed amphipathic α-helixes. It was also observed by Merrifield et al. [27] that a mixture of 
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D-peptides and L-peptides did not influence membrane activity and channel formation. They 
also tested a peptide with the N-terminal end containing D-amino acids and the C-terminal 
end L-amino acids that retained all membrane activity. Chen et al. [28], however, observed 
that substitution of three L-Ala residues with D-Ala to form magainin H lead to reduced 
antibacterial activity. Dathe et al. [29] found that double D-amino acid replacements in a 
model amphipathic antimicrobial peptide either increased or decreased its bioactivity. This 
type of replacement of some amino acid residues with their enantiomers leads to the formation 
of diastereomers and bioactivity depended on the extent of conformational disruption of the 
model peptide’s amphipathic α-helix. Enantiomeric amino acid substitution leads to the 
formation of diastereomers of which bioactivity depended on the extent of conformational 
disruption of the peptide’s amphipathic α-helix. Merrifield [27] proposed that the general 
amphipathic conformation of the antimicrobial peptides must be retained for activity and that 
sequence composition and charge are important, but that peptide length, chirality and amide 
bond direction are not. It is apparent that these peptides are not involved in chiral interaction 
with a receptor molecule or membrane lipids. This may not be the case with iturin A, because 
the possibility of stereospecific interaction with target cell membranes has been suggested. 
Phospholipases in the target cell membrane may act as chiral receptors, as activation by iturin 
A of these enzymes in membrane vesicles of Saccharomyces cerevisiae was observed [30]. 
Furthermore, changes in the invariant tetrapeptide moiety, β-amino fatty acyl-L-Asn2-D-Tyr3-
D-Asn4, resulted in diminished activity. An inactive derivative of iturin A, iturin C, has a L-
Asp2 instead of the L-Asn2 in this moiety [18, 31]. The O-methylation of the D-Tyr3 residue in 
iturin A decreased antifungal and haemolytic activity [32] and also modified its interaction 
with membranes [12, 33]. Another explanation for the loss of bioactivity could be that the 
amino acid modifications change the conformation of the iturin, resulting in inactive 
membrane complexes (no ion-pore formation and membrane disruption). It was found that the 
configuration of the β-NC14 residue did not greatly influence conformation of synthetic iturin 
A2 diastereomers in DMPC liposomes. Cyclisation on the other hand had a marked influence, 
resulting in a different conformation from that of the linear iturin A2 analogues (Chapter 4). In 
this chapter we report on the influence of cyclisation, the configuration of the β-NC14 residue, 
and omission of L-Asn2 on bioactivity. The lytic activity was investigated using M. luteus and 
rabbit erythrocytes as target cells. Antimicrobial activity was evaluated by growth inhibition 
of the gram-positive bacterium, M. luteus, and the fungus, Botrytis cinerea, one of the post-
harvest pathogens of stone fruit and grapes. 
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6.2 Materials 
Freezer stock cultures of Microcuccus luteus were donated by Dr. B. J. H. Janse, department 
of Microbiology, University of Stellenbosch. Spores from Botrytis cinerea were donated by 
Prof. G. Holz, department of Plant Pathology, University of Stellenbosch. Chloroform (99%), 
NaCl, Triton X100, NaCl, potassium dihydrogen phosphate, disodium hydrogen phosphate, 
formaldehyde, sucrose, glucose, sodium citrate and citric acid were from Merck (Darmstadt, 
Germany). Bacto® tryptone, Bacto® tryptone soy broth and Bacto® yeast-extract were from 
DIFCO Laboratories (Detroit, USA). Agar powder was form Saarchem (Krugersdorp, South 
Africa) and low electroendosmosis-type agarose (LE-D1) was from Whitehead Scientific 
(Brackenfell, South Africa). Lysozyme was from Serevac (Cape Town, South Africa), 2-
amino-2-(hydroxymethyl)-1,3-propandiol-hydrochloride (Tris-HCl) was from Boehringer 
(Mannheim, Germany) and Sepharose 4B from Pharmacia (Uppsala, Sweden). Casein and 
Tween 20 were from Fluka Chemicals (Buchs, Switzerland). Microtitre plates (NuncTM-
Immuno Maxisorp) were from Nalge NUNC International (Roskilde, Denmark), Falcon® 
tubes from Becton Dickinson Labware (Lincoln Park, USA) and microcentrifuge tubes and 
culture dishes from Quality Scientific Plastics, USA. Bee-venom melittin and dimyristoyl-L-
α-phosphatidylcholine (DMPC) were from Sigma Chemical Co. (St. Louis, USA). 
Acetonitrile (HPLC-grade, UV cut-off 190 nm) and methanol (HPLC-grade, UV cut-off 205 
nm) were from Romil LTD (Cambridge, UK). Nova-Pak analytical C18 HPLC columns and 
0.45 mikron HV membrane filters were from Millipore-Waters (Milford, USA). Nitrogen gas 
was supplied by Afrox, South Africa. Analytical grade water was prepared by filtering glass 
distilled water through a Millipore Milli Q® water purification system. The linear lipopeptides 
(6-Beta, 7-Beta and 8-Beta) and some cyclic analogues (cyclic 8-Beta and cyclic 7-Beta) were 
synthesised using the Fmoc-polyamide peptide synthesis protocol and purified using semi-
preparative HPLC (described in Chapter 2). 
6.3 Methods 
6.3.1 RP-HPLC of peptides 
Analytical reverse phase HPLC was done on a C18 Nova-Pak column, as part of the purity 
assessment of the lipopeptide peptide preparations (reported in Chapter 2). Capacity factors 
(k’) for the HPLC separations were calculated using the following relationship: 
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k’ = (Rt-Rto) / Rto 
  with Rt the retention time of the peptide and Rto that of acetone or water 
Concentration dependent and time dependent aggregation were also monitored using the 
HPLC analysis described in Chapter 2, section 2.3.6.2. Freshly prepared solutions, containing 
an 8-Beta diastereomeric mixture (concentration range from 0.5 to 5.0 mg/mL), were 
subjected to HPLC to assess concentration dependent aggregation. A freshly prepared solution 
of 7-Beta (1.0 mg/mL) was also subjected to HPLC. After long term storage (±30 days) of the 
peptide solution at −20oC and it was again subjected to analytical HPLC. Aggregation was 
calculated from the following relationship: 
Aggregation        =                                HPLC peak area of aggregated peptide                .    
                                        peak area of free peptide + peak area of aggregated peptide 
6.3.2 Interaction with phospholipid vesicles 
6.3.2.1 Preparation of DMPC-vesicles [adapted from 34] 
Small unilamellar vesicles were prepared by dissolving 50 mg dimyristoyl-L-α-
phosphatidylcholine (DMPC) in 2 mL chloroform in a detergent free thin-walled glass test 
tube. The chloroform was evaporated either under a stream of N2 or under vacuum (rotary 
evaporator) to leave a thin film of lipid on the glass. The lipid was resuspended in 5 mL 50 
mM Tris.HCla, pH 8.3 containing 150 mM NaCl and flushed with N2. The lipid-buffer 
mixture was sonicated in a sonic bath, half filled with 0.1% (v/v) Triton X100b, until the 
solution was translucent. The transition temperature of DMPC is 24oC and it was therefore 
necessary to prepare the liposomes at 35-37oCc. The duration of sonication was 60±10 
minutes (the duration depended on lipid concentration, temperature and energy transfer). The 
preparation normally resulted in roughly uniform sized SUV’s of about 25 nm in diameter. 
(Liposomes have been reviewed extensively in [34, 35].) 
                                                 
a
 Any buffer may be used. The osmotic balance of the vesicle must, however, be maintained to prevent swelling, 
lysis or dehydration. The inert N2 atmosphere is important to stop oxidation of unsaturated fatty acids. 
b
 The detergent in the sonic bath helps with the energy transfer. It is very important to obtain maximum agitation 
of the lipid by optimal positioning of the enclosed test tube in the sonic bath. Bath temperature must also be 
controlled to prevent overheating. 
c
 Liposome formation under the transition temperature (gel state to fluid state) is thermodynamically 
unfavourable and best results are obtained at temperatures above the transition temperature. 
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6.3.2.2 Interaction with DMPC [13, 35] 
The DMPC liposomes, prepared as described in 6.3.2.1, were “purified”  by passing it through 
a Sepharose 4B column (±100 mL bed volume) equilibrated with 0.15 M NaCl (35oC). The 
peak fraction absorbing at 330 nm was collected and used directly in the peptide interaction 
study. The purified DMPC vesicles were mixed in a 125:10 ratio (m/m) with each of the 
HPLC purified linear lipopeptides (diastereomeric mixtures). The mixture was then loaded on 
a Sepharose 4B column (4.5 mL bed volume), saturated beforehand with phospholipid to 
reduce non-specific interaction, and eluted with 0.15 M NaCl at 35oC. Peptide concentration 
was determined by UV spectrophotometry using standard curves described under 6.3.2.3. 
Lipid concentration was determined by the Stewart assay described under 6.3.2.4. 
6.3.2.3 Determination of peptide concentration 
Standard curves were used to determine the peptide concentration in DMPC liposome 
interaction experiments. Peptides were dissolved in 0.15 M NaCl; a concentration series from 
10 to 100 µg/mL was prepared in triplicate and measured at the appropriate wavelength. The 
absorbance of Tyr-containing peptides was measured at 264 nmd and that of 6-Beta at 224 nm. 
The concentrations of the Tyr-containing peptides in the biological activity experiments were 
calculated from a standard curve of Tyr-concentration at 274 nm.  
Three samples per Tyr standard concentration was analysed and the linear curve fit (r2) was 
determined as 0.997 with the linear relationship: 
mmol Tyr/mL = (Absorbance at 274 nm) / 320.3 
6.3.2.4 Determination of phospholipid concentration by the Stewart assay 
The Stewart assay [36] utilises the tendency of phospholipids to form complexes with 
ammonium ferrocyanate in organic solutions. A 0.1 M ammonium ferrothiocyanate solution 
was prepared by dissolving 27.03 g ferric chloride hexahydrate and 30.4 g ammonium 
thiocyanate in 1 L analytical grade water. The solution is stable at room temperature for up to 
6 months. The determination of phospholipid concentration was done on a small volume of 
the stock DMPC (or sample) diluted to 2 mL with chloroform to which 4 mL of the 0.1 M 
ammonium ferrothiocyanate solution was added. The mixture was vortexed for 15 seconds 
                                                 
d
 The interference of the DMPC at 264 nm was less than at 274 nm, the wavelength of maximum absorption for 
the Tyr. 
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and then centrifuged for 5 minutes at 300-500 g to separate the two phases. The chloroform 
layer was removed with a Pasteur pipette and its absorbance determined at 485 nm. The 
concentration of the lipid was determined from a DMPC standard curve with a concentration 
range from 0-500 µg/mL. Six samples per DMPC standard concentration was analysed and 
the linear curve fit (r2) was determined as 0.999 with the linear relationship: 
µg DMPC = (Absorbance at 485 nm − 0.00384) / 7.35 x 10−4 
6.3.3 Lytic and antimicrobial activity 
6.3.3.1 Assay for haemolytic activity [adapted from 18] 
Alsevier’s solution (2.05% (m/v) glucose, 0.42% (m/v) NaCl, 0.8% (m/v) sodium citrate, 
0.055% (m/v) citric acid, pH 7.20) was mixed in equal volumes with freshly drawn rabbit 
blood and left at 4oC for at least 72 hours. Erythrocytes were harvested by centrifugation for 
15 minutes at 800 g, after which the cells were washed three times with 0.9% NaCl in 0.15 M 
phosphate buffer (phosphate buffered saline, PBS) at pH 7.2. The erythrocytes were then 
resuspended in PBS in an equal volume to the original blood volume, counted and diluted to a 
final cell count of 2.5x108 cells/mL. The peptide preparations, dissolved in 50% 
acetonitrile/water, were mixed with 2.5x107 erythrocytes in PBS and incubated for 30 minutes 
at 37oC. The mixtures were then centrifuged for 5 minutes at 1000 g and 100 µL of each of the 
supernatants carefully drawn of and pipetted into a microtitre plate. Absorbance 
measurements at 540 nm of each determination were done on a Titretek Multiscan Plus 
microtitre plate reader. The negative control was 50% acetonitrile/water and 100% haemolysis 
was determined using 200 µg/mL bee-venom melittin. Curve fitting and HC50 (peptide 
concentration inducing 50% haemolysis) calculations were done with the aid of PRISM 2.01 
from GraphPad Software Inc. Data were fitted to a sigmoidal dose response curve with 
variable slope with the equation: 
Y  =  Bottom + (Top−Bottom) / (1+10 (logHC50
 
x Hill slope)
 ) where 
Bottom = Y−value at the bottom plateau; Top = Y value at the top plateau 
logHC50 = X−value of response halfway between top and bottom 
Hill slope = Hill coefficient or slope factor, controls slope of curve 
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6.3.3.2 Cultivation of organisms 
A small aliquot (10 µL of a 100 times dilution) of freezer stock of M. luteus was streaked on 
L-Broth containing agar culture plates (1 g tryptone, 0.5 g yeast extract, 1g NaCl and 2 g agar 
in 100 mL) and grown for 48 hours at 37oC. Single colonies were harvested and grown at 
37oC in L-Broth to mid-log phase (A600 of 0.6±0.2 for M. luteus). 
6.3.3.3 Lysis of M. luteus protoplasts [adapted from 23, 24] 
Protoplasts of M. luteus were prepared by incubation of the bacteria under membrane 
stabilising conditions with lysozyme. An aliquot (1 mL) of M. luteus, grown to log phase in  
L-Broth, was washed twice with 30 mL of 20 mM Tris-HCl (pH 8) by centrifugation (15 min. 
at 800 g). The washed cells were suspended in 20 mM Tris-HCl (pH 8) containing 20% 
sucrose and further diluted to yield an absorbance reading at 600 nm (A600) between 0.4 and 
0.6. The suspension, with 0.5 mg/mL lysozyme added, was incubated at 37oC for 30-90 
minutes. The incubation time depended on the activity of the lysozyme. The protoplast 
formation was monitored by evaluating aliquots under a light microscope. Healthy M. luteus 
tends to form cell groups (2 to 4 or more cells), easily distinguished under a light microscope, 
while the protoplasts tend to be single cells. After incubation the protoplasts were washed by 
centrifugation in 20 mM Tris-HCl (pH 8) containing 20% sucrose by centrifugation (5 
minutes at 800 g). The protoplasts were then resuspended in 20% sucrose solution and diluted 
to an A600 of 0.35 and used immediately. Peptides (200 µg in 20 µL 50% acetonitrile/water) 
were mixed in the cuvette with 480 µL protoplasts. The lysis of protoplasts was monitored 
spectrophotometrically over 5 minutes at 600 nm in a Beckman DU650 spectrophotometer. 
The positive control was 20 µL of 0.15 M NaCl and the negative control 20 µL of 50% 
acetonitrile/water. 
6.3.3.4 Microbial growth inhibition 
A gel-diffusion microassay for growth inhibition was developed in a microtitre plate [37] by 
adapting the ultra-sensitive radial diffusion assay [38] and a microtitre liquid broth assay [39]. 
M. luteus was grown to log phase in L-Broth. The cells were harvested and washed by 
centrifugation (15 min. at 800 g) in Dulbecco’s PBSe. The washed cells were resuspended in 
PBS to an A600 of 0.60 ± 0.02. An 1% low endosmosis agarose gel, containing 1.0 g tryptone 
                                                 
e
 Dulbecco’s PBS (pH 7.4) contained 8.00 g/L NaCl, 0.2 g/L KCl, 0.2 g/L KH2PO4 and 1.15 g/L Na2HPO4. 
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soy broth and 0.02 g Tween, was heated to 45 ± 0.5oC. An aliquot (1000 µL) of the gel, at 
45±0.5oC, was then mixed thoroughly (vortexed for 20 seconds) with 100 µL of the diluted M. 
luteus in a microcentrifuge tube. This mixture was pipetted (70 µL/well) carefully into eight 
wells of a microtitre plate, coated beforehand with 0.5% casein in PBS to prevent non-specific 
peptide interaction [40]. In order to ensure an even spread of gel in each well, a “reversed 
pipetting” technique was adopted: 70 µL of the heated mixture was drawn up with a Gilson 
pipette by fully depressing the plunger and then pipetting into the centre of the well (without 
touching the well bottom or sides) by depressing the plunger to the first “click”. The first row 
(or blank row) in the microtitre plate contained 70 µL gel and Dulbecco’s PBS (10:1 
ratio).The prepared microtitre plate was closed and left for 30 minutes to set at room 
temperature. The peptide solution (30 µL of 10 to 1000 µg/mL stock solution in a 50% 
acetonitrile/water mixture) was placed into the centre of the well (without touching the gel or 
well sides) using a Hamilton syringe. The lightly sealed plate was then incubated at 37oC and 
microbial growth was monitored after 7 to 8 hours by light dispersion readings on a Multiscan 
Titertek Plus microtitre plate reader at 620 nm (A620). The microbial growth was again 
measured after 16 to 18 hours. Growth was terminated by addition of 20 µL 6% formaldehyde 
in methanol when A620 of control wells, containing 30 µL of 50% acetonitrile/water instead of 
the peptide preparation, reached 0.250±0.05. 
 
6.3.3.5 Activity against post-harvest pathogen Botrytis cinerea 
Different amounts (1, 2, 4 or 8 µg) of the peptide preparations, in 10 mL of a 50% 
acetonitrile/water mixture, were spotted on a TLC plate. Each spot (5 mm in diameter) was 
carefully marked with a pencil and the peptide was applied inside the circle using a 
micropipette. The plate with the adsorbed peptide was allowed to dry and then sterilised under 
a UV light (254 nm) for 24 hours. Dry spores (3 mg/500 mL) from B. cinerea were suspended 
in 2% sucrose and applied evenly onto the plate using an aerosol applicator. The plate was 
then incubated in a humid chamber at room temperature for 4 days after which 2% sucrose 
was sprayed on the plate. The incubation was allowed to continue for a further 26 days to 
allow visible growth to take place (brown-grey patches/areas on plate). Growth in each spot, 
containing peptides, was then visually evaluated. 
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6.4 Results and discussion 
6.4.1 Hydrophobic interaction 
The analytical C18 HPLC results of each of the longer lipopeptides were reported in Chapter 2. 
The shorter peptides 5-Beta and 6-Beta aggregated to such an extent at very low 
concentrations that HPLC was not a viable option for purification or analysis. This 
aggregation is attributed to their more pronounced hydrophobic nature derived from the higher 
molecular mass fraction of the β-NC14 residue in these peptides. 
Concentration dependent aggregation was illustrated by using 8-Beta as model peptide. An 
inverse linear relationship was observed between initial 8-Beta concentration and the 
formation of an early eluting aggregate (Rt=4.5 minutes) during analytical C18 HPLC (Fig 
6.1). This aggregate formation corresponded with the decrease of the major fractions eluting at 
9.4 and 9.6 minutes (Fig. 6.1). 
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Figure 6.1    Concentration dependent aggregation of freshly prepared 8-Beta as evaluated 
using analytical C18 HPLC of peptide at different concentrations. The linear 
gradient was developed over 13 minutes with 0.1% TFA in water as solvent A 
and acetonitrile and 10% A as solvent B at a flow rate of 1mL/min; 20 µL of the 
sample was injected per analysis. The linear fit (r2) of both lines is 0.99 and their 
slopes are identical except for its sign (+/−). 
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Analytical HPLC of the cold-stored 7-Beta showed the formation of stable aggregates that 
could be separated by HPLC (Fig. 6.2). Self-aggregation or micellisation, related to the 
hydrophobic/hydrophilic balance, depended on the length of the iturin A2 analogue peptide 
chain. It was also found that aggregation in solution leads to loss of bioactivity, as will be 
discussed later on in this chapter. 
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Figure 6.2     HPLC chromatograms of the purified 7-Beta diastereomeric preparation using a 
150mm X 3.9mm C18 Nova-pak column with freshly prepared sample (A) and 
after long term storage at −20oC (B). A linear gradient was developed over 13 
minutes with 0.1% TFA in water as solvent A and acetonitrile and10% A as 
solvent B at a flow rate of 1 mL/min. Approximately 25 µg peptide was injected 
per HPLC analysis. 
A 
B 
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The capacity factors (k') for each of the longer HPLC purified lipopeptides were calculated 
from retention times on a C18 analytical HPLC column and compared with the molecular mass 
fraction of β-NC14 residue in each peptide in Fig. 6.3 (capacity factors of the detected 5-Beta 
and 6-Beta aggregates ranged between 0 and 5 and were not taken into account). The 
molecular mass fraction of β-NC14 residue in each peptide (and possibly their hydrophobicity) 
correlated to some extent with their HPLC retention as the more polar octalipopeptides eluted 
earlier than the shorter heptalipopeptides in which the D-Asn2 residue was omitted. Blocking 
of the N- and C- termini by cyclisation should, theoretically, lead to a more hydrophobic 
peptide, due to the removal of charged groups from the peptide structure. The cyclic 
lipopeptides, however, eluted earlier than the linear peptides from the ODS (C18) column and 
therefore lower k' values were observed. The loss of retention is probably the result of weaker 
ion-pairing between the mobile phase trifluoroacetate and the peptide, and not because of 
decreased hydrophobicity. The formation of neutral, more hydrophobic species, because of 
ion-pairing with trifluoroacetate, or better interaction with the stationary phase coated with the 
ion-pairing agent, probably caused in the longer retention of the linear peptides. Although the 
diastereomeric peptide pairs are chemically identical, except for the β-carbon configuration of 
the β-NC14 residue, their HPLC retention were different (Fig. 6.3, also refer to Table 6.1). 
This is probably because of conformational differences between the peptide pairs leading to 
differences in retention and solution hydrophobicity. 
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Figure 6.3    Comparison between HPLC capacity factors of eight iturin A2 analogues and the 
molecular mass fraction of β-NC14 in each peptide. 
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The influence of peptide moiety of iturin A on the incorporation/association with membranes 
was investigated by using the three linear analogues (6-Beta, 7-Beta and 8-Beta) and 
liposomes consisting of DMPC. DMPC was chosen because phosphatidylcholine is one of the 
major phospholipids found in eukaryotic membranes and specific interaction by iturin A with 
this phospholipid has also been demonstrated by other investigators [13, 41]. A 125:10 lipid to 
peptide ratio was chosen, to promote interaction and limit liposome fusion and aggregation. 
The peptide-vesicle complexes were separated from the free peptide using gel-permeation 
chromatography (Fig. 6.4). 
A positive correlation between k'-values and the incorporation of the linear peptides in lipid 
vesicles was observed—the higher the k'-value, the more peptide associated with lipid vesicles 
(Table 6.1). The peptide/lipid ratio, before vesicle collapse, was 2 to 3 times lower for 7-Beta 
and 8-Beta than the 0.1 ratio reported for iturin A with DMPC [13], probably because 
differences in peptide structure and the lower peptide concentration used. The tendency of  
6-Beta to self-aggregate in solution (as discussed in Chapter 2) markedly decreased its 
capacity to interact with the vesicles (Fig. 6.4, Table 6.1). Minimal interaction between a 
control peptide containing the iturin heptapeptide moiety, Fmoc-GNYNQPNS, and the 
vesicles was observed (Table 6.1). 
Table 6.1      Summary of the data from hydrophobic character investigation of the iturin A 
analogues using octadecanoylsilane matrices (C18-HPLC) and DMPC liposomes.  
Peptide 
C18 HPLC 
capacity factor 
(k’) 
mole peptide  
mole DMPC 
6-Beta I, II 2.69 (aggregate) 0.019 
7-Beta I (L), II (D) 5.86; 6.00 0.046 
8-Beta I (D), II (L) 5.36; 5.45 0.037 
cyclic 7-Beta I (D), II (L) 5.52; 5.62 not determined 
cyclic 8-Beta I (L), II (D) 5.21; 5.36 not determined 
Fmoc-GNYNQPNS 3.74 0.004 
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Figure 6.4     Example chromatograms of separation of the vesicle-peptide mixtures on a  
4.5 mL Sepharose 4B column (left). The chromatograms on the right show the 
chromatography of the free peptides. Chromatography was done at 35ºC and 
fractions were eluted with 0.15 M NaCl. 
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6.4.2 Biological activity 
6.4.2.1 Haemolytic and lytic activity 
The haemolytic activity of antimicrobial peptides generally relates to their hydrophobicity as it 
was found that the more hydrophobic peptides tended to be more haemolytic [42]. This 
relationship between hydrophobicity and haemolysis was not observed for the iturin A2 
analogues (Fig. 6.5, also refer to Table 6.1). 
 
 
 
Peptide 
Heamolysis of 
rabbit 
erythrocytes 
(HC50, µM) 
8-Beta I (D) 125±7 
8-Beta II (L) 201±3 
Cyclic8-Beta I (L) 169±8 
Cyclic 8-Beta II(D) 61±9 
 
 
 
 
Figure 6.5     Haemolysis of rabbit erythrocytes (2.5x107 cells/mL) by the octalipopeptide 
analogues. The mean of quadruplicate observations and standard error of the 
mean (SEM)  are shown for each data point. The table shows the peptide 
concentration at 50% haemolysis (HC50). Values were calculated from curve 
fitting using PRISM 2.01 sigmoidal curve with variable slope. 
All the octalipopeptides showed haemolytic activity (Fig. 6.5). The haemolytic activity (50% 
haemolysis at 61 ± 9 µM) of synthetic iturin A2 (cyclic 8-Beta II (D)) was comparable with 
results obtained in literature with natural iturin A [18]. All the shorter, more hydrophobic 
heptalipopeptides were not haemolytic in the concentration range used (HC50>250 µg/mL). 
Cyclisation improved haemolytic activity, but omission of the L-Asn2 residue in the 
heptalipopeptides markedly decreased haemolytic activity. From these results it could also be 
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deduced that the configuration of the β-NC14 residue has a strong influence, as cyclic 8-Beta II 
(D) and 8-Beta I (D), both containing the same β-NC14 enantiomer, were the most haemolytic 
octalipopeptides at low concentrations. The activity of the linear 8-Beta (I) decreased at higher 
concentration, probably because of self-aggregation in solution. 
It is known that iturin A preferentially associates with membranes, such as erythrocyte 
membranes, containing neutral phospholipids such as phosphatidylcholine (PC) and 
cholesterol [13, 18]. It was, however, found that iturin A does interact with M. luteus 
protoplasts [23, 24], containing phosphatidylglycerol in its membrane [25]. The lytic activity 
of the diastereomeric peptide mixtures towards M. luteus protoplasts was initially used as an 
assay for bioactivity, as the lysis can be monitored spectrophotometrically by measuring light 
dispersion at 600 nm.  
About a tenfold lower lytic activity for the cyclic 8-Beta mixture than that reported in 
literature [23, 24] was observed (Fig. 6.6). Some of this lower activity could be attributed to 
the contamination of the synthetic iturin A2 with its diastereomer or aggregation of the peptide 
in the stock solution because of the high concentrations used in the assay. Other factors might 
be the inhibition of activity by contamination of divalent cations (Mg2+ and Ca2+) and the 
omission of sodium in the form of sodium-EDTA from the reaction mixture [23, 24]. The 
higher activity reported in early literature [23, 24] may also be the consequence of synergism 
between iturin A and the co-produced surfactin, a biosurfactant [43] that could have 
contaminated their iturin A preparations. The total absence of lytic activity of 6-Beta 
preparation is probably because of its self-aggregation in solution and the omission of the 
invariant Tyr3 (Fig. 6.6). This residue is important in the interaction with target cell 
membranes [9, 13, 32, 33]. Although this method had a low sensitivity, it could be deduced 
that peptide length is a crucial factor in lytic activity—this activity decreased with peptide 
length: 8-Beta>7-Beta>6-Beta (Fig. 6.6). A more reliable method was consequently developed 
to test antibacterial activity [37]. 
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Figure 6.6    The lytic activity of iturin A2 analogues (400 µg/mL) towards M. luteus 
protoplasts. The average of two determinations is shown. 
6.4.2.2 Inhibition of microbial growth 
The iturin A2 analogues were tested against M. luteus as this is one of the bacterial species 
sensitive to iturin A. Growth inhibition of M. luteus was observed after 7.5 hours incubation at 
37oC over a broad concentration range for all the Beta II lipopeptides, whereas the Beta I 
peptides showed only inhibition at very high concentrations (Figs. 6.7-6.9). The results for the 
Beta II peptides also corresponded with the initial results obtained from the lysis of M. luteus 
protoplasts, with the activity of 8-Beta, cyclic 8-Beta >7-Beta (refer to Fig 6.6). The highest 
activity at 30 µg/mL was observed for cyclic 8-Beta II (D), with 8-Beta II (L) the most active 
linear lipopeptide (Fig. 6.9). The M. luteus growth inhibition observed for cyclic 8-Beta II (D) 
(38 ± 3% by 20 µg/mL) was comparable to values reported in literature for iturin A [23]. 
Some growth inhibition was retained, but nearly all was alleviated after 17 hours of incubation 
at 37oC (Figs. 6.7-6.9). It is therefore highly probable that these iturin A2 analogues have 
mostly bacteriostatic activity over the concentration range investigated (3-480 µg/mL). 
Overall the iturin A2 analogues in this study were not strongly antibacterial if compared with 
gramicidin S. Gramicidin S was used as test peptide in the development of the gel-diffusion 
microassay and 50% growth inhibition of M. luteus was obtained with only 3-5 µg/mL peptide 
[37]. 
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Figure 6.7     Percentage growth of M. luteus in the presence of the linear lipopeptides as 
observed over a period of 17 hours incubation at 37oC. The mean of 
quadruplicate observations and the SEM are shown for each data point. The 
100% growth was taken as the light dispersion at 620 nm of the controls. 
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Figure 6.8     Percentage growth of M. luteus in the presence of the  cyclic lipopeptides as 
observed over a period of 17 hours incubation at 37oC. The mean of 
quadruplicate observations and the SEM are shown for each data point. The 
100% growth was taken as the light dispersion at 620 nm of the controls. 
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A 70-100% loss in activity against M. luteus was observed if the peptide solutions were stored 
at −20oC for a week (results not shown). This loss corresponded with the aggregation 
observed when the stored peptide solutions were subjected to analytical HPLC (Figs. 6.1, 6.2). 
It could therefore be deduced that the aggregation in solution leads to diminished activity and 
that the aggregates in solution are not the active form of the peptides. 
Cyclisation did not necessarily improve the activity of the peptides as could be seen from 
results depicted in Fig. 6.9. In the case of 7-Beta I (L) and 8-Beta I (D) their cyclisation to 
form cyclic 7-Beta II (L) and cyclic 8-Beta II (D) improved activity. The reverse was true for 
the other four peptides. The most haemolytic peptide, the synthetic iturin A2 (cyclic 8-Beta II 
(D)), also showed the highest activity at low concentration against M. luteus. 
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Figure 6.9    Percentage growth of M. luteus in the presence of the 30 µg/mL of each of the 
lipopeptides as observed over a period of 17 hours incubation at 37oC. The mean 
of duplicate observations for 7-Beta II (D) and cyclic 7-Beta II (L) and 
quadruplicate observations for the rest of the peptides and the SEM are shown 
for each data point. The 100% growth was taken as the light dispersion at 620 
nm of the controls. 
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The inhibition of growth of B. cinerea in the presence of the lipopeptides was used to assay 
the antifungal activity. A mixture of the 8-Beta diastereomers, at a concentration of 200 
µg/mL, did not inhibit the germination of B. cinerea spores as with witnessed with 
fluorescence microscopy [43]. In a previous study by Levitt [44], however, antifungal activity 
was observed for a diastereomeric mixture of a linear octalipopeptide analogue of iturin A2 
with L-Pro6 as C-terminal and L-Gln5 as N-terminal. 
A TLC-based assay of the germination of spores and growth of B. cinerea over a 30 day 
period was used because of the advantage of multiple determinations under comparative 
conditions (Fig 6.10). The observed antifungal activity of these analogues may be highly 
influenced by the testing method, as is the case with many bioassays. This technique has some 
limitations such as uneven spore growth and possibility of inactivation of the peptide 
preparation by the SiO matrix. The limited amounts of high purity and fully characterised 
peptide preparations (refer to Chapters 2 and 3) prevented in depth investigation of antifungal 
activity. The results from this assay, however, confirmed results obtained by Holz [43] as 
three of the four linear peptides showed little or no antifungal activity. A surprising result was 
the activity of the linear 7-Beta I (L), which is currently under further investigation. All the 
cyclic peptides, except cyclic 8-Beta I (L) showed antifungal activity, with cyclic 8-Beta II (D) 
or synthetic iturin A2 the most active. 
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Figure 6.10   Germination and growth of B. cinerea over a 30 day period at room temperature 
on a TLC plate with different amounts of adsorbed lipopeptide.  
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6.5 Conclusions 
Hydrophobic interaction is generally regarded as an important factor in evaluating the 
potential of amphipathic compounds to associate with cell membranes. However, as 
demonstrated in this study, hydrophobicity does not always correlate with the biological 
activity of these compounds. The interaction with lipid membranes is not only influenced by 
the hydrophobicity of the lipopeptides, but also their tendency to aggregate in solution. The 
linear lipopeptides with the lowest HPLC capacity factors (k’) tended to associate less with 
DMPC. The longer lipopeptides had substantial interaction with lipid membranes. 
Self-aggregation of the iturin A molecules occurs in the target cell membrane [8, 9]. It was 
also observed that the iturin A2 analogues still have the ability to self-aggregate, but the 
peptide preparations that aggregated in solution lost most of their antibacterial activity. This 
observation corresponded to the low bioactivity observed for an O-methylated derivative of 
iturin A, MeTyr-iturin A, having a ten times higher tendency to aggregate than iturin A [9]. 
Cyclisation mostly improved activity and the longer octalipopeptides showed better overall 
bioactivity than the shorter heptalipopeptides. These results may be related to the 
conformation adopted in the membrane. It was shown in Chapter 4 that the structures of the 
octalipopeptide pair (8-Beta I (D), II (L)) differed largely from that of their cyclic analogues. 
One exception is cyclic 8-Beta I (L) which is almost totally inactive. There was little 
difference between the membrane bound structures of the cyclic 8-Beta pair, thus the 
inactivity of this peptide is probably related to the chirality of its β-NC14 residue.  
No clear correlation between the association of the iturin analogues with sodium or the other 
alkali metal ions and bioactivity could be found. It was however observed that the less active 
linear peptides, 7-Beta and 8-Beta, associated with either one ion or two alkali metal ions, 
while the overall more active cyclic peptides associated only with one alkali metal ion (refer 
to Chapter 5). 
For many antimicrobial peptides it is generally found that the more hydrophobic peptides tend 
to be more haemolytic [42], but this was not the case for iturin A and its analogues. A 
dramatic decrease of haemolytic activity was previously reported for a more hydrophobic 
iturin A derivative in which the D-Tyr3 residue was methylated [23]. On the other hand it was 
found that O-acetylation of the L-Ser8 residue, also producing a more hydrophobic iturin A 
derivative, had less influence on its activity [23]. In this study it was found that cyclisation, 
Stellenbosch University http://scholar.sun.ac.za
 6.23
the Asn2 residue and the configuration of the β-NC14 are important in the lytic activity on 
rabbit erythrocytes. The synthetic iturin A2 (cyclic 8-Beta II (D)) and its linear analogue (8-
Beta I (D)) were the most haemolytic at low concentrations, therefore interaction with a chiral 
receptor, in which the β-NC14-L-Asn2-D-Tyr3 tripeptide moiety is important, is possible. 
Candidates for this interaction may be phospholipases (refer to the discussion in the 
introduction). 
The length of the peptide moiety seems to be important in the lytic activity against M. luteus 
protoplasts as the longest peptides were the most active. All the peptides Beta II peptide 
inhibited M. luteus growth, but it is unclear if inhibition was due to cytotoxic or cytostatic 
activity. This activity corresponded with interaction with ODS matrixes (HPLC retention) as 
the diastereomer in each pair with the highest k’ and was the most active. Cyclisation did not 
necessarily improve the activity of the peptides and the configuration of the β-NC14 residue 
had little or no discernible influence on the growth inhibition of M. luteus. The mechanism of 
action against the gram-positive M. luteus is clearly different from that of haemolysis. 
The activity against B. cinerea depended mainly on cyclisation as three of the four cyclic 
peptides showed some inhibition of this fungus. The exceptions were that 7-Beta I (L) also 
showed antifungal activity and that cyclic 8-Beta I (L) was inactive. This may be the result of 
the TLC based assay as hydrophobicity does have an influence on the “release” of the peptide 
from the polar SiO matrix for interaction with the fungal membrane. Cyclic 8-Beta I (L) had 
the lowest HPLC capacity factor of all the longer peptides and 7-Beta I (L) the second highest. 
The influence of the configuration of the β-NC14 on B. cinerea growth is not clear, but as with 
haemolytic activity and M. luteus growth inhibition, the most active peptide was synthetic 
iturin A2. 
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Chapter 7  
Conclusions 
This is the first study where synthetic deletion analogues of iturin A2 and synthetic iturin A2 
have been used to investigate the structure-function relationship of this cyclic antifungal 
lipopeptide, produced by strains of Bacillus subtilis. The aim of this study was the elucidation 
of iturin A’s mechanism of action, known or/and hypothesised features of which can be 
summarised as follows [1, also see Chapter 1]: 
• the recognition of the target cell membrane containing phosphatidylcholine and membrane 
sterols [2]; 
• interaction with the membrane lipids and the induction of aggregated structures [3, 4] of 
unknown size and conformation in the membrane in which the invariant Tyr plays a 
significant role [4, 5]); 
• the activation of phospholipases [6], either directly and stereoselectively or indirectly by 
exposing of the phospholipid substrates to enzymatic action; 
• the association with Na+ and K+ [7] with the possibility of ionophoric action [1] or the 
formation of active complexes including these ions; 
• the formation of weakly anion selective ion-conducting pores [8]; 
• the ultimate leakage of cellular contents and release of vesicles (containing membrane 
lipids and iturin A) leading to cell death [9]. 
In this concluding chapter some of these above features will be related to the results obtained 
by synthesising and characterising eight analogues of iturin A2. Before proceeding, just a short 
summation of the results from the initial synthesis and purification of these analogues. In the 
synthesis of four linear iturin A2 analogues, in which the conserved tetrapeptide moiety,  
(L-Asn2-D-Tyr3-D-Asn4) was sequentially omitted, high yields (92.5 ± 5%) and good coupling 
efficiencies per step (98.7 ± 0.9%) were obtained. Cyclisation of the heptalipopeptide (7-Beta) 
and octalipopeptide (8-Beta) was successful, although the yields of 33% and 30% respectively 
after purification, were somewhat lower than that of 46% reported by Bland [10] for the 
synthesis of iturin A2. The low yields obtained during cyclisation could have been the result of 
8-Beta being predominantly in the “S”-conformation, which would cyclise less readily than 
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the “W”-conformation (structures were predicted by HyperChem®4.5, Chapter 4).  Protected 
precursors was not used in the cyclisation steps, which could also explain the lower yields that 
were obtained. Product losses occurred during the preparation and handling of the 
lipopeptides, because of aggregation and adsorption to plastic. This hydrophobic character of 
the peptides hampered both the purification of some of the shorter analogues and the 
bioactivity studies. The association of the peptides with sodium also influenced the ESI-MS 
experiments described in Chapter 5. The fraction of sodiated peptide in the peptide 
preparation increased with each sample drying procedure and therefore re-purification of 
samples was necessary on occasion. The synthetic products clearly retained some of the 
reported physical character of iturin A [1], namely the tendency to aggregate, adsorption to 
hydrophobic surfaces and affinity for alkali metal ions. It was also found that the biological 
activity (Table 7.1) of the iturin A2 analogues was influenced by peptide length, configuration 
of the β-NC14 residue and cyclisation. 
Table 7.1      Summary of the bioactivity of the iturin A analogues (refer to Chapter 6) 
 
Peptide 
 % M. luteus growth 
inhibition after 7.5 
hours incubation by 
30 µg/mL peptide 
Activity against 
Botrytis cinerea (lowest 
inhibiting amount in 
TLC assay, µg) 
Haemolysis of 2.5x107 
rabbit erythrocytes  
(HC50, µM) 
8-Beta I (D) 8±5 >10 125±7 
8-Beta II (L) 41±4 8 201±3 
cyclic 8-Beta I (L) 4±2 >10 169±8 
cyclic 8-Beta II (D) 54±2 2 61±9 
7-Beta I (L) 0 4 > 250 
7-Beta II (D) 33±5 >10 > 250 
cyclic 7-Beta I (D) 0 4 > 250 
cyclic 7-Beta II (L) 45±5 4 > 250 
Enantiomerically pure β-D-aminotetradecanoic acid was not available at the time our 
synthesis, although this compound was synthesised recently using a protocol reported by 
Bland [11]. The racemic nature of the β-NC14, incorporated into the peptides during the final 
coupling step, invariably led to the production of diastereomeric mixtures of the peptides. It 
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was, however, possible to purify eight of the lipopeptides to chiral purity of about 80% and 
higher (up to 100% for two of the cyclic peptides). The peptides were otherwise of high 
chemical purity as indicated by ESI-MS, HPLC and amino acid analysis. It was necessary to 
ascertain the absolute configuration of the β-NC14 residue in each of the hepta- and 
octalipopeptides and for this a method using chiral liquid chromatography linked to ESI-MS 
was developed (Chapter 3). The introduction of the racemic β-NC14 residue into the iturin A2 
analogues, however, added a new dimension of chirality to this investigation. The 
stereoselectivity of iturin A’s biological action could subsequently be investigated. Evidence 
of stereoselectivity, was obtained from the activity of the iturin A2 analogues on rabbit 
erythrocytes. The synthetic iturin A2 (cyclic 8-Beta II (D)), and its linear analogue (8-Beta I 
(D)), were found to be the most haemolytic in these experiments (Chapter 6). Haemolytic 
activity depended on cyclisation, the inclusion of Asn2 residue in the peptide chain and the 
configuration of the β-NC14. The stereoselectivity is probably conferred by the β-D-NC14-L-
Asn2-D-Tyr3 tripeptide moiety, which may interact with a chiral receptor such as a 
phospholipase. A future investigation of the influence of the four octalipopeptides and 
possibly other octalipopeptide analogues on phospholipase activity may clarify the 
stereoselectivity aspect. 
The tendencies of the peptides to aggregate and interact with hydrophobic matrices were 
exploited to evaluate the contribution of these factors to bioactivity (Chapter 6). The two 
longer linear lipopeptides, 8-Beta and 7-Beta, both associated with phosphatidylcholine (PC) 
vesicles, but the high tendency of 6-Beta to self-aggregate almost negated its membrane 
interaction and bioactivity. The length of the peptide moiety seems to be important in the lytic 
activity against Micrococcus luteus protoplasts as the longest peptides were the most active 
with the order of activity: 8-Beta>7-Beta>6-Beta. All the Beta II peptides showed growth 
inhibition of M. luteus, but are not regarded as strongly antibacterial (Table 7.1). This activity 
correlated with the interactions of these compounds with octadecanoylsilane matrices (HPLC 
retention) as the diastereomer in each lipopeptide pair with the longest retention was the most 
active. Although all the lipopeptides retained the ability to self-aggregate, aggregation in 
solution diminished activity against M. luteus. It is therefore feasible to propose that the 
aggregates formed in solution are not the active forms of these peptides, or iturin A. The 
activity against M. luteus is largely dependent on hydrophobic interaction and independent of 
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the chirality of the β-NC14 residue and cyclisation, therefore displaying a different mechanism 
of action than that responsible for haemolysis. 
The structural investigation of the four octalipopeptides, reported in Chapter 4, revealed that 
the configuration of the β-NC14 residue had little effect on structure, whereas cyclisation had a 
pronounced influence. Two backbone conformations of 8-Beta, namely one with a distorted 
W-structure and the other with a twisted S-structure, were also predicted by structure 
modelling. NMR analyses of 8-Beta indicated a slow conversion between two conformations 
of 8-Beta, possibly a W↔S equilibrium, in which the Tyr residue side chain, and probably 
one or more of the Asn residues, are influenced. Circular dichroism (CD) spectra in buffer 
also revealed a large difference between the structures of the 8-Beta diastereomers. The 
structures of the 8-Beta pair did not differ much in phosphatidylcholine liposomes, therefore a 
single backbone conformation, that differs from that in buffer, possibly including a type II β-
turn, was induced in the lipid environment. This backbone conformation is also different from 
that of the cyclic 8-Beta pair. The difference between the cyclic and linear octalipopeptides 
was also observed in the predicted structures. The induction of a secondary conformation in 
lipid membranes takes place in both the linear and cyclic octalipopeptides. Evidence of the 
ordering of the cyclic octalipopeptides in stacked aggregates to form antiparallel β-sheets in 
PC containing membranes was also obtained by CD. It is proposed that this formation of 
stacked antiparallel β-sheets in membranes that is one of the essential steps necessary for 
biological activity. The low haemolytic activity of the linear octalipopeptides is therefore 
probably related to their structures the membranes. The existence of the so-called 
“hydrophobic hub”, formed by the invariable Tyr residue and the β-NC14 residue, is also a 
possible key to bioactivity, specifically antifungal activity [1, 4, 5]. This hydrophobic hub is 
absent in the predicted S-structure of the linear octalipopeptides and may be influenced in 
cyclic 8-Beta I (L) by the configuration of the β-NC14 residue, resulting in good overall 
bioactivity of only the synthetic iturin A2 (cyclic 8-Beta II (D)) (Table 7.1, Chapter 6). The 
observed antifungal activity (Fig 7.1) of the cyclic heptalipopeptides (cyclic 7-Beta I (D) and 
II (L)) and the linear heptalipopeptide (7-Beta I (L)) is probably because of the close proximity 
of the Tyr residue to the β-NC14 residue diminishing the influence of the configuration of the 
latter. The absence of the invariant L-Asn2 in the heptalipopeptides, however, led to lower 
activity in most cases. Future investigation into the structures of the heptalipopeptides, and 
improved antifungal assays, may help to explain some of these results. 
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The ability of iturin A to bind cations has been observed by several investigators [1, 6], but 
the precise role of this interaction is still unknown. This tendency of the iturin A2 analogues to 
bind the residual sodium from glassware and in the solvents, prompted investigation of this 
interaction with alkali metal ions using ESI-MS (Chapter 5). The cationisation of the 
lipopeptides stabilised the peptide structure under ESI-MS conditions. This stabilisation is 
sequence specific in that the labile L-Gln-L-Pro and D-Tyr-D-Asn
 
bonds are protected or 
shielded by the association with sodium and other alkali metal ions. Two intrinsic binding 
sites for non-solvated sodium ions, situated in the N-terminal peptide moiety, β-
NC14NYN(Q), and the C-terminal peptide moiety, NQPNS, were identified in 8-Beta. The 
structure of natural iturin A2 includes a type II β-turn in each β-NC14NYN and QPNS [12]. 
The predicted low energy S-structure of 8-Beta includes two turns approximating true β-turns 
(Chapter 4). The interaction of non-solvated sodium with most of the amide bond oxygens in 
the predicted turns, specifically that of β-NC14, Asn2, and Tyr3 in the one turn and that of Gln5 
and Pro6 in the other, and with the Gln5 side chain, would provide the protection against low 
energy fragmentation of sodiated 8-Beta species. The omission of amino acid residues in the 
β-NC14NYN tetrapeptide moiety in the shorter lipopeptides led to a reduced capacity to bind a 
second larger cation. The order of alkali metal ion selectivity of all the lipopeptides was 
Na+>K+>Rb+, indicating a size limitation in the interaction cavity or cavities. The cyclic 
lipopeptides preferentially associated with only one cation, probably in the interior of the 
peptide ring of the cyclic peptides. Little or no di-cationised complexes were found, because 
the inclusion of a second cation may be unfavourable because of electrostatic repulsion. It is 
therefore proposed that alkali metal ions can bind in either one of the two β-turns in the 
peptide ring of natural iturin A molecule, with the carbonyl oxygens as chelating atoms. 
In conclusion it is proposed that iturin A’s mechanism of action on eukaryotic cells possesses 
the following features: (a) after interaction, iturin A molecules self-assemble in antiparallel β-
sheets in the phospholipid membrane, (b) alkali metal ions are chelated by the peptide ring 
carboxyl oxygens to form of anion selective pores that cause the slow increase in membrane 
conductance, and (c) phospholipases are stereoselectively activated, in which the β-D-NC14-L-
Asn2-D-Tyr3 tripeptide moiety or hydrophobic hub of β-NC14 and D-Tyr is important. These 
actions result in total membrane disruption and leakage of the cellular contents and 
interference with any of the steps should influence iturin A’s activity. 
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